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Abstract 
Using bioinformatics we have identified stm3071 as a possible regulator of 
anaerobically induced genes involved in metal homeostasis (Price-Carter et al., 
2001) and the aim of this study is to determine the function of stm3071 and 
define the conditions that induce its expression. Cobalt is required for 
incorporation into cobalamin (vitamin B12) which is important during S. 
Typhimurium infection. Vitamin B12 is synthesised de novo under anaerobic 
conditions and is required for metabolism of 1,2-propanediol and ethanolamine 
which act as sources of carbon and nitrogen when Salmonella is in the gut 
(Raux et al., 1996; Thiennimitr et al., 2011). Therefore, sensing Co2+ from the 
environment, and maintaining Co2+ homeostasis, to avoid metal-mediated 
toxicity, is required for vitamin B12 biosynthesis.   
Using λ-red based mutagenesis we have constructed a deletion mutant in order 
to investigate the function of stm3071. We examined the effect of mutation on 
the utilisation of 1,2-propanediol under anaerobic conditions and ability to 
produce vitamin B12. We have also tested the effect of mutation on tolerance to 
cobalt both aerobically and anaerobically. In order to monitor conditions in 
which Pstm3071 is switched on, a Pstm3071::lacZ transcriptional fusion was 
constructed in plasmid pRS415. Levels of β-galactosidase activity were 
measured in the presence of cobalt in both Δstm3071 and SL1344 (wild type 
strain) under anaerobic conditions.  
Anaerobic growth experiments and B12 assays showed that stm3071 is not 
essential for growth or synthesis of vitamin B12. In addition, cobalt tolerance in 
both aerobic and anaerobic conditions was unaffected. However, as measured 
by β-galactosidase assay, our data suggests that Pstm3071 expression is induced 
in the presence of cobalt in the deletion mutant. In contrast, we observed no 
difference in expression of Pstm3071 in the presence or absence of cobalt in 
SL1344.  
 
 
 
10 
 
Acknowlegments 
PhD is one person’s work, however similarly to other things in life my PhD 
journey would not be what it became without help I had received from number 
of people. Thank you all for being part of these years. 
Firstly, I would like to thank my PhD supervisor Dr Clare Taylor. Clare, no words 
can describe how grateful I am. Most of all, thank you for the opportunity to 
work in your lab. Thank you for every lab meeting, every scientific discussion, 
and every scientific disagreement. Also I would like to thank you for allowing me 
to take part in conferences, public engagement events and in becoming an 
active member of our SfAM Society. Thank you for sharing your passion with 
me and for teaching me everything you could. Thank you for those years that 
allowed me to grow substantially not only as a scientist but also as a person. 
Thank you for believing in me when I no longer did.  
I would like to thank technical team of Microbiology lab. Special thanks to Patri 
for your support and keeping the lab in the right order. It was great to have you 
there in my most difficult PhD days. 
I thank my office pals for being there in good and bad times. Special thanks to 
Lucy and Karolina for being there when I needed it the most. 
I would like to thank Jana. Thanks for being my best conference, Twitter and 
SfAM committee pal. Thank you becoming one of my closest friends and for 
assurance that no matter what I knew you would be there for me. We were on 
the same boat and that is what brought us together – you’re one of the best 
young scientists I know and I am proud to be your friend. 
I would also like thank my best friend Magda. Buka, we were in this together 
ever since we arrived in Edinburgh. Thanks for being there for me and for being 
able to encourage me and to cheer me up when even chocolate and wine were 
not helping. Thank you for never doubting me.  
I thank the School for the financial support throughout my PhD and for 
scholarship I received to go to my dream conference in New Orleans. Here, I 
would like to leave special thanks to Bob Wright and Mark Darlison for their 
support. 
Special thanks to the SfAM Society for being such a great family. Thank you for 
all the funding I had received from you and all opportunities given. Special 
11 
 
thanks to Clare and Mark for their encouragement, support and many great 
scientific and non-scientific conversations.  
Lastly, I thank my parents for their continuous support and encouragement. And 
my sister – even so far apart - for the closest relationship, and unconditional 
belief that I could do it. 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
Abbreviations 
°C Degree Celsius  
µM Micromolar  
amp ampicillin  
ABC ATP-binding cassette 
AMPs antimjicrobial peptides 
ATP adenosine triphosphate  
BCA bicinchoninic acid 
BLAST Basic local Alignment Search Tool 
bp base pair  
BSA bovine serum albumin 
CAMPs cationic host defence peptides 
cat chloramphenicol  
CBP Corticosteroid-Binding Protein  
CFU Colony Forming Unit  
CNB12 cyanocobalamin 
COG cluster of orthologue 
DNA Deoxyribonucleic acid  
DTT Dithiothreitol  
EDTA Ethylenediaminetetraacetic acid  
ECF energy coupling factor 
EMSA electromobility shift assay 
h hour 
13 
 
HIF-α hypoxia inducible factor alpha 
IPTG Isopropyl-β-Dthiogalactopyranoside 
kb Kilo base 
kDa Kilo Dalton  
LB Luria-Bertani medium  
Log Logarithmic phase 
LPS lipopolysaccharide 
M molar 
min minute 
ml millilitre 
MW molecular weight 
NCBI National Center for Biotechnology Information 
NCE Non carbon essential medium 
NO Nitric oxide 
NRAMP Natural Resistance Associated pattern 
OD Optical density 
ONPG ortho-nitrophenyl-β-galactoside 
ORF Open reading frame 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
pM Picomolar 
PEP phosphoenolopyruvate 
PPD 1,2-propanediol 
PPC plants and prokaryotes conserved 
14 
 
RNA Ribonucleic acid 
RPM Revolutions per minute 
S second 
SCV Salmonella containing vacuole 
SDS PAGE Polyacrylamide gel electrophoresis 
SPI Salmonella pathogenicity island 
T1SS Type I secretion system 
T3SS Type III secretion system 
T5SS Type V secretion system 
TCA cycle tricarboxylic acid cycle 
tet tetracycline 
TF transcription factor 
TLCC Taylor Laboratory Culture Collection 
TLRs Toll-like receptors 
TNF Tumor necrosis factor 
WT Wild type 
 
 
 
 
 
 
 
 
15 
 
1 Introduction 
 The genus Salmonella 1.1
The genus Salmonella is classified into two species, Salmonella enterica and 
Salmonella bongori, which are thought to have diverged from a common 
ancestor more than 100 million years ago (Doolittle et al., 1996) . Salmonella 
enterica has been intensely studied and there are six known subspecies: 
enterica, salamae, arizonae, diarizonae, houtenae and indica (Brenner et al., 
2000; Crosa et al., 1973). In contrast, there has been scant investigation of S. 
bongori and our knowledge of this species is therefore limited, although recent 
work suggests that S. bongori lies evolutionarily somewhere between 
Salmonella and E. coli (Fookes et al., 2011). 
1.1.1 Salmonella enterica 
S. enterica subspecies are further subdivided into at least 2500 serovars.  
Serovars are determined by serotype which are further categorised into six sub-
groups using the Kauffman-White scheme. This scheme discriminates 
serotypes based on variations in the lipopolysaccharide (O antigen), capsular 
antigen (K or Vi antigen) and flagellar antigens (H antigen) (White 1926, 
Kauffman 1966). Notably, Vi antigens are only found in three pathogenic 
serovars:  Typhi, Paratyphi C and Dublin (Eng et al., 2015). Given the 
complexity of subspecies and serovar naming, salmonellae are normally 
described by omitting the subspecies. For example, Salmonella enterica 
subspecies enterica serotype Typhimurium, is shortened to Salmonella ser. 
Typhimurium or S. Typhimurium (Brenner et al., 2000). 
 Importance of Salmonella as a pathogen 1.2
According to epidemiological analysis there are 93.8 million cases of human 
gastroenteritis caused by Salmonella species occurring globally each year, of 
which 80.3 million are foodborne and 155,000 are fatal (Majowicz et al., 2010). 
Approximately 99% of these infections are caused by S. enterica subsp. 
enterica (I). 
Salmonella infections affect mostly elderly, very young and 
immunocompromised patients.  S. Typhimurium experimental infection in mice 
can be used as a model for the life-threatening human pathogen S.Typhi that 
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causes typhoid fever. Although the incidence of S. Typhi infections worldwide is 
decreasing, the occurrence of non-typhoidal salmonellosis is increasing 
(Majowicz et al., 2010). In addition, due to the increasing incidence of antibiotic 
resistant isolates of S. Typhimurium (Yoke-Kqueen et al., 2008) an 
understanding of how the pathogen survives and investigation of unknown 
virulence factors is crucial and urgently required for developing novel 
antimicrobial strategies.   
 Clinical manifestations 1.3
Given the clinical outcomes of Salmonella infections in humans, salmonellae 
are broadly grouped into either typhoid or non-typhoid Salmonella (NTS). There 
are four main clinical manifestations seen in humans which are gastroenteritis, 
bacteraemia, enteric fever, and chronic carrier state (Darby & Sheorey, 2008).  
1.1.1 Gastroenteritis 
Gastroenteritis is an inflammatory condition of the gastrointestinal tract, caused 
by NTS, usually accompanied by symptoms such as nausea, diarrhoea, 
vomiting and abdominal pain. Such infections are considered ‘mild’ with a short 
incubation period of (6 – 12 h) and are usually self-limiting (Crump et al., 2008).  
At risk groups are more susceptible to NTS infections and tend to experience 
more severe symptoms. 
1.1.2 Bacteraemia 
Bacteraemia can occur when salmonellae invade the intestinal barrier and end 
up in the bloodstream. If the infection is severe, septic shock can lead to death. 
Although almost all serotypes of Salmonella can cause bacteraemia, it is most 
commonly associated with NTS infection where approximately 5% of those 
infected will develop bacteraemia (Woods et al., 2008)  
1.1.3 Enteric fever 
Enteric fever is the collective term for typhoid fever, caused by S. Typhi, and 
paratyphoid fever, caused by S. Paratyphi A, B and C (Connor & Schwartz, 
2005). Enteric fever is the exclusively human infection as the serovars involved 
only affect humans.  Infection arises following ingestion of bacteria in 
contaminated water or food, or following exposure to contaminated faeces.  
Incubation period is usually at least one week and initial gastroenteritis-like 
17 
 
symptoms are followed by the onset of fever (Bhan et al., 2005). As well as 
developing high grade fever (> 38.2°C to 41.5°C) in the second week of 
infection, patients can go on to develop further complications such as slow heart 
rate, muscle pain, enlarged liver, enlarged spleen and rose spots which can 
appear on the chest and abdomen. In serious cases, haemorrhage can occur 
which result in bloody diarrhoea (Kuvandik et al., 2009).  
1.1.4 Chronic carrier state 
Approximately 4% of patients with enteric fever may become chronic carriers of 
S. Typhi or Paratyphi bacteria (Bhan et al., 2005). This is defined as the 
shedding of bacteria in the stools for more than a year after the infection. In 
contrast, NTS is associated with only a 0.1% likelihood of carrier state 
(Hohmann, 2001). 
  Pathogenicity, transmission and disease 1.4
Salmonella infects both human and animal hosts and is a major cause of 
diseases worldwide such as enteric fever, gastroenteritis, bacteraemia and 
systemic infection (Klumpp & Fuchs, 2007). Given the relevant safety of the 
cultivation and natural properties allowing rather uncomplicated genetic 
manipulation, S. enterica was extensively studied and served as a model to 
understand major mechanisms of the infection process.  
Salmonella is able to penetrate the intestinal epithelial barrier and to 
disseminate to the underlying Peyer’s patch (Figure 1.1) (Fields et al., 1986). 
After ingestion, bacteria adhere to ileum of an intestinal mucosa that is nearest 
to the ileocecal valve and becomes translocated via membranous epithelial (M) 
cells. M cells are located in the specialised follicle-associated epithelium (FAE) 
overlying lymphoid aggregates, for instance Peyer’s patches (de Jong et al., 
2012; Fields et al., 1986). M cell features promote adherence and uptake of 
microbes within the lumen which are then translocated to the underlying 
epithelium lymphoid tissue and where the immune response is triggered 
(Kraehenbuhl & Neutra, 2000; Sansonetti, 2004). It was previously 
demonstrated that Salmonella preferentially invades the host through the M 
cells (Clark et al., 1994; Jones et al., 1994; Kohbata et al., 1986; Pascopella et 
al., 1995). The uptake of the bacterium also takes place via engulfment. Antigen 
presenting cells, such as macrophages can recognise and engulf Salmonella 
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which describes an alternative way of entry. Salmonella also evolved the ability 
to invade the enterocytes where it also manipulates cellular structure to cross 
epithelial barriers via dendritic cells (Figure 1.1) (Guo et al., 2007; Sansonetti, 
2004). Once the bacteria cross the mucosal barrier and invade the organism 
reaching the intestinal lymphoid follicles and lymph nodes, some pass through 
to the reticuloendothelial cells and then are spread to liver and spleen (de Jong 
et al., 2012).  
 
 
 
 
 
 
19 
 
 
Figure 1.1. Schematic representation of strategies that allow Salmonella 
spp. to invade and survive within the host (Sansonetti, 2004). Salmonella 
can cross the epithelial barrier via M cells localised in the Peyer’s patches in the 
ileum and possibly colon. Then in subepithelial location can cause macrophage 
apoptosis using injector effectors of the T3SS-1 expressed from SPI-1 and at 
the same time induce inflammation. Salmonella can also switch and express 
SPI-2 which encodes T3SS-2 effectors which allow injection of effector proteins 
and formation of the SCV. That in turn enables bacterium to survive and 
multiply intracellularly. These strategies can trigger infection and systemic 
dissemination at the same time. Alternatively, Salmonella can cross the 
epithelial barrier through the apical pole or pseudopods of the dendritic cells, 
which also supports systemic dissemination of Salmonella (Boumart & Velge, 
2014; de Jong et al., 2012; Sansonetti, 2004).  
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1.1.5 Virulence factors 
Salmonella are thought to have evolved as a pathogen some 100 – 150 million 
years ago (Doolittle et al., 1996) and the genome encodes a variety of factors 
which determine virulence and therefore pathogenicity. Several of these are 
located at discrete genomic loci while several are encoded on the pSLT 
virulence plasmid (Gulig & Doyle, 1993). 
1.1.6 Salmonella pathogenicity islands 
Virulence factors of Salmonella are determined by virulence genes located 
within pathogenicity islands known as Salmonella-pathogenicity islands or SPIs 
(Schmidt & Hensel, 2004). It was established that the presence of virulence 
determinants was acquired by the horizontal gene transfer in the process of 
evolutionary adaptation to the host (A J Bäumler, 1997; Rabsch et al., 2002). At 
least 21 SPIs have been identified in the salmonellae to date (Sabbagh et al., 
2010). However, S. Typhi and S. Typhimurium are known to share eleven 
islands (SPIs1-6, 9, 11, 12, 13 & 16) (Table 1.1) and some of these key SPIs 
(SPIs1-5) will be discussed briefly. 
SPI-1 genes encodes a TS33 along with the sitABCD metal transport operon 
(Mills et al., 1995).  The T3SS is required for invasion of non-phagocytic cells 
and mediation of the translocation of effector proteins into eukaryotic host cells 
(de Jong et al., 2012; Galán, 2001) while the sit genes are required for later 
stages of infection.  SPI-1 genes are expressed under conditions determined by 
the host microenvironment, such as pH, osmolarity, and growth phase. 
According to Schmidt & Hensel, 2004 low oxygen and high osmolarity induce 
invasiveness; while in contrast conditions of high oxygen silence invasiveness 
(Schmidt & Hensel, 2004). There are two-component system global regulators 
such as PhoPQ, EnvZ/OmpR, BarA/SirA, PhoRB and FliZ and Hha, which are 
involved in activation of the virulence cascade (Figure 1.2) (Schmidt & Hensel, 
2004.)  
SPI-2 encodes another T3SS required for intracellular survival which is needed 
for the systemic phase of the disease and proliferation and survival within host 
cells (Ochman et al., 1996). T3SS components encoded on SPI-2 are used by 
bacteria inside the phagosome to prevent phagosome-lysosome fusion and 
enable Salmonella containing vacuole formation (SCV) (Coburn et al., 2007).  
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Major effectors of T3SS-2 encoded on SPI-2 involve SpiC, an actin-binding 
protein that interferes with the hosts cell’s actin cytoskeleton (Hayward & 
Koronakis, 1999), SseF and SseG that interact to ensure intracellular 
positioning of SCV (Deiwick et al., 2006). There are also effectors of T3SS-2 
involved in the process, which are not encoded on SPI-2. These are SifA, that 
maintains phagosomal integrity of the SCV (Ohlson et al., 2008), SifB, PipB, 
PibB2, SseI, SseJ, SseL, SspH2, and GogB (Lavigne & Blanc-Potard, 2008). In 
addition, SPI-2 encodes genes for tetrathionate reductase to enable anaerobic 
growth. However, these are not essential for virulence (Sabbagh et al., 2010). 
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Island Size (kb) Virulence function(s) 
SPI-1 38.8 
T3SS-1, invasion, proinflammatory responses, 
divalent metal cation uptake 
SPI-2 39.8 
T3SS-2, intracellular survival, tetrathionate 
respiration 
SPI-3 (I) 17.3 
Colonisation of GI tract, magnesium uptake 
(SPI-3 (II) & (III) distributed in S. bongori and 
subspecies) 
SPI-4 23.4 T1SS, colonisation of cattle GI tract 
SPI-5 7.6 
T3SS-1 and T3SS-2 effectors, 
enteropathogenesis 
SPI-6 47/58.9 Saf and Tcf fimbriae 
SPI-7 133.6 
Vi antigen, SopE prophage, invasion, 
enteropathognesis, type IV pili 
SPI-9 16.3 Biofilm formation, intestinal colonisation 
SPI-11 14.0 Intramacrophage survival, serum resistance 
SPI-12 6.3 TTSS-2 effector 
SPI-13 19.5 Virulence in chicks 
SPI-16 4.5 Serotype conversion 
 
Table 1.1 Pathogenicity islands shared by S. Typhiumurium and S. Typhi 
and roles in virulence. Adapted from (Gerlach & Hensel, 2007). 
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Figure 1.2. Schematic representation of virulence genes expression 
regulation in S. enterica. Environmental factors have been described to 
modulate expression of SPI-1 genes. Virulence genes are also co-regulated by 
regulatory systems PhoPQ, BarA/SirA, EnvZ/OmpR, PhoRB, FliZ and Hha. 
HilC/HilD displaces a repressor from hilA promoter site which cause HilA to bind 
to invF and prgH promoter site, which induces transcription of InvF and PrgH 
regulating the expression of T3SS virulence genes encoded on SPI-1. Adapted 
from (Schmidt & Hensel, 2004). 
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SPI-3 genes encode for factors important for intracellular survival. This 
pathogenicity island encodes a magnesium transporter MgtCB which is 
commonly present in other intracellular pathogens (Belon et al., 2015). The 
mgtCB operon encodes MgtC, macrophage survival protein, and magnesium 
transport protein MgtB, whose expression is controlled by PhoPQ regulatory 
system (Blanc-Potard et al., 1999). SPI-3 was found to also encode for MisL 
representing a T5SS (type V secretion system) which is known to be similar to 
VirG protein from Shigella flexneri and AIDA-1 protein from entropathogenic E. 
coli. This suggests autotransporter functios responsible for cell-to-cell spread 
are found to enable S. Typhimurium to bind to fibronectin (Blanc-Potard et al., 
1999; Dorsey et al., 2005).  
SPI-4 forms an insertion region of 25 kb similar to those encoding for T1SS 
toxins and effectors required for survival in macrophages (Schmidt & Hensel, 
2004). SPI-4 encodes for SiiE which describes a giant non-fimbrial adhesion 
protein (600 kDa) that was found to mediate binding to the apical side of the 
polarised epithelial cells (Wagner et al., 2014). 
SPI-5 mostly encodes for effector proteins for SPI-1 T3SS-1 including SopA, 
SopB, SopD, SopE, SopE2 and Slrp (Lavigne & Blanc-Potard, 2008; Schmidt & 
Hensel, 2004). This locus is relatively small (7.6 kb) but encodes important 
effectors that take part in key pathogenic events such as membrane ruffling 
followed by bacterial internalisation (McGhie et al., 2009).  
1.1.7 Invasion 
For some time it was considered that the only invasion mechanism occurred via 
a T3SS-1 route also known as a trigger mechanism which involves T3SS-1 and 
bacterial effector proteins (Coburn et al., 2007). However, it is now known that 
another mechanism, called the zipper mechanism is involved in invasion of non-
phagocytic host cells. Trigger mechanism involves cytoskeletal changes that 
are described as ‘membrane ruffling’ (Schlumberger & Hardt, 2006). Effector 
proteins involve SipA, SipC, SopB and SopE2. SipA together with SipC bind 
actin and prevent its depolymerisation (McGhie et al., 2009). Then the effector 
proteins SopB, SopE and SopE2 stimulate Rho GTPases family Rac1 and 
Cdc42, which in turn initiate actin polymerisation via the Arp2/3 complex (Zhou 
& Galán, 2001). Then, once inside the cell, effector SptP inactivates Rho 
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GTPases allowing restoration of actin and at the same time bringing the 
invaded cell to its original state (Murli et al., 2001).  Other T3SS effectors 
subsequently modulate the immune response and survival within the host cell.  
In contrast, the zipper mechanism is initiated by the interaction of a bacterial 
ligand and host cell receptor, which in turn activates a signalling cascade 
leading to localised accumulation of actin and as a result, minor cytoskeletal 
rearrangements (Rosselin et al., 2010). 
 Adaptation to intracellular lifestyle 1.5
1.1.8 Salmonella-containing vacuole formation 
Salmonella is taken up by host cells either by T3SS-1 triggered 
micropinocytosis or via phagocytosis. Effector proteins are then translocated via 
T3SS-2 into the host cell. Following internalisation, the bacterium is enclosed in 
the phagosome which then fuses with the lysosome, acidifies and shrinks down 
to become adherent to the bacterium – a process known as Salmonella 
containing vacuole formation and described in the Figure 1.4 (Haraga et al., 
2008).  
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Figure 1.4. SCV formation and maturation process (Haraga et al., 2008).  
Upon micropinocytosis, a phagosome fuses with a lysosome which results with 
SCV. Then SCV undergoes the maturation process, which is characterised by 
specific endosomal markers. Lysosomal associated membrane proteins LAMP-
1, LAMP-2 and LAMP-3 endosomal markers and GTPase Rab7 as well as 
vacuolar ATPase are associated with trafficking and later time points of SCV 
maturation. SPI-2 T3SS-2 is induced within the SCV and triggers expression of 
the afore mentioned effectors. SifA and BipB2 induce formation of Salmonella-
induced filament (Sif) and regulation of the microtubules – motor accumulation 
of the Sif and SCV. SseJ is a deacylase and SseF together with SseG act on 
microtubules. SCV can persist intracellularly from hours to days. SifA, SifB and 
SseJ proteins localise to SCV and to Salmonella-induced filaments (Sifs).  
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The bacterium senses the acidic environment of the SCV which initiates the 
cascade of various regulatory systems that promote intracellular survival 
including OmpR/EnvZ, PhoP/PhoQ, RpoS/RpoE, PmrA/PmrB, Cya/Cyp as well 
as cyclic diGMP which are involved in resistance to oxidative stress and to 
antimicrobial peptides (Sarnacki et al., 2013). Acidic environment of the SCV 
and concentration of magnesium and calcium ions at 1 mM have been 
observed to influence Salmonella virulence (Hicks et al., 2015; Mouslim & 
Groisman, 2003). There are sensory systems that determine the response to 
the phagosomal environment and trigger the cascade events implicated in 
intracellular survival. PhoQ sensor promotes resistance to the antimicrobial 
peptides (Prost et al., 2007), the domain is bridged to the inner membrane 
aided with metal ion interactions that are responsible for antimicrobial peptide 
sensing (Gunn & Miller, 1996; Prost et al., 2007). Upon phagocytosis bacterial 
surface components undergo serious remodelling and synthesis of enzymes 
responsible for dealing with oxidative and nitrogenous radicals also take place 
(Haraga et al., 2008). 
 
1.1.9 Adaptation within the SCV 
Microarray studies carried out by Eriksson and colleagues (2003) identified 
changes in expression of 919 out of 4451 coding sequences of S. Typhimurium 
of which 384 were upregulated and 535 downregulated (Eriksson et al., 2002). 
In the study, expression profiles of bacterial genes from 4 h after infection in 
murine macrophages were compared to expression profiles of bacteria grown to 
stationary phase in vitro. Interestingly, results showed that only a small 
proportion of genes were upregulated suggesting that intracellular bacteria were 
not in a classical stationary phase (Eriksson et al., 2002a). These changes in 
expression strongly suggest that during transition from the nutrient rich 
environment to the SCV Salmonella undergoes dramatic changes. Additionally, 
4 h post-infection most genes associated with the sifA gene were upregulated; 
SPI-2 regulatory genes were observed to be slightly induced, genes encoding 
for SPI-2 secretion components were moderately induced and genes 
responsible for encoding SPI-2 effectors were strongly upregulated. Conversely, 
SPI-1 genes and LPS encoding genes were found to be down-regulated. 
Results from Eriksson microarray study only confirm, that a strict switch in the 
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regulation of gene expression takes places in Salmonella upon phagocytosis 
events leading to SCV formation. 
The alternative sigma factors were found to also play role in the response to 
nutritional stress associated with the transition to the SCV. Sigma factor RpoS 
controls the expression of Salmonella plasmid virulence spv genes that are 
important in establishing systemic infection (Nickerson & Curtiss, 1997). It was 
revealed that deletion of RpoS resulted in 10-fold decreased virulence in 
comparison to the WT S. Typhimurium (Kazmierczak et al., 2005). It was also 
found that RpoE was responsible for bacterial homeostasis and membrane 
integrity in response to extracytoplasmic stress (such as oxidative stress) and 
deletion of rpoE resulted in S. Typhimurium lethal phenotype for intracellular 
survival in macrophages (Li et al., 2015). It can however be summarised that 
RpoE and RpoS somewhat overlap functionally;  both are important for 
virulence and loss of one of them can be functionally compensated by the other 
(Du et al., 2011; Humphreys et al., 1999). 
Aside from the importance of sigma factors, two-component systems such as 
PhoPQ play a crucial role in SCV transition. The acidic environment of the SCV 
switches PhoP and PmrA (Richards et al., 2012). Two-component regulatory 
systems respond in general to environmental changes such as ion 
concentration (low magnesium, high iron), acidic pH, and presence of cationic 
host defence peptides (CAMPs), also known as antimicrobial peptides (AMPs). 
Those altogether induce major changes and switches the signalling cascade in 
intestinal lumen cells  (Bader et al., 2005; Richards et al., 2012a). 
 
1.1.10 Metabolism in the SCV 
In the SCV compartment glucose serves as a major carbon source for the 
bacterium and it is known to be utilised in a complete TCA cycle (Dandekar et 
al., 2012). Studies show that growth on glucose as the sole carbon source 
switches ppc encoding for phosphoenolopyruvate (PEP) carboxylase that plays 
a vital role in directing the flux into the TCA cycle. However, when ppc was 
missing, the loss was compensated with alternative carbon sources utilisation 
pathways and at the same time no reduced virulence was observed. This, in 
turn indicates that Salmonella has evolutionarily adapted with the ability to 
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switch its metabolism completely upon environmental changes (Tchawa Yimga 
et al., 2006). It also indicates availability of other carbon sources in the 
intracellular environment. Those other carbon sources can also be fed into the 
TCA cycle though transaminase activity.  In the intracellular lifestyle, the host 
provides all the nutrients which are acquired via specific uptake systems (Fig. 
1.5). 
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Fig. 1.5. Schematic representation of various host niches colonised by 
Salmonella and carbon sources utilised (Dandekar et al., 2012). Upon 
ingestion, bacteria first colonise cecal lumen of the gut where L-ascorbate, 
melibiose, propionate, ethanolamine and 1,2-propanediol are available. Then 
bacteria attach to the mucosal layer (where mannose, galactose and glucose 
are available) until they invade macrophages and epithelial cells forming SCV 
(glucose and glycerol). Grey boxes represent predicted carbon sources utilised 
in each environmental niche of the host. Small, grey ovals represent transported 
metabolites at the outside of the bacterial cell and transporters.  
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This survival battle from bacterial side meets the defensiveness of the host 
which leads to dynamics in gene expression as well as the evolutionary 
processes from both sides of the game. Interestingly, carbon source 
metabolism in this aspect serves as a target for not only better understanding of 
the survival strategy but also can be a key to better understanding the virulence 
and aid the search for novel antimicrobial approaches. Microbial defence and 
survival are likely to be limited by the environmental factors of the niche as well 
as the phenotypic traits of the invading bacteria and potential competing 
microbiota (Becker et al., 2006a). Salmonella shows very specific adaptations to 
the environment and the usage of different carbon sources is determined with 
the colonised niche and activated expression of specific transporters (Figure 
1.5). 
Crp as mentioned earlier, acts as a major gene expression global regulator in 
Salmonella. Interestingly Crp through the Csr system was found to also connect 
nutrients and carbon metabolism regulation with virulence factors. It was shown 
that the absence of csrA encoding for regulatory RNA-binding protein lowered 
expression of genes responsible for the utilisation of maltose, 1,2-propanediol 
and ethanolamine, metabolism of tetrathionate and production of hydrogen 
sulphite (Lawhon et al., 2003). It was described by Winter and colleagues that in 
the presence of tetrathionate Salmonella is able to use alternatives to glucose 
as a source of energy (Winter et al., 2010). Another global regulator gene cya 
that encodes for enzyme adenosyle cyclase together with crp (encoding cAMP 
receptor protein CRP) they form cAMP-CRP complex that regulate starvation 
response and thus regulates carbon utilisation genes (Eriksson et al., 2002). 
In 2010, Bowden and colleagues conducted research showing that although 
complete TCA cycle takes place in the Salmonella cell, in the event when 
incomplete TCA cycle takes place it may give bacterium higher rate of survival 
in macrophages suggesting that intermediates can be used in an alternative 
ways. However, within specific host environments complete TCA cycle may be 
advantageous (Bowden et al., 2010). Overall, Salmonella is able to utilise 
glucose combining various pathways to supply both carbon and nitrogen. The 
combination of different pathways provides well balanced management of 
internal metabolites. Additionally, it makes it more difficult to target Salmonella 
infection by blocking key metabolic enzymes (Becker et al., 2006b). 
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Salmonella however, as mentioned earlier, has also evolved with the ability to 
utilise different carbon sources (such as 1,2-propanediol and ethanolamine, 
figure 1.5) and incorporate metabolites into the TCA cycle. In the presence of 
vitamin B12 ethanolamine and 1,2-propanediol can be degraded into acetyl 
coenzyme A that can be directly incorporated into TCA cycle. This takes place, 
in the presence of oxygen or when an alternative electron acceptor is provided 
(Price-Carter et al., 2001). In the event where final electron acceptor is not 
provided ethanolamine and 1,2-propanediol cannot be utilised. Although, the 
spectrum of nutrients available in the gut is complex, it is likely that competing 
microbes limit the accessibility of the substrates that can support fermentative 
growth in the anaerobic environment. Therefore, the ability to utilise non-
fermentable carbon sources gives the bacterium potential advantage over the 
existing intestinal microbiota that only rely on fermentative metabolism  
(Thiennimitr et al., 2011). 
1.1.11 Role of inflammation in nutrient release 
In order to establish the disease Salmonella had to evolve with numerous 
mechanisms that enable the bacterium to overcome many environmental 
factors such as competition, hosts immune system and nutrient stress. 
Throughout its intracellular life Salmonella remains in SCV which is termed as a 
nutritionally deprived environment therefore, the fact that the bacterium is able 
to replicate within the SCV indicates remarkably successful adaptation to this 
intracellular setting (Dandekar et al., 2012). Consequently, an understanding 
how the bacterium has adapted to acquire nutrients is important for developing 
novel strategies for targeting Salmonella infections.  
Neutrophils control S. Typhimurium dissemination which suggest data obtained 
from clinical observations in patients with defects in neutrophil killing 
mechanisms or neutropenia (Winkelstein et al., 2000). Among these patients, S. 
Typhimiurium infection disseminates from the gut which results with 
bacteraemia and often mortality. As a consequence, both neutrophils and 
epithelial cells of the host secrete potent antimicrobial proteins directly into the 
intestinal lumen which might be also responsible for drastic changes of the gut 
microbiota that is associated with the salmonellosis (Barman et al., 2008). 
Interestingly, many studies suggest that inflammatory response in the host is 
beneficial to Salmonella and facilitates its colonisation (Barman et al., 2008; 
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Lawley et al., 2008; Stecher et al., 2007). This inflammatory environment is 
most likely difficult as it requires the bacterium to battle out entire host 
protection mechanisms (including antimicrobial proteins, different nutrient 
availability, and inhibition mechanisms) but might be beneficial to this pathogen. 
It potentially allows the bacterium to anaerobically respire tetrathionate and 
therefore utilise 1,2-propanediol and ethanolamine in a cobalamin-dependent 
manner to successfully outgrow other microbial communities (Winter et al., 
2010).  
 
 Acquisition of metals to support intracellular 1.6
survival  
Intracellular existence of Salmonella and its ability to survive and establish 
infection not only depends on the availability of the carbon sources.  
Certain metals are essential for multiple functions in the biological systems and 
they cannot be displaced by any other molecules. Metals that play known 
biological roles have been classified as essential metals, and these include: Na, 
Mg, K, Ca, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Se, Mo (Waldron & Robinson, 2009). 
Other metals that have not yet been described as playing any biological role 
have been listed as non-essential metals  (Lemire et al, 2013). However, all the 
essential metals, despite their importance, when present in the excess are toxic 
to all living cells.  
Nutrients, such as metals take part in many important processes such as 
bacterial sensing, gene expression regulation and regulation of metabolic 
pathways. Particularly of importance are divalent metal cations that play a role 
in gene responses and act as cofactors in many enzymatic reactions (Eriksson 
et al., 2002a). Some of which are essential, yet their levels are limiting, which in 
turn is strictly associated with expression of the transporting systems. For 
instance Mg2+ was found to be limiting in the SCV. It was reported that 4 h after 
infection in macrophage cells mgtBC involved in Mg2+ transport were highly 
upregulated (Smith et al., 1998). Salmonella has three Mg2+ transporters, 
constitutively expressed CorA, and MgtA and MgtB that were found to be 
expressed when magnesium was limiting (Smith et al., 1998; Snavely et al., 
1989). Interestingly, similar increase in expression of MgtA and MgtB was also 
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observed during S. Typhimurium invasion in epithelial cells which is mediated 
by major virulence regulator PhoPQ system. PhoPQ is known to be involved in 
controlling reaction to antimicrobial peptides, low pH, and response during 
invasion and overall controlling the activity of many genes in response to 
environmental signals (Hicks et al., 2015; Richards et al., 2012 b). Inorganic 
phosphate was also reported to be limiting to Salmonella. It was reported that 4 
h after infection pst genes responsible for phosphate transportation were 
upregulated. Additionally, it is known that SPI-2 genes responsible for 
establishing systemic infection are induced under low phosphate conditions 
which indicates a link to Salmonella virulence (Deiwick et al., 1999). Therefore it 
might be that inorganic phosphate starvation leads to decreased LPS synthesis 
or decreased replication in macrophages (Eriksson et al., 2002a). 
1.1.12 Iron  
Many bacteria, like all living organisms, require transition metals for growth and 
survival. Nearly one third of all proteins and half of all enzymes require at least 
one metal ion in their structure (Andreini et al., 2008; Waldron & Robinson, 
2009). Among those, one of the most important metals is iron. It plays a crucial 
role as a cofactor in many metabolic pathways of both Salmonella and the host 
(incorporated into transferrin, lactoferrin, haem, haemoglobin), therefore both 
pathogen and host compete over it (Schaible & Kaufmann, 2004). Iron however, 
like many other transition metals when unbound appears extremely toxic. Owing 
to its ability to catalyse Fenton chemistry it generates highly reactive hydroxyl 
radicals that are damaging to proteins, membranes and DNA (Lemire et al., 
2013). Iron intensifies oxygen toxicity by catalysing electron transfer from a 
donor molecule to H2O2. Redox-sensing transcription factors regulate reactive 
oxygen species (ROS) and at the same time metal transport systems to ensure 
homeostasis whilst avoiding metal-aided toxicity (Taylor et al., 2009). In the 
presence of high iron concentration Fur protein binds Fe2+ and represses 
transcription of genes involved in iron uptake (Andrews et al., 2003). A genomic 
profiling study showed that around 7% of the Salmonella genome was regulated 
by iron – either directly or indirectly (Bjarnason et al., 2003). Iron is essential for 
Salmonella and as an intracellular pathogen it occupies an  iron-rich niche as 
most of iron is available intracellularly due to the Nramp1 (Natural Resistance 
Associated Protein 1) activity (Atkinson & Barton, 1999). During iron starvation 
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repression of Fur is relieved and transcription of uptake genes is activated. Fur 
also stimulates iron storage by regulating expression of ferritins FtnA, Bfr or Dps 
through small RNA ryhB (Massé & Gottesman, 2002). Fur is involved in 
regulation of virulence genes known to be involved in iron transport (Ikeda et al., 
2005). In S. Typhimurium iron is transported with ABC-type Sit transporting 
system. SitABCD encoding genes are located within SPI-1 and were found to 
be required for mouse systemic infection (Andrews et al., 2003a). Interestingly 
the system was also found to have affinity towards Mn2+, hence it was also 
characterised as MntABCD (Ikeda et al., 2005; Kehres et al., 2002). MntH is 
another regulator that is involved in transporting Mn2+ and is also involved in 
iron uptake, which in the presence of iron is repressed by Fur (Kehres et al., 
2002a). Transporters which in principle have preference towards zinc are also 
known to be involved in iron transport. ZIP transporter is induced both by zinc or 
iron deficiency, ZupT was found to be involved in iron and manganese transport 
in addition to zinc (Cerasi et al., 2014).  
In the event when intracellular iron is not available, bacteria are able to retrieve 
it from iron storage proteins, ferritins. Ferritins not only serve as iron reservoirs 
but also can function as a mechanism of protection from iron-mediated toxicity. 
In S. Typhimurium there are found four ferritins: bactoferritin (Bfr) that accounts 
for majority of the stored iron, ferritin A (FtnA), Ferritin B (FtnB), and DNA-
binding Dps (Velayudhan et al., 2007). Here, Fur also appears to play a role by 
positive regulation of bfr as well as ftnA under high iron conditions and 
negatively regulating ftnB and dps when iron is not available (Velayudhan et al., 
2007).  
Two component system PmrA/PmrB is another two-component system that 
senses and responds to the extracellular iron (Fe3+) levels. This is mainly 
involved in inducing genes leading to an increased resistance to iron levels 
resulting in outer membrane modification (Wösten & Groisman, 1999). 
PmrA/PmrB is induced by high levels of intracellular iron, and downregulates 
pmrA, pmrB, pmrD, pmrF and ugd involved in LPS synthesis and antibiotic 
resistance; where ugd is also co-regulated by low magnesium induced 
PhoP/PhoQ (Mouslim & Groisman, 2003b). Intracellularly those genes were 
found to be repressed, suggesting that Fur repression occurring results with rich 
Fe2+ intracellular levels but not Fe3+. Genes involved with iron acquisition 
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intracellularly were not induced in J774-A.1 infection model (Eriksson et al., 
2002a). Overall it is hypothesised that Fur regulates gene expression in 
response to iron levels and genes that are controlled by Fur are not involved 
with iron but with other functions such as acid tolerance response or virulence 
(Bjarnason et al., 2003; Riesenberg-Wilmes et al., 1996). 
1.1.13 Manganese 
Manganese is another trace element that is required in many cellular 
mechanisms and as mentioned earlier it can potentially substitute iron 
functionally in metyloenzymes and the system responsible for transporting iron 
turned out to have greater affinity towards manganese (Ikeda et al., 2005). 
Manganese is required for manganese superoxide dismutase enzyme SodA 
that plays a role in protection from ROS, and which not so surprisingly is also 
regulated by Fur (Tsolis et al., 1995). Similarly to other transition metals, when 
present in excess, manganese becomes toxic. Metalloregulatory proteins are in 
control of the expression of genes involved in metal acquisition by either 
upregulating or repressing transcription (Que & Helmann, 2000). Here, at the 
same time by regulating virulence those metal ions often serve as an 
environmental signal for switching metalloregulation response strictly linked with 
host invasion. MntR is a manganese-dependent regulator, that just like those 
mentioned earlier regulates expression of both MntH involved in manganese 
transport as well as SitABCD (Ikeda et al., 2005). It belongs to DtxR (diphtheria 
toxin repressor) family of metal-dependent repressors that was very well 
described in B. subtilis (Que & Helmann, 2000). MntR found in S. Typhimurium 
resembles similarities to Nramp2 which is a mammalian metal transporter that is 
known to take part in divalent metal cation transport through the gut epithelium 
based on proton-driven symport (Kehres et al., 2002a). As stated previously, 
MntH was found to have much greater affinity towards manganese. Its 
maximum activity was observed at only 0.1 mM manganese as opposed to 100 
mM ferrous iron (Kehres et al., 2000). As stated earlier SitABCD is involved in 
manganese transport and belongs to ABC-type transporter family. It consists of 
SitA which is a cation binding protein (Kehres et al., 2002b). MntH here is likely 
to function as a proton-coupled divalent cation transporter and SitABCD as an  
ATP-type of transporter, and gets energy for transport from ATP hydrolysis. 
MntH and SitABCD transcription is regulated by MntR and of course Fur 
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possibly simultaneously (Ikeda et al., 2005; Kehres et al., 2002b). Importantly 
both SitABCD and MntH were showed to be implicated in virulence. In 
Nramp1g169 mouse model sitA and mntH were upregulated and were both 
required for complete virulence suggesting that manganese is required for the 
intracellular survival of S. Typhimurium (Zaharik et al., 2004). 
1.1.14 Zinc 
Zinc as another one of those metals that is essential for immunomodulation and 
immune system functioning (Stafford et al., 2013). S. Typhimurium thrives in the 
inflamed gut by expressing ZnuABC described as high affinity zinc transporter 
that overcomes calprotectin mediated zinc chelation. Similarly to other metals 
bacteria compete over zinc with the host resulting in the development of zinc 
sequestration strategies (Liu et al., 2012). Zinc is required for many enzymatic 
reactions as a cofactor, takes part in regulation of replication, transcription, 
translation and also pH regulation and oxidative stress response (Katayama et 
al., 2002). It is suggested that SCV appears in zinc-restricted environment 
therefore it requires high affinity zinc uptake system (Ammendola et al., 2007). 
In S. Typhimurium zinc sensor Zur that belongs to the Fur family acts upon 
ZnuABC expression regulation. Zinc bound Zur represses ZnuABC transcription 
and coordinates with periplasmic protein ZinT. ZinT and ZnuA cooperate in the 
process of zinc acquisition during severe zinc shortage (Petrarca et al., 2010). 
1.1.15 Nickel and cobalt 
In Salmonella nickel and cobalt acquisition mechanisms are a lot less 
described. Nickel is known to be an essential trace element in many 
metalloenzymes such as Ni-Fe hydrogenase. Ni-Fe hydrogenase catalyses 
hydrogen oxidation serving as anaerobic way of gaining energy (Zhang et al., 
2009). In E. coli NikR acts as a repressor of anaerobically expressed nikABCDE 
operon known to transport nickel as a response to high zinc levels (Rowe et al., 
2005; Zhang et al., 2009). NikR covers 99% identity of over 133 amino acids to 
the putative regulator found in S. Typhimurium giving strong evidence of its 
involvement in nickel acquisition especially as it is quite abundant across many 
organisms (Rowe et al., 2005). NikR is also predicted to be involved in 
NikMNQO and NiCoT transporter (Zhang et al., 2009). NikR was described as 
ribbon-helix-helix type of transcription factor (Zhang et al., 2009). In the 
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presence of nicklel, NikR binds DNA resulting with suppression of transcription 
of nikABCDE. In the excess of nickel, there are found low affinity binding sites 
that are active and most likely serve as another way of protection from the metal 
excess (Phillips et al., 2010). 
Cobalt is mainly found in the corrin ring of cobalamin and S. Typhimurium 
different from E. coli, requires cobalt for vitamin B12 de novo biosynthesis 
(Rodionov et al.,  2003) . Amongst genes involved in cobalamin biosynthetic 
pathway there are genes cbiMNQO that share similarities with other high affinity 
ABC-type metals transporters. It is likely that expression of these genes is 
regulated by B12 riboswich. It allows to selectively bind B12 and then to repress 
the expression of target genes. Therefore, levels of CbiMNQO expression might 
not be directly cobalt-dependent but rather be influenced by current B12 
requirement (Dmitry A Rodionov et al., 2003).  
Overall, S. Typhimurium in order to survive developed strategies within the host 
that can be protected from metal mediated toxicity whilst effectively, at the same 
time, being completely able to compete over essential nutrients with the host as 
other gut microorganisms. As a result, this pathogen has evolved with vast 
metal-specific regulatory systems that enable control of the intracellular levels of 
metals, such as Fur, ZntR, MntR, NikR. Some of these regulators act upon a 
particular target gene and some act as global gene expression regulators and 
regulators of particular acquisition systems.  
 Contribution of cobalt to intracellular survival 1.7
Cobalt is an essential trace element for many living organisms as it plays a key 
biological role as the centrally coordinated ion in corrin rings. These corrinoids 
include coenzyme B12 and its cobalamin derivatives being important coenzymes 
in many metabolic reactions (Martens et al., 2002). Zhang et al., (2009) carried 
out genomic analysis to determine that almost all bacterial phyla possess genes 
related to cobalt utilisation (Figure 1.6).  Interestingly, bacteria which have 
adopted a parasitic lifestyle appear to have lost the ability to use both cobalt 
and nickel.  In order to acquire sufficient cobalt for metabolism bacteria possess 
high affinity uptake systems to scavenge it from the environment (Eitinger et al., 
2005). However, when accumulation of cobalt becomes toxic the excess of the 
metal has to be removed from inside the cells by precisely regulated efflux 
systems (Cheng et al., 2011). 
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1.1.16 Cobalt transport 
The best characterised cobalt transport system is the NiCoT family which are 
found amongst a wide variety of bacteria. This family includes at least one 
nickel permease in addition to other proteins with affinities for either nickel or 
cobalt ions (Rodionov et al., 2006; 2003).  The CbiMNQO family is also present 
in a number of bacteria, including Salmonella.  These cobalt transport proteins 
are associated with cobalamin biosynthesis in S. Typhimurium and were found 
to possess conserved domains suggesting their function of tight cobalt 
regulation inside the cell (Raux et al., 1996).  According to Roth et al., (1993) 
these proteins were found to share structural similarities to other members of 
energy dependent membrane transport systems. There were found homologous 
proteins that bore conserved sites suggesting an ABC-transport system.  
According to Blast analysis, CbiO protein appears to belong to an ATP- 
dependent membrane transport protein. It is suspected that CbiO is involved in 
the transport of cobalt as most similar proteins are involved in the active 
transport of metal ions in other microorganisms such as Eschericha, Listeria, 
Citrobacter, Yersinia, Clostridium, Klebsiella, Staphylococcus, Shiglla, 
Enterobacter (Blast analysis of the CbiQ). CbiQ protein is deducted to stabilise 
CbiO as it possesses membrane spanning domains that possibly serve as a 
CbiQ stabiliser. Roth et al., also explains that cbiN and cbiO are likely to encode 
for components of a cobalt active transport system; also they do not show 
significant similarities to other similar systems as anchor peptides with spanning 
membranes evolved more quickly than ATPases thus they are not obvious to 
characterise. 
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Figure 1.6. Distribution of cobalt (and nickel) utilisation genes in bacteria 
(from Zhang et al., 2009).  Phyla in which none of the organisms use cobalt or 
nickel are shown in blue (if containing at least 3 organisms, shown in bold). 
Phyla in which all organisms use both Co and Ni are shown in red (if containing 
at least 3 organisms, shown in bold).  
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1.1.17 Cobalamin pathway in Salmonella    
Scavenging cobalt is required for the vitamin B12 (cobalamin) production that 
was confirmed to be synthesized de novo but only under anaerobic conditions 
(Bobik et al., 1999; Jeter et al., 1984). The coenzyme form of vitamin B12, either 
deoxyadenosylcobalamin or methylcobalamin, is required as a cofactor in a 
number of enzyme-catalyzed reactions (Jones et al., 2013). All salmonellae 
dedicate 1% of their genome to the synthesis of cobalamin (vitamin B12) and 
another 1% of their genome to use this cofactor in support of anaerobic growth 
on two non-fermentable carbon sources - ethanolamine and 1,2-propanediol. 
Thus, the functions of these genes must significantly contribute to Salmonella 
fitness in a natural setting. The entire pathway remains unclear, however it is 
suggested that this ability enhances S. Typhimurium proliferation in an inflamed 
mouse gut (Roth et al., 1993). Cobalamins are complex, non- polymeric 
molecules biosynthesised in cells and present generally in bacteria. Animals 
need cobalamins in their diet, unlikely higher plants (Roth et al., 1993a). In 
humans, vitamin B12 deficiency causes the condition pernicious anaemia and 
also neural tube defects ashumans are unlikely to biosynthesise it. 
Bacteria, for complete biosynthesis of adenosyl cobalamin require around 30 
different enzymes as a coenzyme (Raux et al., 1996). Most of the genes 
involved in vitamin B12 synthesis are clustered in a single operon (cob) mapping 
to 41 minutes on the chromosome (Ailion et al., 1993; Jeter et al., 1984).  The 
cob operon includes 17 cbi genes needed for the synthesis of cobinamide, a 
precursor of vitamin B12  (Chen et al., 1995).   
The structure of B12 coenzyme is built from three major parts. The first 
represents tetrapyrrole-derived corrin ring structure encoded by cobI genes. 
Second part, encoded respectively by cobII genes is dimethylbenzimidazole 
(DBM) nucleotide. And the third part responsible for attachment of the corin ring 
to the DBM, as well as the addition of the coordinating upper coordinating ligand 
for the cobalt, adenosyl or methyl group (Raux et al., 1996). The third part is 
then encoded by cobIII genes (Jeter et al., 1984).  Among bacteria, some of 
them have the ability to produce cobalamin de novo and require it for growth. 
There are also some that only require it to grow but do not possess capacity to 
synthesise coenzyme de novo. S. Typhimurium possesses this ability but can 
only synthesis the coenzyme under anaerobic conditions (Raux et al., 1996). 
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Fig. 1.7. Vitamin B12 and its coenzyme forms (Raux et al., 1996).  
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1.1.18 cbi, pdu and eut genes 
In many bacterial genomes cbi (or cob) genes are clustered with pdu and eut 
genes which are responsible for cobalamin-dependent 1,2-propanediol 
degradation and utilisation of ethanolamine respectively (Klumpp & Fuchs, 
2007).  
The products of pdu operon encodes enzymes required for 1,2-propanediol 
utilisation (Bobik et al., 1999). Their properties allow S. Typhimurium to grow 
using propanediol a sole carbon source which appears in an 
adenosylocobalamin-dependent manner (Adkins et al., 2006). Salmonella 
catabolises propanediol in the way it involves vitamin B12 coenzyme, 
adenosylcobalamin (Ado-CBL) (Bobik et al., 1997). Propanediol is derived from 
the breakdown of fucose and rhamnose (Obradors et al., 1988). These sugars 
are common constituents of intestinal epithelial cells. Therefore, Salmonella 
utilise 1,2-propanediol under anaerobic conditions (Bobik et al., 1997). In 
anaerobic environment 1,2-propanediol is converted into propioaldehyde by an 
Ado-CBL-dependent propanediol dehydratase. Propionaldehyde is then 
metabolised into propanol and propionic acid by  coenzyme-A (Co-A)-
dependent aldehyde dehydrogenase, phosphotransacetylase, propionate 
kinase and alcohol dehydrogenase (Obradors et al., 1988). In the propanediol 
utilisation process energy (ATP molecule) and carbon are provided only if 
reaction takes place anaerobilcally (Jeter, 1990). Experiments conducted with 
mice showed that pdu mutations  refer to the virulence deficiency of Salmonella 
virulent strains (Bobik et al., 1997). Moreover, the pdu operon was revealed to 
be regulated by CsrA and Fis, which are responsible for regulating Salmonella 
pathogenicity (Eriksson et al., 2002). In addition, studies showed that Pdu 
proteins were observed to be 5 times more frequent in significantly more 
virulent strains – such as strain 14025 (Adkins et al., 2006).   
The S. Typhimurium eut gene cluster encodes 17 genes required for the 
degradation and utilization of ethanolamine (eutS, -P, -Q, -T, -D, -M, -N, -E, -J, -
G, -H, -A, -B, -C, -L,-K, -R) (Lawhon et al., 2003). EutBC allows ethanolamine 
metabolism to acetaldehyde and ammonia within carboxysome 
microcompartment that prevents the cell from toxicity of acetaldehyde (Penrod 
et al., 2004). From this reaction, ammonia serves as a source of nitrogen. 
Acetylaldehyde is converted to acetyl coenzyme A by aldehyde oxydoreductase 
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and then subsequently utilised in many metabolic cycles, such as tricarboxic 
acid cycle (Roof & Roth, 1989). Under anaerobic conditions ethanolamine 
utilisation depends on the supply of cobalamin that is synthesised de novo only 
under anaerobic conditions by cob cobalamin biosynthetic genes (Roth et al., 
1996) 
Both of these operons are transcriptionally activated by pocR regulator when 
Salmonella grows on poor carbon sources (Srikumar & Fuchs, 2011). It was 
confirmed by  Heithoff, (1999) that cobalamin synthesis and propanediol 
degradation are required for the intracellular replication of S. Typhimurium. 
There is evidence that genes encoding proteins responsible for propanediol and 
ethanolamine degradation are highly expressed in the gut but only in virulent 
strains  (Garsin, 2010). This ability serves as an indirect contribution to 
Salmonella virulence by providing the useful source of carbon and/or nitrogen 
and also overcoming competition with other microbes that rely entirely on 
fermentative metabolism (Thiennimitr et al., 2011). Additionally, tetrathionate 
was found to be essential as the electron acceptor for the anaerobic growth of 
Salmonella on ethanolamine and 1,2-propanediol (Price-Carter et al., 2001). 
Various studies have linked eut and pdu gene expression with the global 
virulence regulators such as CsrA and Fis that are located on SPI1 serving as 
direct evidence of possible roles in Salmonella pathogenesis (Lawhon et al., 
2003). 
Studies by Bobik et al. in 1999 revealed strong correlation and co-induction of 
propanediol utilisation genes (pdu) and cobalamin synthetic genes (cob) 
revealing that propanediol catabolism is the primary reason for de novo 
synthesis of vitamin B12 coenzymes by Salmonella. To confirm the hypothesis 
independently isolated mutant strains lacking with cobA and pduO genes were 
unable to grow on a 1,2-propanediol minimal medium supplemented with 
vitamin B12 but were capable of growth on medium supplemented with Ado-CBL 
(adenosylcobalamin). Thus, the presence of fully functional pdu operon is 
required for conversion of the inactive form of cobalamin, such as vitamin B12. It 
was described that pduO encodes for protein with adenosyltransferase activity 
which converts vitamin B12 into Ado-CBL that allows 1,2-propanediol 
degradation (Johnson et al., 2001). 
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1.1.19 cbi genes and similarities to stm3071-5 
The putative operon stm3071/3072/3073/3074/3075 was also found to share 
structural similarity to ABC transporters similar to those identified within cbi 
genes (Taylor, unpublished data).  Within stm3071/2/3/4/5 there were domains 
found similar to these found in CbiQ and CbiO.  To date, the precise functions 
of these genes are unknown but we hypothesise that stm3072/3/4/5 are 
involved in cobalt transport while the upstream stm3071 gene may be 
responsible for regulation of the downstream genes (Taylor, unpublished data). 
Interestingly, STM3071 has been shown to be expressed preferentially within 
hypoxic tumour cells (Arrach et al., 2008). 
 Anti-tumour concept 1.8
1.1.20 Hallmarks of cancer disease and therapeutic approaches 
In 2000 Hanahan and Weinberg first coherently defined six common hallmarks 
of cancer: self-sufficiency in growth signals, avoidance of programmed cell 
death (apoptosis), insensivity to growth-inhibitory signals, infinite growth 
potential, sustained blood vessel formation (angiogenesis), and tissue invasion 
and spread to other sites (metastasis) (Hanahan & Weinberg, 2000). Aside from 
these major features of cancer cells there are also many others, such as 
chromosomal abnormalities, inflammation and evasion of the immune system 
and abnormalities in metabolic pathways. In solid tumours, cancer cells outgrow 
healthy tissue and form a lump of cells called tumour (Hanahan & Weinberg, 
2011). The tumour is known to recruit seemingly normal cells that contribute to 
the formation of the tumour microenvironment (Hanahan & Weinberg, 2011).   
Cancer is one of the most dreaded diseases in humans and the most common 
cause of death in the XXI century. New, selective anti-cancer therapies are 
required mainly due to lack of selectivity and high toxicity of the existing 
strategies. Since the XX century, both radiotherapy and chemotherapy have 
advanced into two main therapeutic approaches against cancer. Neither of 
those therapies however eliminate cancer cells and their spread. In addition, 
both chemo- and radiotherapy are toxic to healthy tissues and it is due to: 
incomplete tumour targeting, inadequate tissue penetration, and limited toxicity 
to cancer cells. Hence why such a high rate of morbidity and mortality occurs in 
cancer patients (Minchinton & Tannock, 2006).  
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Selective targeting of the tumour tissue has been the ultimate goal of drug 
delivery research. Over the years controlled drug delivery has advanced 
significantly, however there are still areas where substantial improvements are 
to be made in order to minimise anti-tumour therapy-associated toxic effects 
(Hoffman, 2008). Targeted drug delivery means that the target drug is combined 
with a carrier that in principle should aid that drug to the intended site. An 
effective targeted delivery system must have four characteristics: retain, evade, 
target and release (Mills & Needham, 1999). Different targeting mechanisms 
are needed to distribute the drug to the different parts of the body. Most 
therapies are based on the concept of so-called passive targeting which utilises 
the nature of the tumour. Tumour tissue is characterised by enhanced 
permeation and retention (EPR) effect which is based on the concept that 
molecules of certain size tent to accumulate inside the tumour over the normal 
tissue (Matsumura & Maeda, 1986). The EPR principle is based on exploitation 
of the abnormalities observed in the tumour tissue. These are 
hypervascularisation, aberrant vascular architecture, extensive production of 
vascular permeability factors stimulating extraversion within tumour tissues, and 
lack of lymphatic drainage (Greish, 2010). Administration of macromolecular 
drugs uses the specificity of the tumour tissue to its advantage. Those 
macromolecular drugs, such as lipids, nanoparticles, when injected 
intravenously, selectively accumulate in tumour tissues and remain there for an 
extended period (mainly due to the lack of lymphatic drainage) (Matsumura & 
Maeda, 1986).   
Inflammation and tumour tissue nature have a lot in common. Both are 
characterised by enhanced vascular permeability, which is mediated by number 
of factors such as bradykinin, prostaglandins, nitric oxide, and peroxynitrate 
(Hanahan & Weinberg, 2011). The EPR effect as discussed above has been 
used as a major characteristic in order to selectively deliver macromolecular 
drugs in tumour targeting.  
In addition, necrotic regions of tumours are hypoxic, acidic and often with 
elevated levels of metals (Ionescu et al., 2006). These metals are not 
accumulated in the organism and are processed out through kidneys. However, 
in the case of inflammation this mechanism might be disrupted (Songdej et al., 
2010). Pathological levels of metals are closely related to free radical 
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generation, lipid peroxidation, formations of DNA strand breaks and tumour 
growth in cellular systems (Ionescu et al., 2006). Cobalt exposure itself 
enhances inflammation and this process may be a key contributor to 
malignancy, tumour formation and the onset of cancer  (Saini & Shoemaker, 
2010). Interestingly, studies in various systems have shown that exposure to 
certain metals, such as cobalt, promote a response similar to the hypoxia 
observed in tumours by activating hypoxic signalling by stabilising the hypoxia 
inducible transcription factor 1α (HIF1α) (Vengellur & LaPres, 2004). On the 
other hand elevated levels of cobalamin in blood may be a sign of life 
threatening disease, such as leukaemia (Ermens et al., 2003). 
1.1.21 Targeting tumour with S. Typhimurium 
S. Typhimurium has a unique ability to overcome limitations of standard anti-
cancer therapies. It has the ability to sense and target tumours, to grow in 
tumour-specific microenvironment and the ability to penetrate the tumour. 
Salmonella also exhibits low cytotoxicity and immunogenicity and can be 
relatively easily manipulated genetically (Forbes, 2010).   
The ability to sense tumours is mainly based on sensing hypoxia (less than 1% 
of oxygen). Due to continuous cell proliferation and angiogenesis during tumour 
growth, the newly formed blood vessels are not sufficiently developed and as a 
result not enough oxygen and nutrients are delivered to the tumour tissue. Low 
oxygen attracts facultative anaerobes and favours their proliferation. Genetically 
engineered auxotrophic strains (purine, arginine, and leucine auxothrops) of S. 
Typhimurium were found to colonise tumours better that WT strains (Zhao et al., 
2006).  
Unlike traditional anti-cancer methods such as chemo- and radiotherapy, 
bacteria used to target cancer cells are metabolically active. This allows them to 
penetrate tumour tissue better than synthetic drugs. Another key feature of 
bacteria is their ability to move. Motility allows them to actively move around, 
migrate through complex vascularity of the tumour, and reach it throughout 
(Dang et al., 2001). Highly motile strains such as E. coli and S. Typhimurium 
have been used as microrobots where theranostic molecules were combined 
with motile strains in order to deliver drug directly to the tumour tissue (Park et 
al., 2013). Bacterial accumulation inside the tumour tissue leads to nutrients 
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deprivation and at the same time activation of antitumor immunity lead to 
tumour death (Sznol et al., 2000). 
Tumour nature allows escaping immunity by limiting maturation and infiltration 
of the specialised immune cells. Systemic spread of attenuated S. Typhimurium 
was shown to activate anticancer immunity leading to regression of the tumour. 
S. Typhimurium was shown to activate the inflammasome during early stages of 
cancer through NOD-like receptor. Conserved bacterial components called 
PAMPs (pathogen associated molecular patterns) are recognised by PPRs 
(pattern recognition receptors), also called TLRs (toll-like receptors), which 
recognise molecules shared by pathogens but not host cells (Phan et al., 2015). 
Those bacterial components, such as flagella and, LPS activate TLR signalling 
pathway and induce both innate and adaptive immune responses. NLRP4 
(known as IPAF) is a subset of inflammasomes that recognise cytoplasmic 
bacterial flagellin through bacterial secretion systems (Franchi et al., 2006) 
whilst NRLP3 is activated through endogenous danger signals (damage 
associated molecular pattern molecules), low intracellular potassium 
concentration and, endotoxins. This leads to activation of caspase-1 by 
inflammasomes that results in the cleavage of pro-IL-1β, and pro-IL-18. Thus, 
attenuated S. Typhimurium systemic administration leads to production of pro-
inflammatory cytokines, such as IL-1β, IL-18, TNF-α, and IFN-γ, which in turn 
results in recruitment and activation of macrophages, dendritic cells, and T cells 
– it converts the tumour environment from immunosuppressive to 
immunocompetent (Phan et al., 2015). 
Bacteria can be relatively easily engineered so they can express molecules, 
such as cytotoxic agents, cytokines, RNA interference and prodrug enzymes 
(Zheng & Min, 2016). These agents can be expressed under the tumour-
specific promoters or specifically induced promoters to avoid unwanted 
expression in the healthy tissue (Jiang et al., 2013; LI et al., 2013;  Loeffler et 
al., 2007; Loeffler et al., 2009; Loessner et al., 2007; Ryan et al., 2009). 
Specifically induced promoters come from the external systems, such as L-
arabinose induced PBAD promoter. Mice with murine colon cancer were injected 
with an attenuated Salmonella strain harbouring clyA (gene encoding for 
cytotoxic gene cytolysin). Under the control of PBAD it was shown that clyA was 
expressed leading to tumour regression in mice (Hong et al., 2014). 
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Tetracycline regulated promoter and γ-irradiation-inducible PRecA were also 
investigated as potential promoters for triggering expression of therapeutic 
agents (Ganai et al., 2009; Jiang et al., 2013). Amongst tumour-specific induced 
promoters hypoxia-inducible fumarate and nitrate reduction regulator (Ryan et 
al., 2009) and quorum sensing systems were detected which turns on gene 
expression at high bacterial densities that is usually observed in tumours 
(Swofford et al., 2015). 
New approaches, such as vaccines and biological therapies are providing hope 
with the specific premise of killing of the cancer cells. For instance, bacterial 
therapies exhibited hopeful perspective in targeting cancer more precisely. 
Specifically selected, live, attenuated or genetically modified bacterial strains 
with tumour targeting abilities are capable of multiplying selectively inside the 
tumour cells. Bacteria, as well spores, were used in delivering engineered 
prodrugs and proteins inside the tumour cells (Zheng & Min, 2016). 
It was examined that attenuated S. Typhimurium cells can infect cancerous 
cells in mice. Tumour reduction was observed which was related to the local 
bacterial expression or expression of immune-stimulating molecules IL-18, Fas 
ligand. It was also found that IL-2 encoding Salmonella strains showed better 
suppression of the tumour tissue than Salmonella wild type strains. Attenuated 
S. Typhimurium introduced with human tumour endothelial marker 8 (TEM8) 
DNA was reported to generate a CD8 cytotoxic T-cell response in the animal 
models (Ruan et al., 2009). 
1.1.22 Hypoxia, cobalt and potential candidates for tumour specific 
expression 
Avirulent Salmonella mutants were found to accumulate inside the tumour at 
ratios that range between 250:1 and 9,000:1 and were found to lead to 
reduction or even the cure of cancer in animal models (Pawelek et al., 2003; M. 
Zhao et al., 2006). Necrotic regions of tumours are hypoxic and relatively acidic 
which possibly attract Salmonella to preferentially colonise tumour tissue over 
normal tissue. Arrach and colleagues (2008) used a high-throughput method to 
screen for those Salmonella promoters that are preferentially expressed in 
tumours over healthy spleen tissue. Pstm3071 was noted to be induced inside 
tumour over 2-fold more than in normal spleen tissue. Thus, the data suggests 
that Pstm3071 can serve as a candidate for a hypoxia/tumour specific induced 
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promoter and in the future may be used as a tool for constructing anti-tumour 
recombinant proteins expressed under the specifically induced promoter.  
 Hypothesis and research objectives 1.9
To date Arrach et al., (2008) have observed the upregulation of Pstm3071 when 
Salmonella is present within the solid tumours. Gene stm3071 according to 
NCBI prediction is thought to encode for a potential DNA-binding protein, thus a 
potential transcription regulator of downstream genes. Interestingly, those 
downstream genes are predicted to be involved in cobalt transport. It was 
therefore important to determine NCBI presumed annotation which was based 
on similarities with the cob operon. Interestingly, the conditions observed inside 
solid tumours are similar to those that are thought to induce cob operon 
expression (Srikumar & Fuchs, 2011; Thiennimitr et al., 2011).  
The conditions required for stm3071 promoter upregulation are similar to those 
required for activation of cobalt transport genes along with cobalamin synthesis 
genes (Jeter, 1990). Thus, it is predicted that if Pstm3071 is  upregulated 
selectively in conditions mimicking those present within tumour cells, then 
attenuated Salmonella strains may be used as a novel selective therapeutic tool 
for delivering drugs encoded downstream from the Pstm3071.  
The aim of the study was to determine and characterise the conditions in which 
Pstm3071 is expressed. It was intended to identify whether STM3071 acts as a 
DNA-binding protein and as a consequence, if it is involved in transcription 
regulation of downstream stm3072/3073/7374/3075. Additionally, it was 
important to find out whether the absence of stm3071 would affect Salmonella 
anaerobic growth and exposure to elevated levels of cobalt anaerobically in 
order to find out whether the predicted operon is involved in metal transport. It 
was intended to determine whether stm3071 loss would be essential for 
anaerobic growth in the presence of elevated levels of cobalt. Further, it was 
interesting to determine whether the stm3071 loss would be important in Pstm3071 
activation 
Investigating functions of putative stm3071/3072/3073/3074/3075 operon as 
well as conditions that determine expression of these genes is essential to 
establish possible roles in S. Typhimurium virulence. Understanding of all 
aspects of expression of stm3071/3072/3073/3074/3075 genes could be 
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exploited in terms of seeking for novel antimicrobial and or/anti-tumour 
strategies.   
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2. Materials and methods 
 Bacterial strains 2.1
All bacterial strains used in this study are listed and described in Table 2.1. 
Additionally strains provided as a control for phenotype determination 
experiments are described in Table 2.2. 
S. Typhimurium SL1344 was the wild type strain used throughout this study and 
was obtained from the Taylor Laboratory Culture Collection (TLCC). S. 
Typhimurium LT2 (TR10000) wild type strain and derivatives were kindly 
provided by Professor John Roth (UC Davis, USA) and were used as described 
in appropriate experiments.  S. Typhimurium LB5010a strain was used in site 
directed λ-red mutagenesis. Mutant Δstm3071 was constructed using site-
directed mutagenesis in LB5010a and transduced using P22ϕ into SL1344 and 
TR10000. S. Typhimurium LB5010a galE+ was used as a host strain for P22ϕ 
propagation.  Escherichia coli α-Select strain was purchased from Bioline, UK 
and used for all plasmid propagations; except for plasmid pKD3 which requires 
E. coli DH5α λpir (Bioline, UK). E. coli BL21 (DE3) (Bioline, UK) was used for 
STM3071 protein overexpression.  
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Table 2.1 Bacterial strains used in this study. 
Strain Strain description Reference 
TR10000 Wild type S. Typhimurium LT2 (Ailion & Roth, 
1997) 
TR6583 metE205 ara-9  (Ailion & Roth, 
1997) 
TT11202 metE205 ara-9 metH2355::MudJ $COM 
blue Mud 
(Ailion & Roth, 
1997) 
TT10327 metE205 ara-9 cob-24::MudA (CobI) (Ailion & Roth, 
1997) 
TT17131 metE205ara-9pdu-12::MudJ (Ailion & Roth, 
1997) 
TT17104 metE205ara-9pocR12::MudJ    (Ailion & Roth, 
1997) 
SL1344 Wild type S. Typhimurium  TLCC 
LB5010a S. Typhimurium R
-/M+; galE+ TLCC 
Δstm3071::cm 
LB5010a 
Intermediated deletion mutant resulting with 
stm3071::cm LB5010a 
This study 
Δstm3071 
LB5010a 
Deletion mutant of stm3071 resulting with 
complete removal of stm3071 
This study 
Δstm3071 
SL1344 
P22ϕ was used for transduction of stm3071 
deletion into the WT S1344 strain 
This study 
Δstm3071 LT2 P22ϕ was used for transduction of stm3071 
deletion into the WT LT2 
This study 
E. coli α-Select  F-
deoR endA1 recA1 relA1 gyrA96 hsdR17(rk-
, mk+) supE44 thi-1 phoA Δ(lacZYA-argF) 
U169 Φ80lacZΔM15 λ- 
Bioline, UK 
E. coli DH5α λpir sup E44, ΔlacU169 (ΦlacZΔM15), recA1, 
endA1, hsdR17, thi-1, gyrA96, relA1, λpir 
phage lysogen 
TLCC 
E. coli BL21 
(DE3) 
fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS 
λ DE3 = λ sBamHIo ∆EcoRI-B 
int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5 
TLCC 
 
 
 
 
54 
 
Table 2.2 Description of strains provided by Roth’s laboratory. 
Strain Strain description  
TR10000 Wild type - have the ability to produce B12, to grow on 1,2-
propanediol, and  to grow on minimal glucose (met+). 
 
TR6583 A metE mutant - requires methionine on minimal glucose, 
however has the ability to grow when B12 is provided. B12 
allows the synthesis of methinione using the alternative B12 
dependent metH enzyme.  Used as control strain for testing the 
medium.  If anything is contaminated with B12 -- this strain will 
grow without methionine. If B12 is not produced no growth 
should occur on minimal medium. 
 
TT11202   This strain lacks both methionine syntheses. Requires 
methionine even when B12 is provided. 
 
TT10327 This strain is not able to synthesise B12. If growth on 1,2-
propanediol media occurs, medium must be contaminated with 
B12, or with some alternative carbon source. 
 
TT17131    This strain is defective for use of 1,2-propanediol.   If the 
growth occurs on propanediol, then some alternative carbon 
source had contaminated the media. 
TT17104    This strain is pocR defective - it should not grow on 1,2-
propanediol and it is not able to make B12.   
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Table 2.3 List of primers used in this study. 
Primer name Sequence  Target 
PAL3071R 5’CGGAGTAAAGCTTTGATGACTGTATCTCAC
3’  
stm3071 cloning 
into pPAL7 
PAL3071F 5’GAGTGAATTCTTAACGGGAAGAAATATGC3’ 
STM3071F 5’TGGCCGCTTACGCTGCAATTT3’ stm3071 flanking 
regions to confirm 
deletion 
STM3071R 5’GATGACGGCCCTAACAGCA3’ 
epdF2 5’CGCGTTTCCCGGCCAGATCCAGATCGGTC
ATCTTAATT3’ 
 
epd 5’end flanking 
region 
3071F 5’TCGCTATGCGTACGGTCATAGGTC3’  
 
stm3071 flanking 
region 
3072F 5’TTATGGCGCGTCGCCCGTTT 3’  
 
stm3072 flanking 
region 
3071R 5’CGCGCTGTAGAGGCATTGTGGT3’ 
 
stm3071 flanking 
region 
3071R2 5’ACGCGCCATAAAGTACCTCTTAAAGAGTCG
TCAA3’ 
 
stm3071 flanking 
region 
3072R 5’ATTTAGCGTACGGCTGACATCGC3’ 
 
stm3072 flanking 
region 
3073R 5’CGTGTCGCATCGGACGGAAGA3’ stm3073 flanking 
region 
3073catF 
(formly named 
3073kanF) 
5’CATTTTCCTGCGATGTCAGCCGTACGCTAA
ATGCAT3’ 
 
stm3073 knock-
out 
 
3073catR 
(formly named 
3073kanF) 
5’TATCCATACTCCCGCTTCCGCCAGTATTAG
CAGTAC3’ 
2021catF  5’ACCACAGGTCTGAAGTGGCAAGCATAATA
GTCCTTA3’ 
 
 
stm2021 knock-
out 
 
2021catR 5’AAGGTAAACAACGCCGTGATGACCGGGCT
TGATCGA3’ 
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3073_UP 5’ATTTATTCGTCGCCTGGATG3’ stm3073 knock-
out confirmation 3073_DOWN 5’ATGGTGGGCGACTGTTCTAC3’ 
2021_UP 5’CTCATTCTGATAACGAAACCAC3’ stm2021 knock-
out 
confirmation 
2021_DOWN 5’CAAGTGATTACCGTACAAGGAC3’ 
Pstm3071F 5’- GCTATGAATCCGGTCATAGG -3’ stm3071 promoter 
cloning site, lacZ 
fusion 
Pstm3071R 5’- TGGGATCCAGTCATCGTTAC -3’ 
 
PcbiA_F 
 
5’-ACCCgaaTCCCTACCACAAATG3’ cbiA promoter site 
cloning primers; 
lacZ fusion PcbiA_R 
 
5’-TCATTTCGGATCCAAAATTTATC3’ 
P_Arrrach_stm3
071_F 
 
ATACAAAGCACGAACCACGTTACG stm3071 cloning 
as in Arrach et al, 
2009 promoter site 
cloning primers, 
lacZ fusion 
P_Arrach_stm3
071_R 
 
GGATGGATCCGTGATTCTTAAATA 
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 Bacterial growth media 2.2
2.1.1 Luria-Bertani growth medium 
Luria-Bertani (LB) broth containing 10% (w/v) tryptone (Oxoid, UK), 5% (w/v) 
yeast extract (Oxoid, UK) and 5% (w/v) NaCl (Prolabo, UK) was used for 
aerobic growth at 37ºC or 30ºC in liquid culture at 200 rpm (unless stated 
otherwise) and for STM3071 protein expression. For growth on solid medium, 
LB broth was solidified by addition of 1.5% (w/v), agar or for soft agar at 0.7 % 
(w/v) bacteriological no. 3 agar (Oxoid, UK) was added. All LB media were 
prepared using distilled H2O and sterilised by autoclaving at 121ºC for 20 min.  
2.1.2 NCE (No-carbon-E) minimal medium 
NCE minimal medium containing 29 mM KH2PO4 (Sigma-Aldrich, UK), 28 mM 
K2HPO4 (Sigma-Aldrich, UK) and 16 mM NaNH4HPO44H2O (Sigma-Aldrich, 
UK) was prepared in distilled H2O and sterilised by autoclaving at 121ºC for 20 
min. The medium was supplemented with trace metals (0.3 μM CaCl2, 0.1 μM 
ZnSO4, 0.045 μM FeSO4, 0.2 μM Na2Se2O3, 0.2 μM Na2MoO4, 2 μM MnSO4, 
0.1 μM CuSO4, 3 μM CoCl2, and 0.1 μM NiSO4; Sigma-Aldrich, UK). Unless 
otherwise indicated carbon sources were provided at the following 
concentrations: 11mM glucose (Sigma-Aldrich, UK); 43 mM glycerol (Sigma-
Aldrich. UK); and 50 mM 1,2-propanediol, 50 mM potassium acetate (Sigma-
Aldrich, UK), and 40 mM sodium tetrathionane (Sigma-Aldrich, UK) as a final 
electron acceptor for the anaerobic growth. Regardless to carbon source used 
NCE minimal medium was supplemented with 20 µg ml-1 histidine (Sigma-
Aldrich, UK). All medium components were prepared in acid washed glassware 
(washed in 4% nitric acid, Sigma-Aldrich, UK) or plastic ware and using metal-
free reagents. Media supplements were sterilised by autoclaving or filter 
sterilised using 0.2 µm sterile filters (Whatman, UK).  
2.1.3 M9 minimal medium 
M9 minimal medium containing 50 mM Na2HPO4* 7H2O (Sigma-Aldrich, UK), 
22 mM KH2PO4 (Sigma-Aldrich, UK), 8 mM NaCl (Sigma-Aldrich, UK), 18 mM 
NH4Cl (Sigma-Aldrich, UK); salts were sterilised by autoclaving at 121ºC for 20 
min. Medium was supplemented with 2 mM MgSO4 (Sigma-Aldrich, UK), 0.1 
mM CaCl2 Sigma-Aldrich, UK), 0.4 % (w/v) glucose and 20 µg ml-1 histidine.  
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2.1.4 Media supplements 
Antibiotics ampicillin (Sigma-Aldrich, UK) and chloramphenicol (Sigma-Aldrich, 
UK) were prepared at 100 mg ml-1 and 25 mg ml-1, and used at 100 µg ml-1 and 
25 µg ml-1concentrations respectively, unless stated otherwise. Antibiotics were 
prepared in distilled H2O and filter sterilised using 0.2 µm sterile filters. 
 Plasmid purification 2.3
2.1.5 Plasmid purification using Qiagen Qiaprep Miniprep Kit 
Bacterial plasmids used in this study were purified using Qiaprep Miniprep Kit 
(Qiagen, UK), where high quality DNA was required for downstream reactions, 
according to manufacturer’s instructions. A volume of 1-5 ml of overnight culture 
was transferred to a sterile microfuge tube. Bacterial cells were harvested by 
centrifugation at 10,000 x g for 1 min at room temperature (all centrifugation 
was conducted in Mikro 200 R Benchtop Centrifuge, Hettich, UK). Plasmid DNA 
was extracted using Qiaprep spin columns provided with the kit. DNA was 
eluted from the column in 30-50 µl of PCR water (Bioline, UK). Purified plasmid 
DNA was verified on 1 % (w/v) agarose (agarose molecular grade, Bioline, UK) 
gel electrophoresis and restriction digest and stored at -20°C. 
2.1.6 Plasmid purification using TELT miniprep 
TELT solution containing 50 mM Tris base (Thermo Fisher Scientific, UK), pH 
7.5, 62.5 mM EDTA (Sigma-Aldrich, UK), 2.5 mM LiCl (Sigma-Aldrich, UK), and 
0.4 % (v/v) Triton 100x (Biorad, UK) was prepared in distilled H2O and sterilised 
by autoclaving at 121ºC for 20 min. A volume of 2-5 ml of overnight culture was 
centrifuged at 10,000 x g for 1 min at room temperature. The resulting pellet 
was resuspended in 800 µl of TELT solution and 80 µl of 100 mg ml-1 lysozyme 
(Sigma-Aldrich, UK); prepared in TELT solution. Samples were boiled for 120 s 
at 95ºC and then incubated on ice for 15 min. Following the incubation, 
precipitated protein content was collected by centrifugation for 15 min at 10,000 
x g. Supernatant was transferred to a fresh tube containing 600 µl of 
isopropanol. Samples were mixed by inversion and incubated for 5 min on ice to 
allow DNA precipitation. DNA was pelleted by centrifugation for 30 min at 
10,000 x g followed by subsequent washing with 750 µl of 70 % ethanol (Sigma-
Aldrich, UK). DNA pellet was air dried for approximately 15 min at room 
temperature and then suspended in 50 µl of PCR water (Bioline, UK). In order 
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to allow more efficient DNA resuspension, samples were incubated at 65ºC for 
approximately 1h. Purified plasmid DNA was verified on 1 % (w/v) agarose gel 
electrophoresis and restriction digest and stored at -20°C. 
  Restriction digest 2.4
Analytical restriction digests of vectors or constructs were prepared in a sterile 
microfuge tube in a final volume of 20 µl. A volume of up to 10 µl of plasmid 
DNA, 2 µl of appropriate 10 x concentrated buffer (Roche, UK) was added. 
Depending on the number of restriction enzymes (Roche, UK) used for the 
reaction PCR water was added to a final volume of 20 µl. Restriction enzyme 
was added last at the volume of 1 µl. Reaction tube was incubated in a water 
bath at 37°C (unless stated otherwise) for 1h. The outcome of the reaction was 
verified using 1% (w/v) agarose gel electrophoresis and stained with Gel Red 
stain (Biotium, UK) or Safe View (NBS Biologicals, UK) 
 Genomic DNA isolation 2.5
2.1.7 Qiagen – Puregene Yeast/Bact. Kit B method 
Genomic DNA was isolated using QIAGEN – Puregene Yeast/Bact. Kit B. A 
volume of 1 ml of bacterial overnight culture was harvested and pellet collected 
by centrifugation at 10,000 x g for 5 min at room temperature. Overnight 
cultures were grown in a shaking incubator at 37°C or 30°C (depending on the 
antibiotic sensitivity temperature) at 200 rpm.  
2.1.8 CTAB method 
CTAB/NaCl mixture containing 4.1 % (w/v) NaCl and 10 % (w/v) CTAB 
(hexadodecyltrimethyl ammonium bromide), Thermo Fisher Scientific, UK) was 
prepared in distilled H2O and heated to 65ºC prior the procedure.  A volume of 
1-5 ml of overnight culture was harvested by centrifugation at 10,000 x g for 5 
min at room temperature. Bacterial pellet was resuspended in 567 µl of TE 
buffer (10 mM Tris, 1mM EDTA) followed by addition of 3 µl of 20 mg ml-1 
proteinase K (Sigma-Aldrich, UK) and 30 µl 10 % (w/v) SDS (Sigma-Aldrich, 
UK). Samples were incubated at 37ºC for 1h until the solution became clear and 
viscous. A volume of 100 µl of 5 M NaCl was added and samples were mixed. 
Previously prepared CTAB/NaCl mixture was preheated to 65ºC. A volume of 
80 µl CTAB/NaCl was added, mixed well and incubated at 65ºC for 10 min. A 
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volume of 750 µl Phenol:chloroform:isoamyl alcohol (25:24:1) (Thermo Fisher 
Scientific, UK) was added, mixed well and followed by centrifugation at 10,000 x 
g for 5 min. Top layer was carefully transferred to a fresh microfuge tube 
containing 450 µl of isopropanol. The samples were mixed by inverting 5-7 
times until the DNA was visible. DNA was centrifuged down for 5 min at 10,000 
x g followed by subsequent wash with 750 µl of 70 % ethanol. DNA pellet was 
air dried for approximately 15 min at room temperature and then suspended in 
200 µl of PCR water (Bioline, UK). In order to allow more efficient DNA 
resuspension samples were incubated at 65ºC for approximately 1h or 
overnight at room temperature to allow slow dissolving.  Genomic DNA samples 
were verified using 1 % (w/v) agarose gel electrophoreses in order to confirm 
quality. DNA was stored at 4ºC.  
 Agarose gel electrophoresis 2.6
Tris-acetate-EDTA (TAE) 10 x concentrated buffer (Sigma-Aldrich, UK) was 
diluted to the final concentration of 1x concentrated solution with distilled H2O. 
TAE 1 x buffer is a solution containing a mixture of 0.4 M Tris acetate and 0.01 
M EDTA with pH approximately 8.3. The appropriate amount of agarose was 
weighed out to obtain desired gel concentration. Agarose was dissolved in 1x 
concentrated TAE buffer by heating in the microwave oven on defrost setting for 
approximately 2 min until agarose was dissolved completely. The mixture was 
then cooled down to approximately 50ºC and SafeView (NBS Biologicals, UK) 
nucleic acid stain (where stated) was added to the final concentration of 5µl per 
100ml agarose. Gel was then poured into tray and comb was inserted. Once gel 
was set it was placed in the tank filled with 1x TAE buffer. Where stated, 
agarose gel was post-stained with Gel Red stain according to manufacturer’s 
instructions.  
Samples were prepared by mixing 5x DNA loading buffer (Bioline, UK) and 
were applied onto the gel. A concentration of about 400 ng (varies from strain to 
strain, where needed gDNA was diluted 1:10 or 1:100) of DNA was applied onto 
the wells. The gel was run until the bromophenol blue tracking dye has run to 
the front of the electrophoresis (approximately 40 min at 100 V). DNA was 
visualised using Bio-Rad-Mol Imager ChemiDoc XRS+ imaging system with 
ImageLabTM software at ethidium bromide setting.  
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 Preparation of competent cells 2.7
2.1.9 Chemically competent cell preparation 
Solution 1 containing 10 mM MgCl2 (Thermo Fisher Scientific, UK), 50 mM 
CaCl2, and 10 mM MES Sodium salt (2-(N-Morpholino) ethanesulfonic acid 
sodium salt, Sigma-Aldrich, UK) was prepared. Solution 2 containing 10 mM 
MgCl2, 50 mM CaCl2, 10 mM MES Sodium salt, and 15 % (v/v) glycerol was 
prepared. Both solutions were prepared in distilled H2O and sterilised by 
autoclaving at 121ºC for 20 min. Both solutions were cooled down to 4ºC prior 
use.  
E. coli strains α-select; BL21 (DE3); DH5α λpir and S. Typhimurium strains 
SL1344; LB5010a and TR10000 were incubated overnight in 10 ml LB broth at 
37ºC at 200 rpm. A volume of 10 ml LB broth was supplemented with 15 mM 
MgCl2 and inoculated 1:50 with the overnight culture. Cells were grown until 
mid-log growth phase (OD600 approximately 0.4-0.6). Optical density was 
measured using spectrophotometer Spec 6300 Jenway. Cells were harvested 
by centrifugation for 10 min at 4000 x g, at 4ºC (Multifuge 3LR). Pellet was 
washed in 3 ml ice cold Solution 1 and incubated on ice for 20 min. Cells were 
harvested by centrifugation for 5 min at 4000 x g at 4ºC. Supernatant was 
discarded and bacterial pellet was resuspended in 600 µl of ice cold Solution 2. 
Competent cells were prepared in aliquots of 100 µl and stored at -80ºC.  
2.1.10 Electrocompetent cell preparation 
S. Typhimurium strains SL1344, LB5010a and TR10000 were grown overnight 
in 10 ml LB broth at 37ºC at 200 rpm. A volume of 1 ml of fresh LB broth was 
inoculated 1:50 with the appropriate overnight culture. Bacterial cells were 
grown at 37ºC at 200 rpm until mid-log growth phase (OD600 approximately 0.4-
0.6). Cells were harvested by centrifugation for 5 min at 4000 x g at 4ºC. 
Subsequently cells were washed twice with sterile ice cold distilled H2O 
followed by resuspension in 250 µl of 10 % (v/v) sterile, ice cold glycerol. 
Prepared electrocompetent bacterial cells were aliquoted at 100 µl and stored at 
-80ºC until further use. 
62 
 
 Bacterial transformation 2.8
2.1.11 Chemical method with CaCl2 
A volume of 50 µl of previously prepared or purchased (Bioline, UK) chemically 
competent cells was mixed with 5 µl of plasmid DNA. Cells and DNA mix was 
incubated on ice for 15 min. Cells were heat-shocked at 42ºC in water bath for 
90 s followed by 2 min incubation on ice. A volume of 1 ml was added to the 
mixture followed by 30-60 min recovery incubation at 37ºC (or at 30ºC for 
pKD45 and pCP20) at 200 rpm. Recovered cells were spread out on a selective 
LB agar and incubated overnight at 37ºC (or 30ºC where appropriate). 
2.1.1 Electroporation method 
Sterile electroporation cuvettes, 2mm (Geneflow, UK) were cooled on ice. A 
volume of 50 µl electrocompetent cells were mixed with 5 µl of plasmid DNA 
(DNA concentration: 30-50 µg ml-1) unless stated otherwise. Followed by 10 min 
incubation on ice the mixture of cells and DNA was transferred to a pre-cooled 
electroporation cuvette. Electroporation was performed using Gene Pulser, 
Biorad, UK using pre-set bacterial protocol - 2mm gap, 2.5 kV setting. A volume 
of 1 ml of fresh LB broth was added immediately to shocked cells followed by 
30-60 min incubation at 37ºC (or at 30ºC for pKD45 and pCP20) at 200 rpm. 
Recovered cells were spread out on a selective LB agar and incubated 
overnight at 37ºC (or 30ºC where appropriate).  
 2.9 Gene disruption  2.9
2.1.2 λ-Red based homologous recombination 
λ-Red mediated mutagenesis was used to introduce non-polar mutation in 
stm3071, stm3073 and stm2021 genes in S. Typhimurium LB5010a. The 
procedure was based on the protocol of Datsenko and Wanner (2000). 
LB5010a transformants carrying Red helper pKD46 plasmid were grown in 10 
ml LB broth with ampicillin and 1 mM L-arabinose overnight at 30ºC. Fresh 10 
ml of LB broth, supplemented with ampicillin and L-arabinose was inoculated 
1:50 and grown at 30ºC until OD600 reached 0.4-0.6. Then the cells were made 
electrocompetent by concentrating 100-fold and washing twice with 10 % (v/v) 
ice cold glycerol. PCR products were generated using primers with homology to 
the disrupted genes. pKD3 plasmid carrying cat cassette (chloramphenicol 
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resistance gene) was used as a template – table 2.3. PCR products were 
verified using agarose gel electrophoresis and purified using QIAquick PCR 
purification kit (Qiagen, UK) according to manufacturer’s instructions. 
Electroporation with PCR product at the concentration 10-100 ng was 
performed as stated in 2.8.2. Recovery step was prolonged to maximum of 2h, 
37ºC at 200 rpm. Cells were spread out on selective agar with chloramphenicol 
and incubated at 37ºC. Obtained colonies were tested for ampicillin sensitivity 
for loss of the Red-helper pKD46 plasmid. If some still carried resistance, 
bacteria were grown at 43ºC and then tested for resistance loss again.  
 PCR verification 2.10
A cat gene encoding chloramphenicol resistance was previously constructed in 
place of stm3071 using λ-Red site directed mutagenesis (Datsenko & Wanner, 
2000) and was confirmed by PCR with stm3071F and stm3071R primers (this 
study).  
 Antibiotic resistance gene elimination 2.11
Temperature-sensitive, chloramphenicol and ampicillin resistant plasmid pCP20 
that shows thermal induction of flippase (FLP) synthesis was transformed into 
the strain carrying mutation Δstm3071::cm. Transformants were selected at 
30ºC and then cultured at 43°C to eliminate pCP20 plasmid; and then tested for 
loss of all antibiotic resistances. The loss of cat cassette from the bacterial 
chromosome was confirmed by PCR with stm3071F and stm3071R primers. 
 P22 transduction 2.12
2.1.3 Donor phage propagation and quantification 
S. Typhimurium LB5010a galE+ host strain was grown overnight in LB broth at 
37ºC, 200 rpm. Bacteriophage P22 HT101 was diluted serially in 0.9 % (w/v) 
NaCl. A volume of 100 µl of each phage dilution and 100 µl of LB broth was 
mixed with 2.5 ml of melted LB soft agar. The mixture was poured onto the 
fresh LB agar plate and incubated overnight at 37ºC. Bacteriophage titre was 
determined. The plate with confluent plaques was soaked overnight with 0.9 % 
NaCl. The soak was aliquoted and stored at 4ºC with few drops of chloroform. 
This step was performed to propagate WT P22 HT strain. For donor strain 
propagation Δstm3071::cm bacterial strain was used as a host strain. 
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2.1.4 Transduction with bacteriophage P22 
Recipient strain cells (S. Typhimurium SL1344 or TR10000) were grown 
overnight in 10 ml of LB broth at 37ºC, 200 rpm. Donor bacteriophage was 
diluted to 108 pfu ml-1. A volume of 100 µl (108 bacterial cells) and 100 µl of the 
phage dilution was mixed to allow multiplicity of infection of 0.1 phage per cell. 
The mixture was incubated at 37ºC for 60 min for chloramphenicol resistance at 
200 rpm. Following the incubation period the cells and phage mix was plated 
directly on selective medium and incubated overnight at 37ºC. The 
transductants were picked early in order to avoid excessive contamination. 
Colonies were picked using a small, sterile tip, from the top of the colony to 
avoid contact with the surrounding medium. Colonies were streaked out on 
green indicator plates and incubated overnight at 37ºC. Bacteriophage P22 
strain H5 was diluted in T2 buffer and 20 µl was struck on a green indicator 
plate in a line down the centre of the plate. Large light green colony from the 
streak plates were selected and tested for correct phenotype and incubated 
overnight. Light green colonies are phage-free (Smith & Levine, 1967). Dark 
green colonies are phage-infected lysed cells. Phage free transductants were 
streak out on LB plates and growth overnight. Strains were grown and frozen in 
50 % (v/v) glycerol at -80ºC.  
2.1.5 Green indicator plates 
Green plates used for differentiation between phage infected and phage free 
cells are poorly buffered rich plates with an excess of glucose and two pH 
indicator dyes Alizarin yellow and Aniline blue. Plate mix containing 0.8 % (w/v) 
triptone, 0.1 % (w/v) yeast extract, 0.5 % (w/v) NaCl, 1.5 % (w/v) agar, 6.5 mg 
ml-1 Aniline blue (Sigma-Aldrich, UK) and 62.2 mg ml-1 Alizarin yellow (Sigma-
Aldrich, UK) was prepared in 1000 ml of distilled H2O and sterilised by 
autoclaving at 121 ºC for 20 min. The mixture was cooled down to 50 ºC and 
prior pouring medium was supplemented with 16.8 ml of 50 % (w/v) glucose. 
 Metal tolerance assays 2.13
Cobalt (II) sulphate hepta-hydrate (Sigma-Aldrich, UK) at a concentration of 1M 
was prepared in metal free distilled H2O and filter sterilised with 0.2 µm filter. 
Further concentrations of cobalt were prepared aseptically in plastic ware with 
metal free sterile distilled H2O. S. Typhimurium SL1344 and mutant strain 
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Δstm3071 were exposed aerobically and anaerobically to cobalt concentration 
ranging from 0 – 500 µM in M9 or NCE glucose metal depleted minimal media. 
Media conditions as described in media section (2.2.2 and 2.2.3). Cells were 
incubated (inoculum 1:50) anaerobically in minimal media at 37°C. To compare 
the growth of both strains the OD595 readings were obtained using Dynex Tech 
spectrophotometer, MX02 model. Data was generated using Revalation 4.25 
software and analysed using Microsoft Excel 2007. 
Overnight culture for M9 experiments was M9 medium and for NCE glucose, 
NCE glycerol was used for overnight aerobic culture growth. For anaerobically 
grown cells, medium was pre-incubated 24h prior inoculation to ensure medium 
anaerobicity.  
 Viable count – Miles and Misra method 2.14
A dilution series of an aliquot of the growing cultures exposed to different 
conditions as described were performed in PBS (phosphate buffered saline, 
Sigma-Aldrich, UK). Three spots of 10µl of each dilution were pipetted onto the 
LB agar plate and incubated overnight at 37ºC. The viable count was 
determined by counting the number of colonies present in each 10 µl zone at a 
particular dilution, obtaining the mean and calculating by multiplying by the 
appropriate dilution factor. Growth was described as colony forming units per ml 
in original culture (cfu ml-1). 
 Protein expression and purification 2.15
 Overexpression on STM3071 2.16
E. coli BL21 (DE3) cells bearing recombinant plasmids were grown overnight in 
10 ml of LB broth supplemented with ampicillin. A volume of 50 ml LB medium 
was pre-warmed and supplemented with ampicillin prior the inoculation (1:50) 
with of overnight culture. Cells were grown until mid-log growth phase (OD600 
approximately 0.4-0.6) was obtained. A volume of 1 ml of pre-induced samples 
was taken prior the induction. Bacterial cells were harvested by centrifugation at 
10,000 x g for 1 minute at room temperature and stored at -20ºC for further 
protein analysis of pre-induced sample. Induction of expression was performed 
by addition of Isopropyl β-D-thiogalactopyranoside (IPTG, Sigma-Aldrich, UK). 
IPTG was added to the final concentration of 1mM to remaining culture and 
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incubated either at 37ºC with vigorous shaking (200 rpm) for 4h or 20ºC with 
shaking overnight (14-16h). Following incubation period 1 ml of the culture was 
harvested by centrifugation at 10,000 x g for 1 minute at room temperature, 
labelled as post-induced sample and stored at -20ºC for further analysis. The 
remaining cells from post-induced culture were harvested by centrifugation, 
stored at -20ºC and used further in protein purification experiments.  
 Determination of protein concentration – 2.17
Bicinchoninic  acid assay (BCA assay) 
Proteins concentration was determined by the technique developed by 
Bradford, 1976 using the QantiPro BCA protein assay kit (Sigma-Aldrich, UK). 
BCA working reagent was prepared by mixing bicinchoninic acid (prepared 
according to manufacturer’s instructions) and copper (II) sulphate, pentahydrate 
4% solution in 50:1 ratio until the correct colour was obtained.  
Protein Standard Solution containing 1.0 ml of solution consisting of 1.0 mg ml-1 
bovine serum albumin in 0.15 M NaCl with 0.05% sodium azide (Sigma-Aldrich, 
UK) as a preservative. Protein standards were prepared to concentrations 
ranging from 0.0 mg ml-1 to 1.0 mg ml-1 using 10mM Tris/HCl (Thermo Fisher, 
UK) pH 7.4 as a diluent. 
Protein samples were prepared by diluting the obtained bacterial pellet in 50µl 
of 10mM Tris/HCl pH 7.4 for pre-induced samples and 100µl for post-induced 
protein samples.  
The assay was conducted according to the manufacturer’s protocol for 
microtitre plate experiment. A volume of 10 µl of each sample was loaded onto 
the 96-well microtitre plate in duplicates. Protein standards were applied onto 
the microtitre plate in duplicates in order to generate standard curve. A volume 
of 200 µl of BCA working regent prepared prior the experiment was applied into 
all wells. The plate was incubated at 37ºC for 30 minutes until the colour 
developed. The absorbance was measured at 550 nm using Dynex Tech 
spectrophotometer, MX02 model. Data was generated using Revalation 4.25 
software and analysed using Microsoft Excel 2007. 
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 Sodium dodecyl sulphate polyacrylamide gel 2.18
electrophoresis (SDS-PAGE) 
2.1.6 Preparation of samples 
Bacterial pellet from pre-induced samples was suspended in 50 µl 2x SDS 
sample buffer (Sigma-Aldrich, UK), and pellet from post-induced samples in 100 
µl 2x SDS sample buffer. Samples were denatured by boiling at 95ºC for 5 min 
using heating block (Stuart SBH13OD) and loaded onto the SDS gel.  
Samples used for BCA assay were prepared with 10x BugBuster protein 
extraction reagent (Novagen, UK) and 1mM Tris pH 7.4, 10x SDS sample buffer 
(20% (w/v) SDS, 500 mM Tris (v/v), pH 7.6, 1% bromophenol blue (Sigma), 
50% (w/v) glycerol, and 1 µl 1 M dithiothreitol (DTT, Sigma-Aldrich, UK).  
Samples were denatured by boiling at 95ºC for 5 min using heating block. The 
appropriate volume of samples loaded onto SDS gel was estimated using BCA 
assay.  
2.1.7 Monitoring expression levels by SDS-PAGE analysis 
Electrophoresis was performed using Bio-Rad Mini-Protean Tetra System tank. 
Gels (15% (v/v) acrylamide) were prepared accordingly; resolving gel: 1.2 ml 
H2O, 2.5 ml 30% acrylamide (Sigma-Aldrich, UK), 1.3 ml 1.5M Tris, pH 8.8, 0.05 
ml 10% (w/v) sodium dodecyl sulphate, 0.05 ml 10% (w/v) ammonium 
persulphate (APS, Sigma-Aldrich, UK), 0.002 ml 
tetramethylethylenediamine  (TEMED, Sigma-Aldrich, UK); stacking gel: 0.68 ml 
H2O, 0.17 ml 30% acrylamide, 0.13 ml, 0.01 10% SDS (w/v),  0.01 ml 10% APS 
(w/v), 0.001 ml TEMED. 
Casting apparatus was assembled according to the manufacturer’s instructions 
(Biorad, UK). Resolving gel was prepared and poured between the glass slides 
at appropriate volume, covered by layer of isopropanol (Sigma-Aldrich, UK) and 
left to set (approximately 20 min). Isopropanol layer was poured off, and 
stacking gel was applied. The comb was placed immediately after the stacking 
gel was poured between the glass slides. The comb was left to set and for the 
further use.   
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SDS electrophoresis 10x concentrated running buffer was prepared prior the 
electrophoresis, containing 3.03% (w/v) Tris base, 14.42% (w/v) Glycine 
(Sigma-Aldrich, UK) and 1% (w/v) SDS.   
Gel was placed in the tank containing 1x running buffer. Samples were applied 
into wells at a volume ranging 5-30 µl depending on the concentration of 
samples. Protein marker was applied at a volume of 5 µl (ColorBurst, Sigma-
Aldrich, UK or SeeBlue Plus standard, Invitrogen, UK). The gel was run at 140 
V for approximately 60 min (Biorad, UK Power Pac 3000).  
Gels were stained using SimplyBlue (Invitrogen, UK) according to the 
manufacturer’s instructions. Where appropriate, the recommended staining time 
was increased from 1h to overnight to improve quality of protein bands. The 
intensity of protein bands was analysed using Bio-Rad-Mol Imager ChemiDoc 
XRS+ imaging system with ImageLabTM software. 
2.1.8 Monitoring expression levels by Silver Staining SDS-PAGE 
analysis 
Silver staining procedure was conducted using reagents from ProteoSilverTM 
Plus Silver Stain Kit (Sigma-Aldrich, UK). The following solutions were prepared 
prior to the procedure: 30% (v/v) ethanol; Fixation Solution containing 30% (v/v) 
ethanol,  10% (w/v) acetic acid (Sigma-Aldrich, UK); Sensitizer solution 
containing sodium dithionite (Sigma-Aldrich, UK) 25 mg ml-1 (freshly prepared); 
Staining solution containing 0.2% AgNO3 (Sigma-Aldrich, UK) with 37% 
Formaldehyde solution (Sigma-Aldrich, UK); Developer solution containing 6% 
sodium carbonate (Sigma-Aldrich, UK), 4 µg ml-1 sodium thiosulfate (Sigma-
Aldrich, UK).  
Gels were placed in a clean dish with sufficient volume of fixation solution to 
cover and incubated for 2h with gentle shaking at room temperature using 
Stuart mini orbital shaker SSMI at 50 rpm. Gels were washed 3 times for 10 min 
with 30% ethanol and 2 times for 10 min with ultrapure deionised water at room 
temperature with gentle shaking. After washing steps, gels were incubated with 
sensitizer solution for 1 min and then washed immediately 2 times with ultrapure 
deionised water for 1 min. Staining solution was applied to the gel and 
incubated for 25 min with gentle shaking at room temperature followed by 
further washing with ultrapure deionised water for 1 min. Developer solution 
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was then applied and incubated with gentle mixing. A volume of 5 ml of Stop 
solution (EDTA, Sigma-Aldrich, UK) was added immediately after bands were 
developed. Gels were then stored in the dark at 4 ºC. The intensity of protein 
bands was analysed using Bio-Rad-Mol Imager ChemiDoc XRS+ imaging 
system with ImageLabTM software. 
2.1.9 Protein purification 
Profinity exact Mini purification starter kit (Biorad) was used for STM3071 
protein purification.  
Previously expressed protein in E. coli BL21 (DE3) was extracted from the cells 
with 10x BugBuster protein extraction reagent (Novagen, UK) in lysis buffer 
containing 100 mM sodium phosphate, pH 7.2 (Sigma-Aldrich, UK). A volume of 
10 ml of bacterial culture was centrifuged and the resulting pellet treated with 
700 µl of 1x BugBuster in 100 mM lysis buffer, and vortexed at high speed for 1 
min to aid cell lysis. Lysed cell extract was centrifuged for 15 min at 10,000 x g. 
The supernatant was transferred to a fresh microfuge tube and labelled as the 
soluble fraction. The remaining pellet was resuspended in 700 µl of 1x 
BugBuster in 100 mM sodium phosphate and labelled as the insoluble fraction. 
Solubility of the protein was verified by SDS PAGE analysis. Proteins were 
stored at 4°C until purification. 
Bind/wash buffer 100 mM sodium phosphate, pH 7.2 was pre-.chilled to 4°C. 
The storage buffer 100 mM sodium phosphate, 0.02 % sodium azide, pH 7.2 
was removed by centrifugation 30s at 1,000 x g. The resin was equilibrated by 
washing twice with bind/wash buffer to remove any residual NaN3 from the 
resin. A volume of 500 µl pre-chilled to 4°C protein lysate was applied on a 
resin and incubated for 30 min on ice on a rocking platform to allow the tagged 
protein with β-subtilisin subunit to bind to the resin. The column was centrifuged 
for 30s at 1,000 x g at room temperature. The unbound material was collected 
and labelled as a flowthrough and stored at 4°C. The resin was washed twice 
with bind/wash buffer. Washed flowthrough material was collected, labelled as a 
wash material and stored at 4°C. Elution buffer containing 100 mM sodium 
phosphate and 100 mM sodium fluoride (Sigma-Aldrich, UK) was applied at a 
volume of 500 µl onto the resin and was incubated at room temperature for 30 
min on a rocking platform. Following the incubation period the supernatant 
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containing purified protein was collected by centrifugation at room temperature 
for 30s at 1,000 x g. Purified protein was stored at 4°C and analysed by SDS 
PAGE. After analysis protein was kept in 20% (v/v) glycerol and stored at -20°C.  
 Modified β-galactosidase assay 2.19
S. Typhimurium SL1344 strains carrying lacZ fusion plasmids were used in this 
assay to test conditions inducing gene expression. All lacZ fusions were based 
on a promoter-less pRS415 (control plasmid, encoding lacZ reporter gene). 
Strains were exposed to various conditions under anaerobic and aerobic 
conditions until OD600 reached 0.4-0.6. Cells were grown in M9 or NCE minimal 
medium with or without the addition of metal at MPC (minimal permissive 
concentration). Overnight cultures were always grown aerobically for M9 in M9 
glucose and for NCE in NCE glycerol. Cultures were inoculated 1:50 with an 
appropriately prepared overnight culture.   
Z buffer containing 0.06 M Na2HPO4*7H2O (Sigma-Aldrich, UK), 0.04M 
NaH2PO4 (Sigma-Aldrich, UK), 0.01 M KCl (Sigma-Aldrich, UK), 0.001M MgSO4 
7H2O (Sigma-Aldrich, UK), 0.5M β-mercaptoethanol, always added fresh (2-
ME) (Sigma-Aldrich, UK) was prepared in distilled H2O. Phosphate buffer, pH 7 
and Stop buffer 1M Na2CO3  and 4 mg ml
-1 ONPG in phosphate buffer were 
prepared in distilled H2O immediately prior the procedure.  
Cultures were diluted 1:100 or 1:10000 in Z buffer and treated with 0.1% (w/v) 
SDS (1 drop) and chloroform (2 drops) in order to permeabilise cell membranes. 
The content were vortex at high speed and left to settle for 30 min at room 
temperature. A volume of 176 µl of each sample was added to 96-wel plate in 
duplicates. Test samples were treated with 35 µl of ONPG to test for 
colorimetric reaction. As soon as the yellow colour was developed the reaction 
was stopped by addition of 88 µl of Stop buffer; added to all test and blank 
wells. Then a volume of 35 µl of ONPG was also added to all remaining blank 
wells. ONPG mimics lactose but it does not activate the lac-Z operon (Lapage & 
Jayaraman, 1964). After ~20 min when the yellow colour was developed, the 
Stop buffer was added to each row. A concentration of 1M Na2CO3 inhibits the 
reaction. Addition to each row prevents odd rows from lac-Z operon activation – 
negative controls. After Stop buffer was added, a volume of 35 µl of ONPG 
solution was added to odd rows. Then using microtitre reader the absorbance 
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was measured at 405 nm. The result was analysed using MS Office excel 
software.  
 Electromobility shift assay (EMSA) 2.20
EMSA protocol was adapted from Campbell et al., 2007. Plasmid DNA pUC19 
was re-circularised by restriction digest with EcoRI and used as a competitor 
DNA. Predicted operator-promoter regions (probes) were amplified  with 
primers listed in table 2.3. For each construct 5 parallel PCR reactions were 
combines and purified using purified using QIAquick PCR purification kit 
according to manufacturer’s instructions. Equal quantities of competitor DNA 
and probes were mixed together with the binding buffer containing 20 mM Tris 
ph 7.8, 1 mM DTT, 1mM EDTA, 2.5% (v/v) glycerol, 50 µM spermidine (Sigma - 
Aldrich, UK). Pre-equilibrated, purified STM3071 was added to binding 
reactions at different concentrations. Binding reactions were then incubated at 
room temperature for 30 min. Following incubation, the entire reaction volume 
was applied onto the 5% non-denaturing Tris-borate-EDTA (TBE. 446 mM Tris, 
445 mM boroc acid, 10 mM EDTA, ph 8) polyacrylamide gels prepared using 
Bio-Rad Mini Protean 3 system. Polyacrylamide gels underwent preliminary 
electrophoresis in 1 x TBE at 90 V for 90 min prior sample loading. Samples 
were then applied and run at 250 V for 3 min before being separated at 120 V 
for 60 min. One lane containing DNA loading buffer was used as an indicator for 
migration of DNA fragments through the gel. Gel was stained using Gel Red 
stain and visualised using Bio-Rad-Mol Imager ChemiDoc XRS+ imaging 
system with ImageLabTM software at ethidium bromide setting. 
 B12 assay 2.21
S. Typhimurium cultures were grown overnight from a single colony in M9 
medium with or without 1.2 µg CoSO4*6H2O for 24h under anaerobic 
conditions. The medium was pre-equilibrated in anaerobic chamber for 24h 
prior the inoculation. 
MacConkey base agar plates containing 2 % (w/v) peptone (Oxoid, UK), 0.5 % 
(w/v) bile salts (Sigma-Aldrich, UK), 0.5 % (w/v) sodium chloride, 0.0075 % 
neutral red (Sigma-Aldrich, UK), 0.0001 % cristal violet (Sigma-Aldrich, UK) and 
1.2 % agar. MacConkey agar base plates were supplemented with 
supplemented with 1% 1,2-propanediol and 1 mg ml-1 CoCl2*6H2O. Negative 
control plates were not supplemented with CoCl2*6H2O (Paiva et al., 2009). 
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Medium was inoculated 1:50 from the aerobic overnight culture and incubated 
anaerobically overnight. Then, bacteria were cultured on MacConkey base agar 
plated and incubated at 37°C for 24h.  
 Molecular cloning 2.22
In order to clone operator-promoter sites of stm3071 , stm3071 Arrach et al., 
2008 version and cbiA into pRS415 appropriate primers were designed and are 
listed in table 2.3. All regions were amplified from S. Typhimurium SL1344 
genomic DNA (Materials and Methods; 2.5.2) using appropriate primers. 
Polymerase Chain Reactions (PCR) were set up on ice according to the table 
below: 
 Single reaction (μl) 
2x MyTaq HS Mix (Bioline, UK) 25.0 
Forward primer (10 μM) 0.5 
Reverse primer (10 μM) 0.5 
Template – genomic DNA 1.0  
PCR grade water (Bioline, UK) 23.0 
 
 
PCR cycling was carried out under the following conditions:  
 
5 min @ 95°C - 1 cycle  
 
30 s @ 95°C  
30 s @ X°C -    25        cycles  
X min @ 72°C  
 
10 min @ 72°C  - 1 cycle 
 
 
Following the amplifications procedure PCR products were purified using 
Qiagen purification kit (Qiagen, UK) according to manufacturer’s instructions. 
PCR products and donor vector promoterless pRS415 were subjected to 
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restriction enzyme procedure using EcoRI and BamHI restriction enzymes 
(Roche, UK) accordingly following as in Materials and Methods section 2.4. 
Following restriction inserts and recirculised vector were subjected to incubation 
at 65°C for 1h in order to allow restriction enzymes heat-inactivation. Ligation 
PCR product : pRS415 vector ratio was adjusted to 3:1. Ligation was performed 
using T4 ligase and the reaction was set up as follows: DNA, 10x ATP (Roche, 
UK), T4 ligase and 10x ligation buffer (Roche, UK) and incubated at 4°C 
overnight. Ligation reaction was transformed into E. coli α-select Bioline, UK, 
Gold efficiency cells according to 2.8.1 procedure (Materials and Methods). 
Constructs were confirmed by DNA sequencing and introduced into the 
restriction minus S. Typhimurium strain LB5010a. Isolated constructs extracted 
from LB5010a were electrotransformed into SL1344 as described in (2.7.2 
Materials and Methods). Β-galactosidase assays were performed with obtained 
strains as described in 2.13. 
 Bioinfomatics analysis 2.23
All nucleotide and amino acid sequences were obtained from the NCBI 
database and subjected to BLAST analyses using either the BLASTp or 
BLASTx algorithm as appropriate. For multiple alignments of sequences, the 
ClustalW alignment tool and Multalin were applied. 
 
 Statistical analysis 2.24
Bacterial numbers (growth) and changes in β-galactosidase activity were 
transformed logarithmically before statistical analysis using a Student t-test.  
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3. Chapter 3 – Bioinformatics analysis 
 Predicting the function of stm3071  3.1
In the Introduction section, it was described that transition metals are essential 
for multiple biological functions (Lemire et al., 2013). There were given 
examples of such metals in the context of their biological role and transcriptional 
regulation of genes responsible for metal sensing and expression regulation of 
their acquisition mechanisms. This section focuses on seeking the evidence as 
to whether stm3071 is a part of the putative operon involved in cobalt transport 
and whether STM3071 is important in expression regulation of this potential S. 
Typhimurium cobalt transport system. 
3.1.1 Nutrient acquisition – classification of transporters in bacteria 
The ability to transport nutrients across biological membranes is fundamental in 
all three kingdoms. Transporters are grouped with regards to energy used by 
transporting proteins. Primary transporters are proton-pumping ATPases or 
ATP-binding cassettes (ABCs) that use the energy obtained from ATP 
hydrolysis. Secondary transporters on the other hand couple transport to 
electrochemical gradients across the membrane (Eitinger et al., 2011). 
ABC transporters form one of the largest protein superfamilies of paralogous 
sequences across species (Davidson & Maloney, 2007). With regards to 
genome size, the highest number of ABC systems is found in bacteria 
(Davidson et al., 2008). Canonical ABC transport systems share a common 
structural feature, which is two transmembrane domains (TMDs) which form a 
translocation channel and two nucleotide-binding domains (NBDs) which 
hydrolyse ATP. In the ABC superfamily, there have been distinguished 
exporters, importers and non-transporters which do not to possess 
transmembrane domains. In 2008 Davidson proposed classification method of 
the ABC transporters. Based on sequence similarities there have been 
described III classes of ABC systems have been described; class I with fused 
TMDs and NBDs, class II including nontransport ABCs, and class III with TMDs 
and NBDs formed by separate polypeptide chains. In ABC importers substrate 
binding proteins (SBPs) are required for function (Eitinger et al., 2011).  
ECF transporters represent a newly discovered category of ABC transporters 
(Eitinger et al., 2011; Rodionov et al., 2006; Slotboom, 2013; Swier et al., 2015). 
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This type of transporters consists of ABC ATPase domains (A components, 
described as EcfA and EcfA’), a conserved transmembrane protein (T 
component EcfT) and a transmembrane substrate-capture protein (S 
component, also known as S-unit) (Fig 3.1 (a)). ECF components lack SBP 
domain, which differs them the most from ABC transporters (Rodionov et al., 
2009).  
For years, it was a subject of discussion to understand the mechanism fully as 
well as to explain the machinery of the S-unit. It was recently proposed that the 
S-unit serves as a substrate binding and substrate translocation unit (Slotboom, 
2013; Swier et al., 2015), presented in fig 3.1 (a). They are usually involved in 
transport of transition metals such as Co2+ and water soluble vitamins (Eitinger 
et al., 2011; Slotboom, 2013). EcfA, EcfA’ and T-component together with ATP 
facilitate translocation of the S-unit (described below in fig. 3.1 (b) (Slotboom, 
2013; Xu et al., 2013). 
As reviewed by Swier et al., (2015), presented in fig. 3.1 (b), it was observed 
based on crystallography studies that S-unit translocates to an almost 
perpendicular position to the T-component. Thus, when S-unit was observed in 
that position and did not contain the substrate, the state of the transporter has 
been defined as resting state (step 1, fig 3.1 b). Presented in fig. 3.1 (b), S-unit 
undergoes almost 90° rotation (step 2), which allows it to reach the substrate 
binding site on the outer surface of the membrane. This mode of action is still 
considered speculative due to lacking evidence on a biochemical level and the 
crystal structure does not provide information on dynamic rearrangements 
(Finkenwirth et al., 2015).  
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(a)
 
 
(b)
 
 
Fig. 3.1 (a) Schematic representation of the ECF transporter. EcfA and 
EcfA’ represent cytoplasmic, highly similar ATPases. EcfT represent the 
integral membrane protein and S subunit represents substrate specific domain. 
EcfAA’ and EcfT together form a module the binds and translocates the S-unit. 
Black dot embedded in the S subunit represents substrate (adapted from ter 
Beek et al., 2011). (b) Schematic representation of the ECF transporter 
mechanism of action. Step 1 – ECF complex in post-translocation state binds 
ATP, which releases empty S-unit (yellow) by disruption of the hydrophobic 
interface (red). This results in reorientation of the S-unit into perpendicular 
position towards the outer membrane – step 2. In this position S-unit is able to 
bind the specific substrate (3) from the extracellular side of the membrane. Step 
4 – ATP hydrolysis aids S-unit to the starting position (5) while regenerating the 
hydrophobic interface (6) and binds it back to the EcfT component (cyan). This 
results in release of the substrate to the cytoplasm (adapted from Swier et al., 
2015).  
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Diverse nutrients, such as sugars, amino acids, peptides, polypeptides, 
xenobiotics, vitamins and ions are transported with ABC transporters. These 
transporters have specific high affinity substrate-binding proteins (SBPs) that 
mediate the uptake of nutrients (Lubelski et al., 2007).  
Transporter classification system includes 33 subfamilies of ABC importers that 
take onto account both functional and phylogenetic information (Saier et al., 
2016). Those subfamilies of canonical ABC transporters include importers such 
as: carbohydrate uptake transporters, amino acid uptake transporters, sulphate 
transporters (OppABCDF in S. Typhimurium and Lactobacillus lactis), ferric iron 
uptake transporter (SfuABC in Serratia marcescens), vitamin B12 uptake 
transporter (BtuCDF in E. coli), manganese/iron/zinc chelate uptake transporter 
(MntABC in Neisseria meningitides), and methionine uptake transporter 
(MetNIQ in E. coli) (Eitinger et al., 2011). The transporter classification system 
does not include ECF transporters, however it classifies members of ECF 
transporters as ABC systems or secondary active transporters.  
ECF are described as an abundant class of importers for micronutrients in 
bacteria and archaea. Substrates described as specific for ECF type 
transporters are water soluble vitamins, cofactors and metabolic precursors, 
tryptophan and queuosine and its metabolic precursors, and the metals nickel 
and cobalt. Similarily to canonical ABC importers, they contain ABC ATPase 
subunit and therefore couple ATP hydrolysis to substrate uptake. The 
fundamental difference between those two systems is the absence of the 
extracytoplasmic SBP in ECF uptake systems. ECF systems have been 
classified into two classes. I class is encoded by operons that consist of two 
genes for A units, T unit and an S-unit gene. Class II on the other hand consist 
of conserved A and T units and has a highly diverse S unit that can function for 
different transporters and can be scattered around the genome and might be 
expressed constitutively, or under control of metabolite-responsive riboswitches 
or transcription factors (Rodionov et al., 2009). 
3.1.2 Back-up plan – cbi operon 
It is clear that bacteria sense metals and those metals take part in regulation of 
expression (Lemire et al., 2013). It is also clear that the regulation of metal 
acquisition needs to be strictly controlled as the excess of those metals may be 
lethal to the cell (Eriksson et al., 2002). In nature, most organisms have at least 
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one alternative to a gene that plays an essential role (Zhang & Lin, 2009). In the 
event of mutation which might result in loss of the function of an essential gene 
of some sort, the cell either prokaryotic or as well as eukaryotic has a ‘back up 
plan’. There are usually genes that are likely to be expressed under different 
conditions and regulated by different mechanisms (Koonin, 2003). 
As previously described in Chapter 1, S. Typhimurium has a demand for cobalt 
as it requires this metal for cobalamin biosynthesis. The cbiMNQO genes, 
presented below in fig. 3.2, share structural similarities with other ABC-type 
transporters and are located within close proximity to cobalamin biosynthetic 
genes (Raux et al., 1996; Rodionov et al., 2006). Genomic context of cbiM 
(stm2023) presented in fig 3.2 below annotates it as encoding for cobalamin 
biosynthesis protein CbiM (protein coding). Subsequent genes of the putative 
operon cbiN and cbiQ are described as cobalt ABC-transporter substrate-
binding protein CbiN and cobalt ECF transporter T component CbiQ, 
respectively. Downstream cbiO encodes for energy coupling factor (ECF) ABC 
transporter ATP-binding protein. Roth and colleagues, (1993) identified 
cbiMNQO gene cluster and predicted that it functions without periplasmic 
substrate-binding protein. Their hypothesis was confirmed a few years later 
which suggests that functionality of transporter (cbiMNQO) can be corrected by 
an increase in cobalt concentration in the medium (Rodionov et al., 2006). This 
represents a prime example of ECF type of transporter which this cluster is 
classified as (Eitinger et al., 2011). T component of the transporter, encoded by 
cbiQ, was identified to be abundant across the other species and is usually 
flanked by ATPase genes (cbiO) but not the periplasmic substrate binding 
protein. According to Eitinger et al., (2011) many annotations were done by 
mistake – the presence of the CbiO determines that those were annotated 
correctly. They usually appear independent or within proximity of an adjacent S-
unit gene (encoding substrate-binding subunit) (Eitinger et al., 2011).  
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Fig. 3.2 Genomic context of cbiM; source NCBI. Prediction result of genomic 
context of cbiM – indicated in red, showing as protein coding, counterclockwise 
transcribed. Downstream cbiNQO are indicated with the same direction of 
transcription and are predicted to encode ECF ABC-type cobalt transporter 
(Rodionov et al., 2003) .  
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Rodionov and colleagues (2006) confirmed that CbiO (A unit) as a nucleotide-
binding unit needs to dimerise to function (as presented in fig 3.1 – A and A’ 
dimerise). The function of other components of the system was predicted to 
form amino acid similarities (CbiMNQ). CbiM was predicted to have seven 
transmembrane domains, CbiN to have two transmembraine domains, and 
CbiQ belonging to a family of T proteins. It was confirmed that in the absence of 
CbiO in recombinant E. coli, basal transport activity of Co2+ was observed. This 
suggest the alternative cobalt transporter activity (Rodionov et al., 2006). It was 
also observed that Co2+ and Ni2+ transporters are an exception among ECF 
systems as their S unit (CbiMN) appears heterooligomeric. Cobalt and nickels 
transporters have been reported to share similarities (CbiMNQO and 
NikMNQO). However, the Cbi system was found to have a strong preference 
towards cobalt (Rodionov et al., 2006). 
Genomic location of genes encoding ECF transporter units determines 
transporter group classification. There are two subcategories of the ECF 
transporters. In I group S-unit is specific to the particular ECF module whilst in 
the II group ECF module interacts with various S-units of different substrate 
specificities. Additionally, in II group S-unit can be released from ECF module 
and compete with other units to bind to the module (Karpowich et al., 2015).   S-
units are a very substrate-specific and therefore were difficult to classify as they 
represent very diverse group and share relatively very little sequence identity, 
approximately ~15% (Karpowich & Wang, 2013). With accordance to Rodionov 
and co-workers (2006) CbiMN ECF transporter was classified to I group. They 
were also described to require additional small integral membrane proteins 
which are predicted to facilitate binding of the substrate – this mechanism 
however remains unclear (Rodionov et al., 2006; Zhang et al., 2010).  
3.1.3 stm3071/3072/3073/3074/3075 identification 
NCBI database annotates cboQ (stm2021) as cobalt ECF transporter T 
component CbiQ. Search result for cbiQ domain in S. Typhimurium also 
identifies STM3073 cobalt ABC transporter permease (stm3073) (fig. 3.3), 
which to date has not been described in the literature and its biological function 
has not been confirmed. Amino acid sequence alignment has been provided 
and presented in fug 3.3. 
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Fig. 3.3. CbiQ and STM3073 – function prediction investigation. A. NCBI 
gene search result for CbiQ annotation. Search result identifies CbiQ in S. Typhi 
and Yersinia entercolitica subsp. Entercolitica 8081. Red box indicates for CbiQ 
annotations in S. Typhimurium; cboQ and stm3073. B. Amino acid sequence 
alignment of CbiQ and STM3071.  
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Fig. 3.4. Schematic visualisation of genomic context of stm3073 and 
stm3071 queried from NCBI. A Represents genomic context of stm3073 (in 
red) and its neighbouring genes location in the genome; indicated as protein 
coding and clockwise transcribed. B Represents genomic context of stm3071 
(in red) and its neighbouring genes. Gene type described as protein coding and 
described as putative DNA-binding protein; and clockwise transcribed. 
Transcription direction of upstream epd indicated in the opposite, counter 
clockwise direction.  
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Presented on the previous page, in fig 3.4 A genomic context of stm3073 shows 
localisation, orientation and neighbouring genes. Upstream stm3071 and 
stm3072 as well as downstream stm3074 and stm3075 are transcribed in the 
same direction, which is the main criterion for operon prediction (Brouwer et al., 
2008; Rogozin et al., 2004). 
Domains located downstream from stm3073 (stm3074 and stm3075, fig. 3.4 A) 
are annotated as ATP-binding proteins (table 3.1). This, as described by Roth et 
al. (1993) and Rodionov et al. (2006), suggests correct classification to ECF 
transporters – S-unit should be located within close proximity to ATP-binding 
units. Additionally, according with ECF classification it is likely that 
stm3072/3073/3074/3075 module belongs to the II group of the ECF 
transporters – similarly to cbiNQO. ECF transporters as described earlier, are 
defined as a subgroup of ABC transporters involved in the uptake of 
micronutrients in prokaryotes (Erkens et al., 2012). Described in fig 3.2 are ECF 
transporters that have been characterised to consist of two conserved 
peripherial ATPases (here stm3074 and stm3075), the integral membrane 
protein EcfT (stm3073) and a non-conserved integral membrane protein that 
determines substrate specificity which here represents cobalt-specific 
transporter (Rodionov et al., 2006; ter Beek et al., 2011). All predicted functions 
were listed in the table 3.1 and predicted annotations compared to 
corresponding genes of the cbiMNQO cluster.  
Sequence encoding stm3071 opens a putative operon. According to NCBI, 
stm3071 is annotated as a putative DNA-binding protein (fig. 3.4 B).  
Summarised and compared in table 1, stm3071 does not have an equivalent in 
cbiMNQO cluster.  
Genes located upstream from cbiM encode for cobalamin biosynthesis pathway 
and are regulated by end-product repression and also co-regulated by PocR 
regulator (Roth et al., 1993a). Gene encoding putative DNA-binding protein 
STM3071 opens the tandem (presented in fig 3.4 B). The sequence located 
upstream from stm3071, epd is transcribed in the opposite direction (fig. 3.4 B). 
Therefore, it is likely that stm3071 opens the predicted operon and due to 
sequence similarities with other DNA-binding proteins it is possible that acts as 
a transcriptional regulator of downstream genes potentially involved in cobalt 
transport.  
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Predicted role – NCBI 
annotation 
stm3071/3072/30
73/3074/3075 
Predicted role – NCBI annotation cbi operon 
DNA-binding 
protein 
stm3071 cobalamin biosynthesis 
protein CbiM, 
transmembrane protein 
 
cbiM 
ECF transporter 
S-unit 
stm3072 cobalt ABC transporter 
substrate-binding protein 
CbiN, transmembrane 
protein, (ECF transporter S-
unit) 
cbiN 
cobalt ABC 
transporter 
permease (cobalt 
ECF transporter T 
component CbiQ) 
stm3073 cobalt ECF transporter T 
component CbiQ 
cbiQ 
cobalt ABC 
transporter ATP-
binding protein 
stm3074 energy-coupling factor 
ABC transporter ATP-
binding protein 
cbiO 
ABC transporter 
ATP-binding 
protein 
stm3075   
Table 3.1. Summary of the predicted function of identified predicted operon 
stm3071/3072/3073/3074/3075 in comparison to predicted functions of 
previously described cbiMNQO genes. Indicated in bold genes names are 
predicted to have analogous function. Summary based in accordance with NCBI 
predicted annotations.  
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 Operon prediction  3.2
Operon prediction is described in literature as one of the biggest challenges in 
microbial functional genomics (Brouwer et al., 2008; Rogozin et al., 2004). 
Generally, genes that are classified as operons usually are arranged in tandem 
in a genomic sequence, delimited by promoter at the beginning of the tandem 
(Chen et al., 2004). In literature an operon is described as a cluster of 
consecutive genes arranged in tandem that share the same orientation of the 
transcription (Rogozin et al., 2004). Intergenic distances between should be 
shorter than the inter-operon distances and operon is usually delimited by a 
promoter and terminator. Additionally, genes should have similar predicted 
functions and functional category. Ideally, those genes should be well 
conserved amongst phylogenetically related species – comparative genomics 
are one of the most reliable approaches in protein prediction. Rogazin and 
colleagues, (2004) described co-regulation of expression and summarised the 
co-existence of the regulator genes with functional genes. In some cases the 
regulator is present within close proximity to the operon, however this is 
relatively uncommon and the classic and most described example is the lacZYA 
operon in E. coli (Lawrence & Roth, 1996).  
Analysis of cbiMNQO shows that they are co-localised with genes involved in 
cobalamin biosynthesis and are regulated by coeznzyme B12 riboswitch 
elements, suggesting implication in Co2+ uptake (Rodionov et al., 2006; Roth et 
al., 1993b). Experimental analysis confirmed the bioinformatics predictions, thus 
it cbiMNQO cluster is characterised as an operon.  
Presented in fig 3.3, stm3071/3072/3073/3074/3075 share the same 
transcription orientation on the strand and according to the genome map are 
adjacent in the cluster. Predicted functions of those genes suggest they are 
likely to form a cobalt transporter. First of the identified genes in tandem is 
predicted to encode a putative DNA-binding protein, which in literature suggests 
that it acts a regulator of downstream genes (Aravind & Landsman, 1998; 
Galperin, 2006). 
Operon prediction software was used to analyse 
stm3071/3072/3073/3074/3075 cluster (fig. 3.5). Accessed on 
microbesoline.com website tool provides operon prediction analysis based on 
proximity of analysed genes and on how conserved they are in other genomes. 
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The tool also takes into account whether analysed genes are predicted to 
encode proteins with related functions as well as expression data when 
available (Price et al., 2005). Prediction indicated transcription orientation as 
well as that described above identifies conserved domains found across genes. 
Identified COG1661 domain within stm3071, based on the functional 
predictions, is listed as a putative DNA-binding protein (fig. 3.5). Downstream 
genes are predicted accordingly as described above to encode putative ECF 
ABC-type transporter involved in cobalt transport.  
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Fig 3.5. Operon prediction analysis. In the operon viewer query gene 
stm3071 is shown in dark blue and downstream genes that are predicted to be 
part of the putative operon are presented in light blue. Arrowhead indicates the 
transcription direction. Numbers below the genes indicate the intergenic 
distance between two adjacent genes. Negative numbers indicate overlapping 
genes. Genes are named either by the gene name or synonym that is linked to 
its predicted function. Here, stm3071, the query gene is labelled with the 
predicted gene function – DNA-binding protein COG1661. Genes stm3073 and 
stm3074 are indicated as COG-CbiQ and COG-CbiO respectively. CbiQ 
indicates for the similarities with ABC-type cobalt transport systems, permease 
component CbiQ, whereas CbiO for ATPase component. (source: 
http://www.microbesonline.org/cgi-bin/fetchLocus.cgi?disp=1&locus=150368) 
(Dehal et al., 2010). 
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Additionally, the Procaryotic Operon DataBase was used to compare the above 
prediction. This software uses an operon prediction algorithm, which provides 
operon data prediction across 1200 procaryotic genomes and collectively aims 
to list all operons not only based on prediction results but also to include 
experimentally confirmed data, if available (Taboada et al., 2012). Both, 
cbiMNQO as well as stm3071/3073/3074/3075 were analysed using Operon 
DataBase prediction tool (fig. 3.5). The algorithm used considers intergenic 
spaces between consecutive genes as well as functional relationship scores of 
the STRING database between different groups of orthologous proteins 
accordingly with COG (Clusters of Orthologues) database (Taboada et al., 
2012).  
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Fig. 3.6. Operon predictions analysis for stm3071/3072/3073/3074/3075 and 
cbiABCDEFGHJKLMNQOPUST operons and pocR. Result obtained from 
Procaryotic Operon DataBase (Taboada et al., 2012). Selected STM3071 in the 
analysis appears independently to predicted operon stm3072/3073/3074/3075. 
Analysis provides information about gene name (if characterised), gene 
location, left and right position, gene orientation, gene product, and position in 
the predicted operon. The result was selectively chosen out of the entire list of 
operons predicted for S. Typhimurium. 
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In terms of cbi operon, it was clear from previous research that cbiMNQO are 
part of cbi genes that encode for cobalamin biosynthesis. It was also previously 
described that the operon is regulated by the end-product (Roth et al., 1993b). 
Located in the nearest neighbourhood of cbi genes, PocR acts upon as a 
transcriptional regulator (Rondon & Escalante-Semerena, 1992, 1996). It is 
possible that STM3071 is expressed under specific conditions, as it requires 
activation of cobalt transport of some sort.  
Further to speculations as to whether investigated genes function as an operon, 
it was analysed whether the orthologous cluster appears within other species. 
Microbesonline software provides a phylogenetic approach to comparative 
genomics of queried genes with other organisms. Result obtained provide 
information about identified domain (COG) name, and neighbouring clusters 
(COGs) as well as and tree orthologues (Dehal et al., 2010). 
To further investigate similarities and conservancy of the described genes, 
nucleotide sequence of stm3071 was analysed using gene tree finder 
(microbesonline.org). Similarly, to the previous analysis most conservancy was 
detected amongst other Salmonella strains. There were also identified in 
Citrobacter koseri, Laribacter hongkongensis and Providentia rettgeri. 
Citrobacter is a non-pathogenic bacterium but is also associated with the gut. 
Importantly, it can be observed that query genes are flanked in all genomes with 
the same genes suggesting their similar function and importance in these 
organisms. This predicted operon is also likely to have conserved function in 
other organisms due to similarities in adjacent genes also suggesting analogous 
location on their genomes. Flanking upstream epd encoding for erythrose 4- 
phosphate dehydrogenase located upstream from stm3071 and is marked as 
transcribed anticlockwise and at the same time in the opposite direction from 
the stm3071. Located downstream from stm3075, tktA and trpA encoding for 
transketolase and transposase respectively, are transcribed clockwise similarly 
to the predicted operon.  
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Fig. 3.7. Tree Browser gene centric view for S. Typhimurium gene 
stm3071, accessed at Microbesonline (Dehal et al., 2010). COG1661 domain 
identified within stm3071 encodes for putative DNA-binding domain (indicated in 
cyan). Downstream stm3072 is described as hypothetical protein and/or across 
listed organisms as putative inner membrane protein (indicated in turquoise).  
COG-CbiQ is described as ABC-type cobalt or multidrug transport system 
(indicated in gold). COG-CysA with predicted ATPase component, conserved 
across other species (indicated in light blue).  
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Tree browser analyser was used for gene context analysis of the cbi genes. 
This shows conservative domains across the putative operon and predictions of 
the gene functions. The view determined for stm3071 shows that all genes in 
the predicted operon are protein coding (fig. 3.7). 
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Fig. 3.8. The species view for stm3071 (Dehal et al., 2010). The gene tree is 
presented on the left and species tree on the right. Gene tree leaves were 
labelled numerically and correspond with species tree. In species tree green 
colour indicates that every genome in this group contains a gene from the 
shown part of the tree. Citrobacter appears to have only one gene in 2 genomes 
so it might be likely that COG1661 was acquired in the event of horizontal gene 
transfer. Species tree also indicates that is very common in Salmonella genus.  
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Fig. 3.9 The evidence view of the similarity conservancy patterns amongst 
other organisms. This view represents a phylogenetic display of the 
organisms. This allows viewing clusters of orthologous groups of genes in other 
organisms, here referring to proteins. Colours represent quantitative similarities 
of the protein in other species, where dark brown stands for 100% identity. 
Required medium confidence score was standardised at p≤0.4. 
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The picture on previous page (fig. 3.9) represents visual illustration of the 
phylogenetic occurrence of the queried genes. It shows that the putative operon 
occurs with highest sequence identity in Salmonella enterica. 
Investigated further from the evidence view (fig 3.9), proteins that shared most 
conservancy amongst other organisms were analysed based on the nucleotide 
sequence identities. The most similar organisation of the putative operon was 
found in Salmonella species. Similar patterns were also detected in other 
pathogens, such as Escherichia albertii, Providencia stuarti, Klebsiella oxitoca, 
and also Shigella flexneri. Interestingly, most commonly occurring genes found 
in other species were stm3074 and stm3075. Both of these encode for putative 
cobalt ABC transporter ATP-binding proteins.  
The phylogenetic approach is another important criterion in operon prediction 
approach serving as another piece of evidence that 
stm3071/3072/3073/3074/3075 might function as an operon.  
 STM3071 3.3
Using String 10 software, a correlation view of stm3071 was generated. 
Correlation evidence of stm3071, presented over the page, represents 
interaction evidence between stm3071 and other genes. Gene stm3071 is 
described to encode for putative DNA-binding protein STM3071. Fig. 3.9 over 
the page further shows the evidence of possible interaction with downstream 
genes. Most interactions in the evidence view of stm3071 are linked to 
downstream genes predicting for co-occurrence and neighbourhood. Genes 
stm0916 and stm1038 described as predicted major tail proteins and 
hypothetical ybjC were linked to stm3071 based on co-occurrence evidence. 
NCBI results describe major tail proteins as containing Ig-like domain which are 
members of the family that are found in bacterial and phage surface proteins 
such as intimins. Most interactions were detected between stm3072, stm3073, 
stm3074 and stm3075.  
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Fig. 3.10 The String 10 network view for stm3071. Combined screenshots 
from String 10 software analysis which has been queried with stm3071 of 
S. Typhimurium. Coloured lines between proteins indicate various types of 
interaction evidence. Network view shows correlations between genes in the 
predicted operon. Blue indicates co-occurrence amongst other organisms, 
green stands for neighbourhood of analysed genes, red indicates for gene 
fusion, and light blue for homology. String 10 software (source: http://string-
db.org/). 
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3.2.1 Analysis of proteomic context 
NCBI conserved domains finder was used to analyse STM3071 amino acid 
sequence (source: http://www.ncbi.nlm.nih.gov/protein/). Amino acid sequence 
of STM3071 was obtained from NCBI and presented in fig. 3.11 B over that 
page. 
The first of the genes stm3071 was analysed using NCBI conserved domains 
finder and DUF296 was identified (Fig. 3.11 A). This represents a domain of 
unknown function. According to NCBI this protein is largely found in archea, 
bacteria and plants and contains an AT-hook motif that suggests a role in DNA-
binding. Three conserved histidine residues appear to form a zinc-binding site 
and that domain has been observed to form homotrimers. It occurs together 
with a thioredoxin-like domain. Proteins possessing zinc fingers typically 
function as molecules that bind RNA, DNA proteins or other small molecules 
(Ali et al., 2012). There are three types of AT-hook proteins and these were 
classified according to their sequence similarities (Aravind and Landsman, 
1998). AT-hook motifs are associated with known functional domains as seen in 
a chromatin proteins and DNA-binding proteins (histone folds, homeodomains, 
zinc fingers). They usually support changes in a DNA structure and function as 
a polypeptide of multidomain. The number of experiments conducted on AT-
hook containing proteins demonstrated that they play an important role in 
chromatin structure and act as transcription cofactors (Kim et al., 1997; Slama-
Shwok et al., 2000). 
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Fig.3.11 NCBI conserved domains finder. A. This putative domain is found in 
protein containing AT-hook motif that strongly suggests DNA-binding function of 
this protein, zinc-binding site (Aravind and Landsman, 1998). B. Amino acid 
sequence of STM3071. 
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 Summary 3.4
Summarising the above findings, it is likely that stm3071/3072/3073/3074/3075 
represent a putative operon. It may be that they exist as a copy for cbiMNQO 
genes and are important for the organism in case of loss of function. It is also 
possible that they are expressed under completely different conditions and their 
occurrence is separate to cbi genes. These genes are present across 91 other 
species associated with the gut, which might suggest that they are expressed 
and are needed for intracellular survival. Thus it is also likely that they were not 
acquired by horizontal transfer. This also suggests that they are likely to be 
functional. There is a question, however whether stm3071 plays a separate role 
or is a part of the putative operon.  
STM3071 is predicted to act as a DNA-binding protein and it is not clear 
whether it plays a role as a transcriptional regulator of downstream genes or 
whether it is not related to the downstream cluster. There is also potential that 
STM3071 might act as a metal regulatory protein due to the presence of 
predicted zinc binding site. Investigation of the role of STM3071 is described in 
the next chapter. 
 
 
 
 
 
 
 
 
 
 
 
102 
 
4. Chapter 4 – Investigation of STM3071  
 Introduction - DNA-binding and zinc-binding 4.1
proteins in bacteria. 
In chapter 3 it was discussed that based on the sequence identity STM3071 
might represent DNA-binding protein due to the presence of an AT-hook motif 
and a putative zinc-binding site. Thus, it is possible that it may function as a 
transcriptional regulator of downstream genes putatively involved in cobalt 
transport.Cellular regulation of transcription occurs at the level of initiation. In 
order for the process to happen recognition of a specific DNA sequence needs 
to occur and is mostly performed by proteins under strictly controlled conditions 
(Alberts et al., 2002). Regulation of transcription is the most critical control point 
in gene expression (Seshasayee et al., 2011). Transcriptional factors are 
usually identified based on the presence of a DNA-binding motif using 
sequence searches against protein family databases (Finn et al., 2014). DNA-
binding proteins in bacteria represent a varied group of proteins. The first 
identified DNA-binding protein in prokaryotic organisms was helix-turn-helix 
(HTH), and that type of motif was initially considered to be exclusive for 
bacteria. It was characterised by an X-ray crystallography and it was the cyclic 
AMP receptor protein of E. coli (McKay & Steitz, 1981). Now, HTH is a well-
known motif that was identified in many DNA-binding proteins and across many 
species both prokaryotic and eukaryotic. Another commonly identified DNA-
binding motif is Zn-binding site (Alberts et al., 2002). Whilst the HTH motif 
consists of amino acids, zinc fingers coordinate one or more zinc atoms as 
structural components. DNA-binding proteins that contain a zinc-binding site are 
common in eukaryotic organisms, however not so frequently identified in 
bacterial organisms. Those found in bacteria are termed histone-like proteins 
and they are involved in DNA modulation in processes such as replication, 
recombination, repair, and  transcription (Dillon & Dorman, 2010; Drlica & 
Rouviere-Yaniv, 1987).  
Bacterial proteins that contain zinc-binding sites are usually involved in 
repression of transcription in response to heavy metal toxicity but the Zn-finger 
DNA-binding domain is mostly found in eukaryotic organisms. Zinc acts as a 
conformational inducer to structural rearrangements leading to repression 
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(Ebert & Altman, 2008; Petrarca et al., 2010). Zinc-binding transcriptional 
regulators represent a rather diverse group and in some cases binding is 
specific not only to zinc but can also involve other divalent metal cations 
(Hantke, 2001). 
There is a rather small set of non-HTH bacterial DNA-binding proteins amongst 
those that were identified. Accordingly, with as mentioned above the zinc-finger 
DNA-binding domain is prevalent across eukaryotic transcription factors (TFs) 
but is rare in bacteria. C2H2 Zn-finger (cysteine and histidine coordinated zinc 
ion) was identified in Ros/MucR of Agrobacterium tumefanciens (Chou et al., 
1998; Esposito et al., 2006) and also MucR of Rhizobium meliloti (Keller et al., 
1995), however it differs to the eukaryotic ones. They have less residues and 
only 2 pairs of metal-chelating ligands (Esposito et al., 2006). Zinc ribbon is also 
found in bacterial TFs, however it is not a primary DNA-binding domain but 
rather interacts with RNA polymerases, such as NrdR found in E. coli that acts 
as a regulator of the ribonucleotide reductase operons (Torrents et al., 2007). 
There has also been identified AT-hook motif to occur in bacterial TFs. AT-hook 
proteins in eukaryotic organisms belong to the high mobility non-histone 
chromosomal group (HMG-I(Y)) which bind to minor grooves of DNA via 
conserved 9 amino acid domain called AT-hook. This motif is also prevalent in 
eukaryotic organisms and not so frequent in prokaryotic (Aravind & Landsman, 
1998). Thus, bacterial proteins containing AT-hook have not been very well 
characterised. 
 Protein function investigation 4.2
4.1.1 Prediction analysis 
Based on sequence characteristics and predicted function STM3071 was 
proposed as DNA-binding protein acting as potential regulator of downstream 
genes. 
Initially, STM3071 was annotated with DNA-bind prediction. In-depth 
investigation of the sequence revealed that the amino acid sequence of 
STM3071 does not contain the PRGRP sequence, which represents the 
functional AT-hook domain responsible for minor groove binding (Aravind & 
Landsman, 1998). However, as it was previously annotated, the domain 
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resembles similarities with proteins that contain AT-hook. CnD3 software was 
used to visualise 3D protein structure – presented in figure 4.1 over the page. 
 
 
 
Fig. 4.1 Cn3D software prediction of conserved domains identified within 
STM3071. (a) Visual representation of DUF296 (domain of unknown function). 
Usually associated with proteins that also contain AT-hook motifs based on 
which protein is predicted to play role in DNA-binding as a whole. Three 
conserved His residues indicated in yellow, appear to form zinc-binding site – 
the domain was observed to form homotrimers and was associated with 
thioredoxin-like in uncharacterised cyanobacterial proteins. (b) Visual 
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presentation of 3 domains (in green), homotrimer with coordinated 3 zinc atoms. 
(combination of screen shots; generated using Cn3D 4.3 software) (Marchler-
Bauer et al., 2015).  
Annotation summary accessed on NCBI predicts zinc-binding site evidence 
based of Vibrio cholerae Q9KM02 protein that also represents putative zinc-
binding site. Based on sequence similarities with Archaeglobus fulgidus AF0104 
protein homotrimer formation prediction was annotated (NCBI).  
4.1.2 Construction of recombinant protein 
To investigate the function of STM3071, nucleotide sequence encoding 
predicted protein was cloned into pPAL7 expression vector in order to obtain 
recombinant protein for further analysis.  
The ability to express and purify large quantities of recombinant proteins in 
combination with whole genome sequencing has revolutionised many fields of 
biology including drug discovery. The most commonly used expression system 
is  E. coli due to relatively high yields of protein, quick doubling time and high 
growth rates  (Miroux & Walker, 1996). The ability to express and purify 
recombinant protein in large quantity allows to determination of its biochemical 
properties, which are crucial for complete protein characterisation (Rosano & 
Ceccarelli, 2014).  
Engineered subtilisin pro-domain was fused to the N-terminus of the STM3071. 
The pro-domain acts as a high affinity tag that is automatically removed by an 
auto-cleavage reaction during the elution from subtilisin affinity chromatography 
resin. Encoding STM3071 nucleotide sequence was cloned in frame into pPAL7 
expression vector under T7 strong promoter in order to obtain heterologous 
protein construct. The 8 kDa Profinity eXact tag containing EEDKLFKAL amino 
acid sequence is specifically recognised by genetically engineered proteolytic 
enzyme subtilisin active site that was immobilised on the resin (Biorad, UK). 
The tag is a form of a wild-type subtilisin BPN prodomain that contains cleavage 
recognition sequence of the subtilisin mutant. Exo-recognition sequence for the 
subtilisin increases the binding activity to the enzyme active site which 
enhances cleavage specificity to the tag (Ruan et al., 2004).   
The nucleotide sequence was amplified and ligated into HindIII and EcoRI sites 
in pPAL7 (fig. 4.2). 
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Fig. 4.2 Schematic drawing of pAZ1/stm3071 expression vector construct. 
A. Sequence encoding stm3071 was cloned into HindIII and EcoRI restriction 
site (indicated in orange); inserted in frame with Profinity eXact tag (in blue), 
under the control of T7 lac promoter (light blue). Indicated in green bla encodes 
for ampicillin resistance. Indicated in maroon lacI repressor binds to DNA and 
prevents RNA polymerase from escaping promoter region. In the presence of 
IPTG repressor changes allosteric coordination allowing RNA polymerase to 
elongate – expression of the recombinant protein is controlled upon IPTG 
induction.  B.  Sequence of Profinity eXact and cloning region. Cloning into 
HindII and BamHI allows precise fusion. Purification results in a tag-free target 
protein without amino acids after cleavage Profinity eXact of the tag. 
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Nucleotide sequence of stm3071 (NC_003197.2) was amplified from S. 
Typhimurium SL1344 with PAL3071R and PAL3071F primers (table 2.3) and 
cloned into pPAL7 expression vector (Taylor, unpublished data).  
Selected clones were recovered and transformed into E. coli α-select cells 
(Bioline, UK). Plasmid DNA was isolated from 26 selected clones. Each clone 
was tested for insert presence by PCR with primers used for cloning 
(PAL3071R and PAL3071R). PCR products were analysed using gel 
electrophoresis and cloning was confirmed successful in most selected 
constructs (fig. 4.3).   
A number of 4 successful clones were selected and sequenced. Sequencing 
was carried out with provided pPAL7 sequencing primer. Obtained sequences 
were aligned against the original stm3071 sequence (NC_003197.2) to test for 
any potential errors (fig. 4.4). 
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Fig. 4.3 Agarose gel electrophoresis analysis of amplified stm3071 inserts 
from cloning vector pPAL7. Lines 1 and 14: DNA size marker (Hyperladder 
1). Lines 2-13 and 15-26 PCR products. Successful cloning was confirmed by 
PCR with PAL3071F and PAL3071R cloning primers. PCR product ~400 bp. 
Gel electrophoresis (1% agarose gel) analysis indicated cloning was successful 
in most selected clones.  
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Fig.4.4 Alignment of 5 selected constructs against to the original query 
sequence representing stm3071 from S. Typhimurium (NC_003197.2). 
Analysis was conducted using Multalin software 
(http://multalin.toulouse.inra.fr/multalin/). pAZ5 was found to have incomplete 
gene sequence and was not used further in this study. Remaining constructs 
were correct and pAZ1 was renamed pAZ1/stm3071 and used further in this 
study (Corpet, 1988).  
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4.1.3 Recombinant protein expression and purification 
 
Selected pAZ1/stm3071 construct was transformed into E. coli BL21 (DE3) cells 
for expression. The purification procedure was conducted according to the 
manufacturer’s instructions (Biorad, UK) as described in chapter 2.  
Expression of STM3071 was induced by addition of IPTG to a final 
concentration of 1 mM in LB medium when cells were in mid-log phase (OD600 
at approximately 0.5). Induction at 37°C was carried for 4 h and O/N at 20°C. 
Expression experiments were conducted at 20°C and 37°C in order to optimise 
the procedure and obtain high level of expression with the highest possible ratio 
of recombinant protein in soluble form. Total protein content was separated into 
soluble and isoluble fractions using BugBuster protein extraction reagent and 
analysed by SDS-PAGE electrophoresis (fig. 4.5). 
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Fig 4.5 Solubility determination of STM3071 overexpressed at different 
temperatures in LB rich media. Expression was analysed by SDS-PAGE. A 
volume of 10 µl of insoluble and soluble fractions extracted from E. coli BL21 
(DE3) using 1x BugBuster in 0.1 M sodium phosphate, pH 7.2. Pre-induced 
(Pre) and post-induced (Post) with IPTG samples were treated with 2x SDS 
sample buffer. A volume of 8 µl of pre-induced samples  and 4 µl of post-
induced samples was loaded onto 15% polyacrylamide gel and SimplyBlue 
(Invitrogen, UK) stained after separation. Protein size markers  were used as a 
molecular weight reference to confirm the correct size of the protein. A shows 
solubility analysis of STM3071 expressed at 37°C and B at 20°C. Protein was 
equally expressed both at 20°C (B) and 37°C (A). Solubility studies shown more 
soluble STM3071 was obtained from cells cultured at 20°C. Overexpressed 
recombinant proteins of the correct size are indicated with arrows. 
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As presented in fig. 4.5, it was determined that STM3071 can be expressed in 
E. coli in soluble form. Solubility determination showed that certain fractions of 
overexpressed STM3071 remained in insoluble form. SDS-PAGE analysis of 
overexpressed, recombinant STM3071 showed it was soluble both at 20°C and 
37°C, with relatively higher proportion of soluble STM3071 obtained at 20°C 
(fig. 4.5 B).  
According to Sorensen and Mortensen, (2005) medium composition and growth 
temperature are important factors in optimisation of heterologous protein 
expression (Sørensen & Mortensen, 2005). It was difficult to observe whether 
soluble subset of STM3071 was achieved at 20°C or 37°C (Fig. 4.5). Thus, 
purification procedures were conducted with proteins expressed at both 
temperatures.  
4.1.4 Purification of STM3071 
Prior purification procedure molecular weight of STM3071 was determined 
based on the information accessed on NCBI. The protein consists of 141 amino 
acids and its molecular weight was calculated at 15.6 kDa. The tag attached to 
the STM3071 is 8.2 kDa. Molecular weight of recombinant protein is 23.8 kDa 
(already indicated in fig. 4.5).  
Purification of STM3071 was performed using Profinity exact Mini purification 
starter kit (Biorad, UK). Purity was analysed by SDS PAGE (fig. 4.6). 
Purification procedure was carried out under exactly the same conditions for 
both protein extracts obtained at 20°C and 37°C. Cleavage was obtained by 
subtilisin activation using sodium fluoride elution buffer (according to 
manufacturer’s instructions). This allowed C-terminus cleavage of the 
recognition sequence, resulting in purified and tag-free native form of STM3071. 
SDS PAGE analysis shows that there was observably higher levels of purified 
STM3071 obtained from cells induced at 20°C (fig. 4.6). 
Purification of STM3071 overexpressed at 20°C indicated higher ratio of soluble 
subset (fig. 4.6) and following temperature was selected as more efficient in 
obtaining higher levels of soluble STM3071.  
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Fig. 4.6 Profinity eXact affinity-tagged STM3071 purified Profinity eXact 
purification system (Biorad, UK). Samples were analysed on a 15% 
polyacrylamide gel and stained with Simply Blue (invitrogen, UK). Lanes 1 (fig. 
A and B) indicate protein markers used as a molecular weight reference 
(Sigma-Aldrich, UK). Lanes 2 (fig. A and B) a volume of  8 µl of pre-induced; 
lanes 3 (A & B) a volume of 4 µl of post-induced samples were treated with 2x 
SDS sample buffer. Lane 4 in fig A represents eluted tag free STM3071 of 
overexpressed at 37°C. Lane 5 in fig B represents eluted tag free STM3071 
overexpressed at 20°C.Lanes 5 in fig A and lanes 6 and 7 in fig B are host 
protein contaminants washed from the resin by 0.1 M sodium phosphate, pH 
7.2 bind/wash buffer. Line 6 represents eluted tag-free maltose binding protein 
(MBP) control of the purification procedure. In fig B STM3071 purified protein 
was run twice the column therefore not as many contaminants in the 
flowthrough are present in comparison with purification at 37°C (A). Protein of 
the correct size indicated with arrows.  
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Fig. 4.7. Bovine serum albumin (BSA) standard curve. Absorbance was 
determined using plate reader at 550 nm wavelength absorbance. Based on 
linear trend line standard curve equation, concentration of STM3071 was 
calculated.   
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Following purification Bicinchoninic assay (BCA) was carried out to determine 
the concentration of STM3071 (fig. 4.7). BCA assay is a biochemical method 
that allows protein concentration determination in the solution based on 
colorimetric reaction (Smith et al., 1985). Prepared set of standards at different 
concentration and two samples of STM3071 of unknown concertation were 
measured at 550 nm wavelength with plate reader. The concentration of 
STM3071 was calculated based on linear trend standard curve equation 
presented in fig 4.7.  
STM3071 protein concentration obtained from 2 cultures (sample 1 (20°C): 489 
µg ml-1, sample 2 (20°C): 546 µg ml-1). Molecular weight of the purified protein 
was determined based on its amino acid sequence (MW of STM3071 =  
15230.396 g mol-1). Protein was stabilized in 20% glycerol, aliquoted and stored 
at -20°C until further analysis.   
4.1.5 Investigation of STM3071 DNA-binding properties 
 
Electrophoretic mobility shift assay (EMSA) also known as retardation shift 
assay is well described and a sensitive method for DNA-protein interactions 
(Garner & Revzin, 1981). EMSA was carried out according to Campbell and 
colleagues, (2007). Prior to the procedure, an aliquot of STM3071 was analysed 
using SDS-PAGE to confirm the presence of protein in the sample and rule out 
potential protein degradation (fig. 4.8). 
 
 
 
117 
 
 
Fig. 4.8 Profinity eXact affinity-tagged STM3071 and purified STM3071 
SDS-PAGE analysis. Samples were analysed (a volume of 5 µl of each, 
prepared in 2x sample buffer) on a 15% polyacrylamide gel and stained with 
Simply Blue (Invitrogen, UK). Figure represents cropped image that visualises 
proteins of interest. Tagged STM3071 (Profinity eXact tagged STM3071) was 
obtaned from total lysate of the corresponding culture that STM3071 was 
purified from and saved for further analysis. Thawed purified STM3071 was 
confirmed present and not degraded.  
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Gel retardation assya used to detect DNA-protein complexes is a powerful 
method for charaterisation of the interactive systems between nucleid acids and 
proteins (Hellman & Fried, 2007). In a classical way, cell lysate is combined with 
the probe cognate nucleotide binding. Protein interaction with DNA usually 
occurs within the promoter-operator region. In prokaryotic organisms the 
promoter region is usually located at -10 and -35 upstream from the 
transcription start site of the first gene in the operon (Apostolaki & Kalosakas, 
2011).  
Promoter prediction analysis was conducted with software that estimates the 
potential consensus sequence. The upstream region from stm3071 was 
accessed at NCBI and analysed using PePPER webserver for prediction of 
prokaryote promoter elements and regulons (de Jong et al., 2012). Analysis 
upstream from stm3071 region from of S. Typhimurium detected two potential 
promoter sites (fig. 4.9 a).  
As described in chapter 3 and earlier in this chapter it remains unclear whether 
STM3071 should be considered DNA-binding. In chapter 3 it was discussed that 
it remains ambiguous whether stm3071 functions as a part of 
stm3071/3072/3073/3074/3075 operon or whether it functions as an 
independent regulator. Therefore, for DNA-binding investigation study upstream 
and downstream region of stm3071 was investigated. In order to perform this, 
as schematically presented in fig. 4.9 B, regions located from the nearest 
proximity from the stm3071 were amplified and used in DNA-binding 
investigations.  
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Fig. 4.9. DNA-binding sequence predictions. (A) Represents sequence of 
region located upstream from stm3071; this region represents most probable 
binding DNA-binding sites for STM3071 with underlined predicted consensus 
sequences, underlined in bold. (de Jong et al., 2012). Sequence represents 601 
bp region from base 3287625 to 3288225 of S. Typhimurium. This sequence 
was also used further in expression experiments. (B) Schematic visualisation of 
predicted regions. Blue arrows indicate regions testes against STM3071. 
Regions were amplified with primers as listed in table 2.3 and used in DNA-
binding study. Amplicons are presented in fig. 4.10. 
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To test potential binding activity four regions were chosen due to nearest 
proximity to the stm3071 were amplified using PCR. The specific primers used 
for amplification are listed in chapter 2, table 2.3. PCR products were analysed 
using agarose gel electrophoresis. Following amplification, PCR products were 
purified using Qiagen purification kit (Qiagen, UK) according to manufacturer’s 
instructions PCR purification method. DNA concentrations of amplicons were 
determined spectroscopically. Samples were stored at -20°C until further use in 
EMSA binding assay. 
Primers were designed for amplification of regions as indicated in fig. 4.9 B. 
PCR was performed and results are presented in fig. 4.10 A and B. Indicated 
amplified sequences were used in electrophoretic mobility shift assay (EMSA) 
studies (Campbell et al., 2007) to test for interaction with purified STM3071. 
Located upstream from stm3071 region was predicted with two possible 
consensus sequences. However, considering controversy as to whether 
stm3071 is part of the predicted operon, downstream regions were also 
amplified. It is possible that is STM3071 acts as a regulator then it could 
theoretically bind within stm3071 or stm3072 region. Thus, EMSA were carried 
out with ‘gap’, ‘3071’, ‘3072’, and ‘3071-3072’ probes. Probes indicated in fig. 
4.10 as ‘not used for analysis’ also represent regions within putative operon and 
can be applied in future analysis. Primers for these regions were design for 
controls in case of successful binding activity of STM3071. 
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Fig. 4.10. Agarose gel electrophoresis analysis of PCR products prepared 
for EMSA binding assay. Purified genomic DNA of SL1344 was used as PCR 
template. A.1. DNA size marker (Hyperladder 1); 2. Region amplified with 
epdF2 and 3071R2 (‘GAP’ probe - 1947bp;); 3.epdF2 and 3071R (not used for 
analysis); 4. 3071F & 3071R (‘3071’ probe - 426 bp). B. 1. DNA size marker 
(Hyperladder 1); 2. Region amplified with 3071F and 3073R (not used for 
analysis) 2489bp. 3. 3071F and 3072R (‘3071-3072’ probe - 1067bp). 4. 3072F 
and 3073R (not used – 1320 bp); 5.  3072F and 3073R (not used- 1321bp); 6. 
3072F and 3072R (‘3072’ probe - 580bp).  Samples analysed on 1% agarose 
gel. Probe names correspond to scheme in fig. 4.9 (b) 
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Mobility shift assay was used to test the ability of STM3071 to bind double-
stranded amplified regions. Probes named ‘gap’, ‘3071’, ‘3072’ and ‘3071-3072’ 
were tested against STM3071. All probes were adjusted to the same 
concentration at approximately 100 ng of target and competitor DNA. 
Competitor used for reactions was re-circularised with restriction enzyme digest 
vector pUC19 (2.6 kb). Binding reactions were set up with varying 
concentrations of purified STM3071. Retardiation of the DNA probe’s extent of 
migration indicated that the specific DNA-protein interaction occurred. No 
retardation was observed in any of tested conditions presented in figure 4.11 
over the page. 
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Fig. 4.11. STM3071 binding analysis. A, B, C represent pictures of gel 
retardation assay. A and B from left as labelled 0,2,5 or 10 µM of purified 
STM3071 was tested against probes ‘3072’, ‘3071-3072’, ‘gap’ and ‘3071’. 
Equal amounts of specific target DNAs as well as competitor DNA were added. 
Re-circularised pUC20 (2.6 kb) plasmid was used as unspecific DNA 
competitor. No retardation was observed with tested probes. C. Probes were 
prepared consequently as in A and B. Additionally cobalt was added at 
concentrations as indicated in the picture. Competitor DNA was not added. No 
retardation was observed.   
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 Summary 4.3
Taking into account that based on predictions the structural nature of STM3071 
as a potential DNA-protein are not exaclty known, it is difficult to predict and 
determine the conditions to test its biological activity. 
The average S. Typhimurium genome GC content is at about 52.2 % 
(Papanikolaou et al., 2009). In most organisms genes that were acquired by 
horizontal transfer are usually AT rich. GC content of the putative operon was 
determined and it does not appear to exhibit GC content lower that S. 
Typhimurium genome average (GC content of region from 5’ end of epd to 3’ 
end of stm3075 is 56%). Thus, it can be predicted that the analysed region was 
not acquired by horizontal gene transfer, which in any case is a parallel 
assumption with that discussed in chapter 3, the co-occurrence of analysed 
genes in other organisms and prevalence across Salmonella genus (chapter 3, 
fig. 3.7 and 3.8).  
Papanikolaou and colleagues, (2009) demonstrated that genes with a lower AT 
ratio are usually targeted by H-NS rather than conserved genes within genome. 
During the evolution process bacteria acquire genes through horizontal transfer. 
Those foreign sequences are usually energy cost effective thus they likely to 
decrease the fitness of the microbe. Histone-like proteins were found to act as 
silencers of horizontally acquired genes due to their ability to bind AT-rich 
regions and thus regulate their transcription. MvaT heterogeneous silencer was 
found to act upon AT-rich region. However, even though it possessed some 
functional similarities with PPC-like domain and H-NS proteins it was not found 
to share any structural similarities with AT-hook motif (Ding et al., 2015). This 
example shows that this group of regulators may vary in terms of structural 
features as well as functional properties.  It is also possible that the AT-hook 
motif was selectively chosen for eukaryotic chromatin in the process of 
evolution. Why it is present in some prokaryotic organisms however, remains 
unclear.  
STM3071 was found to contain a predicted metal-binding site and conservative 
domain found in other AT-hook motif domains, but not contain the AT-hook 
motif itself. It is predicted however that it exists as a homotrimer that 
coordinates 3 atoms of zinc together. Three conservative histidines do not 
resemble similarities with zinc-finger like proteins but based on predictions are 
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likely to act as metal binding protein or metal acquisition genes regulator. In 
chapter 3 it was discussed that it is not entirely obvious if stm3071 is a part of 
the operon with stm3072/3073/3074/3075 genes. It might be that it is not 
involved in their regulation. It is also possible that its expression is induced by 
another factor which might in turn regulate downstream genes.  
NCBI prediction suggests similarities with thioredoxin-like proteins. They 
represent uncharacterised cyanobacterial proteins and the conserved domain in 
their structure has a linkage to Plants and Prokaryotes Conserved (PPC) 
domain. This domain consists of hydrophobic C-terminal region and is found in 
proteins with the AT-hook motif – which explains the annotation (Lin et al., 
2007). Three conserved histidine residues possibly form a zinc-binding site and 
as presented in fig. 4.12 (B) it is likely to form homotrimers. Thus, it might be the 
case that STM3071 cooperated with another protein which has an AT-hook 
motif in its structure. 
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Fig. 4.12 (A) Schematic visualisation of AT-hook motif (in red), PPC domain 
(in yellow), and hydrophobic site (asterisk) of Pyrococcus hirikoshii PPC protein 
– based on crystallography performed by Lin et al., (2007).  (B) Sequence 
alignments of PPC-homologs found in in other organisms. Asterisks indicate 
highly conserved regions, colons and periods indicate for strong and weak 
conservancy, respectively. (Lin et al., 2007) 
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According to Aravind and Landsman, (1998) AT-hook motifs are common in 
eukaryotic organisms but not so much in bacteria. CarD protein of Myxococcus 
xantus was identified in 1994 by Nicolás and co-workers (Nicolás et al., 1994). 
The same group confirmed DNA-binding properties a couple of years later. It 
was demonstrated that CarD was binding AT-rich sequences. The protein was 
however identified as slightly different to corresponding eukaryotic motif; CarD 
was missing the first proline in the motif (Nicolas et al., 1996). The protein was 
annotated as transcriptional regulator (NCBI; fig. 4.13 below). The record was 
discontinued in the light of relatively recent results. CarD contains C-terminal 
DNA-binding domain with four repeats of RGRP, AT-hook that resembles high 
mobility group A (HMGA) (Nicolas et al., 1996). HMGA in eukaryotic organisms 
are described as DNA architectural factors that interact with other proteins and 
take part in various processes from transcription regulation, RNA processing 
and, DNA-repair to chromatin remodelling (Sgarra et al., 2010). It was 
described, however, that CarD mirrors HMGA in terms of its DNA-interaction 
properties but CarD itself was also found to mediate interactions with itself and 
with RNA polymerase (Garcia-Moreno et al., 2010). CarG that forms complex 
with CarD, which contains a zinc-binding site and is required for stabilisation of 
the whole complex with DNA. CarD/CarG complex (CarG always co-exists with 
CarD) has been reannotated recently and it is therefore possible that STM3071 
(possibly in similar way to CarG) coordinates with another protein that possibly 
anchors specific DNA-binding motif. Due to the three conserved His residues 
and the putative zinc-binding site it is possible that it takes part in regulation of 
the transcription and facilitates the DNA-binding process. 
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Fig. 4.13. NCBI search for CarD of Myxococcus xanthus gene ID. Record 
shows that gene annotation was discontinued in May 2015.  
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Additionally considering the predicted metal-binding site and possible regulation 
of metal acquisition process, the addition of metal in excess might be necessary 
to consider for further analysis. Reportedly, EDTA as a strong chelator has 
exhibited inference with the DNA-binding reaction (Huang et al., 2004). 
Interestingly, according to Arrach and co-workers it was noted that stm3071 
promoter was found to be preferentially activated when Salmonella was present 
within solid tumours. The hypoxic environment of the tumour aligns with the 
concept that cobalamin is only synthesised under anaerobic conditions. Cobalt 
is required for this process, thus following on from there, genes involved in 
cobalt acquisition should be switched on in the same environment (Bobik et al., 
1997; Jeter, 1990; Jeter et al., 1984). Thus, it is possible that low oxygen or an 
anaerobic environment might be a crucial determinant of the allosteric 
conformation of STM3071. 
Thus, in the next chapter conditions under which promoter of stm3071 is 
induced, were examined and discussed. 
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5 Chapter 5 – Characterisation of stm3071 
 Introduction 4.4
In chapter 4 it was discussed that in order to be able to investigate biological 
function of the STM3071, precise conditions that induce its expression need to 
be established.  
5.1.1 What induces stm3071 expression 
Interestingly, an intergenic region located upstream from stm3071 was identified 
as hypoxia-induced (Arrach et al., 2008). Thus, the main focus of this chapter is 
verification of conditions that upregulate Pstm3071. 
Salmonella are facultative anaerobic bacteria that naturally accumulate in a 
wide variety of solid tumours as opposed to normal tissue (Arrach et al., 2010; 
Wall et al., 2010; Zhao et al., 2007). Necrotic regions of the tumour are hypoxic 
and relatively acidic compared to normal tissue (Raghunand et al., 2003).  
Avirulent mutant strains, as mentioned earlier were described to prefer tumours 
over normal tissue in ratios as high as 9,000:1 (Arrach et al., 2008) and appear 
to contribute to tumour reduction in animal models (Zhao et al., 2006).  
Work carried by Arrach and co-workers (2008) shows the promoter of stm3071 
is preferentially activated within solid tumours. In the study, high-throughput 
methods were used to screen Salmonella promoters selectively expressed in 
solid tumours. Promoter activity was measured from bacteria grown in spleen 
tissue and tumours. Out of a range of promoters that were activated in the 
tumour tissue, 5 were selected and amongst those Pstm3071 was identified. 
Those 5 promoters were then analysed in vivo in a group of tumour-bearing 
mice. Results show that although Pstm3071 produced relatively low signal in 
tumour, it was undetectable in normal tissue (Arrach et al., 2008).  Accordingly, 
with full understanding of the function and role of STM3071 it can be 
investigated further whether attenuated Salmonella strains with tumour targeting 
abilities could serve as a novel and selective way of introducing anti-tumour 
therapeutics under control of selectively induced promoter.  
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5.1.2 What is the function of stm3071? 
The availability of complete bacterial genomic sequences has provided the 
world of molecular biology with enormous insight of genome organisation. 
Identification of ORFs, intergenic regions and the predictions of gene 
expression regulation, although still poorly understood, can only be possible 
through access to entire genome sequence. Applications of mutational analysis 
have become a major tool of identification of encoding genes and their function. 
Over the past decade, lambda-red mediated recombination also known as 
recombineering has found many applications and served as a rapid and 
relatively simple way of making gene disruption (Mosberg et al., 2010). 
As discussed in previous chapters it remains unclear whether stm3071 is a part 
of putative operon potentially encoding genes involved in cobalt transport. It 
also remains unclear whether it acts upon those genes as a transcriptional 
regulator which might also be involved in metal sensing. It is also not known 
whether STM3071 exists on its own and/or if it interacts with other protein that 
facilitates DNA-binding. It also remains unanswered under what conditions it is 
expressed. According to data collated by Arrach and co-workers, (2008), it 
might be that Pstm3071 is selectively activated under low oxygen conditions. It is 
also possible and considering its metal-binding site predictions it might be that 
its induction is metal-dependent. 
In order to address some of the above questions single-gene knock-out strain of 
Δstm3071 and Pstm3071::lacZ transcriptional fusion were constructed, and tested 
against a range of conditions. 
 Δstm3071 construction  5.2
Δstm3071::cat was constructed previously, directly in SL1344 strain according 
with published procedure (Datsenko & Wanner, 2000).  
To confirm the replacement of stm3071 with chloramphenicol resistant cassette, 
PCR was carried out – presented in fig. 5.1 below. Primers used for 
amplification of this region were designed with approximately 200 bp flanking 
sequence to allow complete deletion detection. Amplification was carried with 
Δstm3071::cat isolated genomic DNA as a DNA template – to confirm gene 
replacement; and with SL1344 genomic DNA used as template in control 
reactions. 
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Fig. 5.1 Agarose gel electrophoresis analysis of PCR products – 
replacement of stm3071 with cat cassette. Lane 1 DNA size marker 
(Hyperladder 1). Lane 2 PCR product with WT gDNA used as a template – 768 
bp; positive control. Lane 3 Confirmation of cat cassette replacement – 1500 bp 
(cat cassette size 1100 bp) chloramphenicol resistance gene was inserted in 
place of stm3071. Carried out with 1% agarose gel. 
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Fig. 5.2 Δstm3071 construction confirmation. Agarose gel electrophoresis 
with PCR products amplified with primers designed to amplify flanking region of 
stm3071; Lane 1 Hyperladder I (molecular size marker). Lane 2 g DNA isolated 
from WT SL1344 was used as a template in PCR. This was to confirm the 
correct size of the region in the WT – positive control (768 bp). Lane 3 gDNA of 
Δstm3071::cat LB5010a (1500 bp) was used to confirm stm3071 replacement to 
cat cassette. Lane 4 Δstm3071 – complete knock-out confirmation. gDNA of 
Δstm3071 LB5010a strain was used as a template in PCR with flanking 
stm3071 primers. Corresponding band size (363 bp) confirms complete 
stm3071 deletion. 
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To remove cat cassette Δstm3071::cat was transformed with pCP20 encoding 
temperature activated flippase (Datsenko & Wanner, 2000). Elimination of cat 
was confirmed first by growing strain on chloramphenicol and/or ampicillin. PCR 
carried with selected strain and primers STM3071F and STM3071R and 
confirmed stm3071 knock-out from bacterial chromosome (fig. 5.2). Mutation 
was first generated in LB5010a strain and then transduced with P22 to  WT 
stains SL1344 and LT2 strains. 
P22-derived transductants were obtained as described in chapter 2 and 
screened on green agar plates to obtain lysogen-free colonies and the deletion 
mutant was transduced back to into a clean wild-type strain. The complete 
absence of the structural gene was verified by PCR (fig. 5.3) with primers 
STM3071F and STM3071R listed in table 1, materials and methods (Smith & 
Levine, 1967). 
Following transduction and confirmation fresh overnight liquid culture of 
Δstm3071 strain was combined with sterile glycerol to final concentration of 
50%. Prepared culture was aliquoted in sterile cryovial tubes and placed at -
80°C.  
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Fig. 5.3 P22 derived transduction confirmation of Δstm3071 SL1344 strain. 
Agarose gel electrophoresis with PCR products; Lane 1 Hyperladder I 
(molecular size marker). Lane 2 gDNA of  WT SL1344 used as a template for 
positive control – stm3071 in place (768 bp). Lane 3 Δstm3071 – complete 
knock-out confirmation (363 bp). 
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 Generation of lacZ fusions 5.3
Genetic fusions have been widely used in molecular biology to study aspects of 
gene expression in prokaryotic organisms. Mainly, because they are simple to 
construct, and the activity of the fused reporter gene can be easily quantified by 
sensitive biochemical assays. In order to quantify the activity of investigated 
Pstm3071 the predicted promoter site was cloned into a promoter-less pRS415 
plasmid (Simons et al., 1987).  
Arrach and co-workers, (2008) have noted Pstm3071 to be induced at higher levels 
in tumour than in spleen. They have also listed a number of other predicte were 
suggested to be tumour-specific. Amongst those PcbiA was classified.  
In 1993, Roth and colleagues described PcbiA region as involved in 
transcriptional regulation of cob operon (B12 biosynthetic genes). Genes 
encoding biosynthetic pathway of cobalamin are known to respond to 
intracellular levels of adenosylcobalamin (Escalante-Semerena et al, 1990). In 
cob operon cbiA encodes for amidase which takes part in a rather late part of 
the biosynthetic pathway. It was previously described that B12 biosynthesis 
takes place under anaerobic conditions (Roth et al., 1993), thus PcbiA was used 
as a control in beta-galactosidase analysis which allowed quantifying of 
promoter activity.  
Amongst other promoters that were upregulated under anaerobic conditions, 
PadhE was described and in 2011 it was defined as tumour selective activated 
promoter (Chen et al., 2011). Amongst several screened proteins, AdhE was 
found to be up-regulated by over a hundred-fold. PadhE was thus selected as 
another lacZ expression control fusion. However, the aim of this fusion was to 
test the activity during infection assays in human carcinoma cells to determine 
tumour specificity and was not used in this study. 
In chapter 3, it was identified that predicted Pstm3071 site might involve two 
consensus sequences. The version of Pstm3071 used in Arrach study involved a 
333 bp upstream region from stm3071 location whilst the version predicted by 
this study analysis involved 404 bp upstream region. Thus, in order to avoid 
confusion Arrach version was named PArrach and it refers to shorter version of 
stm3071 predicted promoter region. 
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5.2.1 Molecular cloning of promoters into pRS415 promoter-less 
vector 
Genomic DNA of SL1344 S. Typhimurium strain was isolated (fig. 5.4 A) and 
confirmed by gel electrophoresis. Promoter regions of stm3071, stm3071 
(Arrach et al., 2008), and cbiA were amplified from SL1455 gDNA using 
primers: Pstm3071F & Pstm3071R, P_Arrach_stm3071F & 
P_Arrach_stm3071R and PcbiAF & PcbiAR, respectively (primers sequences 
are listed in table 1, chapter 2). Primers for amplification of promoter regions 
were designed with EcoRI and BamHI restriction sites overhangs.  
Subsequently PCR was conducted for each set of primers in 5 separate 
reactions. Annealing was carried at 50°C and extension step for 10 min. In 
order to confirm amplification reactions were tested for presence of a band of 
correct size using gel electrophoresis. Reactions carried with same set of 
primers were combined and purified using PCR purification reagents 
accordingly as described in chapter 2. Promoter-less vector pRS415 and 
purified PCR products were digested with EcoRI and BamHI restriction 
enzymes (fig. 5.4 B & C). 
Following restriction digest ligation reactions were set up accordingly as 
described in chapter 2. Colonies that grew overnight in medium with ampicillin 
were selected, and plasmid DNA was extracted. Plasmid DNA of clones that 
grew on ampicillin was used as template in PCR reactions (fig 5.5 A, B, and C). 
Selected successful fusions were then verified by restriction enzyme digest (fig. 
5.6).  
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Fig. 5.4. Molecular cloning (A) gDNA of SL144. Line 1 Hyperladder I (DNA 
size marker). Lane 2 Diluted 1:10 gDNA used as a template in PCR reactions. 
Line 3 gDNA. (B) Lane 1 Hyperladder I (DNA size marker). Lane 2 amplified 
Pstm3071 region (404 bp) and digested with EcoRI and BamHI. (C) Lane 1 
Hyperladder I (DNA size marker). Lane 2 pRS415 digested with EcoRI and 
BamHI restriction enzymes. Lane 3 amplified PadhE region, not used in this 
study. Lane 4 amplified PcbiA region (325 bp) and digested with EcoRI and 
BamHI. Lane 5 amplified PArrach region (333 bp) and digested with EcoRI and 
BamHI.  Gel electrophoresis performed with 1% agarose gel.  
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Fig. 5.5. Verification of selected clones - lacZ promoter fusions 
confirmation carried by PCR.  Lanes 1 in A, B and C indicate Hyperladder I 
(DNA size marker). (A) Pstm3071 clones (404 bp) – cloning successful in lanes 3. 
13, and 14. (B) PcbiA clones (325 bp) – successful in lanes 2, 4, 5, and 6. (C) 
PArrach clones (333 bp) – successful in lanes 2, 4, 6, 7 ,8 ,9; PcbiA clones (325 bp) 
– successful cloning in lanes 10 and 11. Gel electrophoresis performed with 1% 
agarose gel.  
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Fig. 5.6 Verification of selected clones - lacZ promoter fusions restriction 
enzyme digests confirmation.  Lanes 1 in A, B and C indicate Hyperladder I 
(DNA size marker).  (A) All plasmids were digested with EcoRI and EcoRV. 
Lane 2 pRS415 (9.5 + 1.3 kb). Lines 3-6 PArrach::lacZ (pArrach_stm3071) (9.5+1.6 
kb). Lines 7-9 PcbiA::lacZ (9.5+1.6 kb). (B) Lane 2 pRS415 digested with EcoRI 
and EcoRV (9.5 + 1.3 kb). Lane 3 Single digested pRS415 with BglII (10.8 kb). 
Line 4 and 5 EcoRI and EcoRV Pstm3071::lacZ (pTP) (9.5+1.6 kb). Lane 5 and 7 
BglII single digest, specific restriction site for pTP (1.5 kb). Gel electrophoresis 
performed with 1% agarose gel.  
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Fig 5.7 Alignment of selected constructs against to the original query 
sequence from S. Typhimurium. Analysis was conducted using Multalin 
software (http://multalin.toulouse.inra.fr/multalin/) (Corpet, 1988). All selected 
and sequenced constructs resembled 100% identity with queried regions.  
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Constructed pstm3071::lacZ (pTP), pArrach(stm3071::lacZ) (pArrach) and 
pcbiA::lacZ were sequenced to confirm identity of cloned regions. One of each 
selected constructs were selected, plasmid DNA was extracted and stored at -
20°C until further analysis. 
5.4 Phenotypic characterisation of Δstm3071 
In chapter 3 it was hypothesised that stm3071 is a part of predicted operon that 
potentially is involved in cobalt transport. It was also proposed that based on 
sequence identities it may function as a transcriptional regulator. It remains 
uncertain whether it plays role in the expression regulation of proximal genes or 
whether it is responsible for regulation of different distal cluster. It is also 
unclear whether its expression is metal dependent. Sequence similarities and 
recent research could also suggest that as proposed in chapters 3 and 4, 
STM3071 might not directly be involved in DNA-binding but it is possible that it 
coordinates with other protein, similarly to other regulators found in bacteria 
(Abellón-Ruiz et al., 2014). However, as discussed in chapter 3 in order to 
investigate the function of STM3071, it needs to be understood under what 
conditions stm3071 is upregulated.  
It was mentioned earlier in this chapter, that Arrach et al, (2008) noted Pstm3071 
as preferentially induced in solid tumours. This, however, needs confirmation as 
to whether promoter was hypoxia-induced or whether that was dependent on 
other factors only associated with tumour tissue. Hypoxia, is defined as a 
reduction or complete lack of oxygen in tissues or cells. This happens in the 
event of oxygen supply reduction or sudden increase of oxygen consumption, 
which is what is observed in highly proliferating cells such as in solid cancers 
(Swinson & O’Byrne, 2006). During hypoxia, hypoxia inducible factor alpha 
(HIF-α) is expressed and it is responsible for regulation of the expression of 
genes that are involved in vascularisation and higher oxygen demand 
(Semenza, 2000). Cobalt was described to induce hypoxia in cells by inducing 
HIF-α (Wu & Yotnda, 2011). This might suggest that hypoxia can be induced by 
cobalt, and then it is possible that hypoxia-induced genes might be also co-
regulated by cobalt. This also aligns with the predicted function of stm3071 as 
involved in regulation of the expression of genes potentially involved in cobalt 
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import. Taking it from there, I might be possible that both hypoxia (anoxic 
environment) and cobalt are involved in stm3071 upregulation. 
The anaerobicity aspect as mentioned previously in this thesis, is associated 
with S. Typhimurium ability to synthesise vitamin B12 (Jeter et al., 1984). Thus, 
if cobalt is mainly required for B12 biosynthesis then homeostasis regulation of 
this toxic metal is likely to take place under anaerobic conditions. Vitamin B12 
paradox however, is based on the fact that cobalamin is synthesised in the 
absence of oxygen, and bacteria require cobalamin for 1,2- propanediol 
utilisation. This can only occur when the final electron acceptor is provided, and 
usually oxygen plays that role, hence the paradox (Price-Carter et al., 2001). On 
the other hand, as described by Winter et al., (2010) Salmonella during invasion 
in the intestinal epithelium in order to outcompete the resto of the gut microbiota 
induces inflammation. During the inflammation, thiosulfur compounds are 
converted into tetrathionate, which can be used as a final electron acceptor 
(Winter et al., 2010). Thus, it suggests that bacterium itself evolved with the 
ability to modulate the host environment and therefore to out-compete other 
pathogens, other symbiotic bacteria and to establish infection.   
5.4.1 Exposure to cobalt 
In order to address whether the mutation affects the ability to grow in the 
presence of cobalt and to determine the concentration that limits growth of S. 
Typhimurium, growth experiments were conducted in the presence of 
increasing concentrations of cobalt. Experiments were carried both under 
aerobic and anaerobic conditions and in minimal media. Minimal media limited 
the access of potential metals chelators that are naturally existing in rich media. 
Minimal media were prepared in acid washed glassware to reduce the 
possibility of other metals contamination. Exposure to cobalt in minimal media 
shows the same trend for both SL1344 and Δstm3071. Mutated strain did not 
grow in any different manner than WT. In experiments carried in M9 media (fig. 
5.8), anaerobic growth was less supported in comparison to anaerobic growth in 
NCE glucose media (fig. 5.9). Interestingly under anaerobic conditions both 
strains exhibit greater tolerance to cobalt. However, this was more observable 
in M9 media. Viable count of cultures exposed to cobalt was performed for 
experiment carried in M9 media in order to compare observations from OD 
measurements.  
145 
 
 
Fig 5.8 Loss of stm3071 does not influence tolerance to cobalt (M9 
medium). Overnight cultures of SL1344 and Δstm3071 grown in M9 with 
glucose medium were diluted 1:50 into fresh M9 media with increasing 
concentrations of cobalt. Aerobic cultures were incubated at 37°C, 200 rpm for 
4-5 hours, until OD600 reached ~0.4-0.6. Anaerobic cultures, also incubated at 
37°C, 80 rpm were measured after 5-6 h until OD600 reached ~0.2-0.4. For 
anaerobic experiments, media were pre-equilibrated overnight in anaerobic 
cabinet. Data points represent the mean of 3 independent experiments 
performed in triplicate. Error bars represent standard error of the mean. 
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Fig 5.9. Loss of stm3071 does not influence tolerance to cobalt (NCE 
medium). Overnight cultures of SL1344 and Δstm3071 grown in NCE with 
glucose medium were diluted 1 in 50 into fresh NCE + glucose media with 
increasing concentrations of cobalt. Aerobic cultures were incubated at 37°C, 
200 rpm for 4-5 hours, until OD600 reached ~0.4-0.6. Anaerobic cultures, also 
incubated at 37°C, 80 rpm were measured after 5-6 h until OD600 reached 0.4-
0.6. For anaerobic experiment, media were pre-equilibrated overnight in an 
anaerobic cabinet. Data points represent the mean of 3 independent 
experiments performed in triplicate. Error bars represent standard error of the 
mean. 
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Fig 5.10 Loss of stm3071 does not influence tolerance to cobalt (M9 
media, viable count). Overnight cultures of SL1344 and Δstm3071 grown in 
M9 medium were diluted 1:50 into fresh M9 media with increasing 
concentrations of cobalt. Media were pre-equilibrated overnight in an anaerobic 
cabinet. Cultures were incubated for 7h, at 37°C, 80 rpm. Following exposure, 
cell count was determined using viable count as described in chapter 2. Data 
points represent the mean of 3 independent experiments performed in triplicate. 
Error bars represent standard error of the mean. 
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S. Typhimurium SL1344 and mutant strain Δstm3071 were exposed to titrated 
cobalt concentrations under aerobic and anaerobic conditions. Loss of stm3071 
does not influence the ability to tolerate higher concentrations of cobalt. It was 
noted, that under anaerobic conditions toxic effect of cobalt was subtler. There 
was an observed fold-change reduction of growth at concentration of 50 µM 
[Co2+], the same for both strains (fig 5.10). 
5.4.2 Anaerobic growth with 1,2 propanediol 
Scavenging cobalt is required for biosynthesis of vitamin B12 (Jeter et al., 
1984). Cobalamin is required for 1,2-propanediol utilisation (Adkins et al., 2006). 
During inflammation, S. Typhimurium modulates lumen environment and is able 
to accommodate tetrathionate as a final electron acceptor in the process of 
propanediol utilisation which at the same time give it an advantage over the rest 
of the microbiota present in the gut (Winter et al., 2010). 
Knowing that 1.2-pronanediol can only be utilised when cobalamin is provided; 
and taking onto account that a final electron acceptor must be present in order 
for propanediol to be metabolised, S. Typimurium SL1344 and Δstm3071 
aerobic growth was monitored in the presence or absence of cobalamin with 
1,2-propanediol as the only carbon source. This was carried out in NCE 
medium supplemented with 50 mM concentration 1,2-propanediol. Overnight 
cultures, grown in NCE glucose medium were prepared anaerobically to allow 
cobalamin synthesis.  
This was to test whether Δstm3071 ability to produce cobalamin was affected. 
Growth in medium supplemented with cyanocobalamin (150 nM CNB12) and 
propanediol was used as a positive control. Positive controls showed no 
difference between WT or Δstm3071 strain. There was also no observable 
difference in growth between two strains when CNB12 was not added. 
However, more growth was observed when medium was supplemented with 
CNB12 (fig. 5.11). 
The same experiment was also carried out under anaerobic conditions, 
however no growth was observed as the alternative electron acceptor was not 
provided (fig 5.12).  
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Fig. 5.11 Growth of SL1344 vs Δstm3071 with 1,2-propanediol with or 
without CN-B12 under aerobic conditions. Loss of stm3071 does not affect 
the ability to produce cobalamin. Overnight cultures, grown in NCE glucose 
medium were prepared anaerobically to allow cobalamin synthesis. Cultures 
were then incubated aerobically (final electron acceptor was not added) for 30h, 
at 37°C, 200 rpm. 1,2- propanediol was added as carbon source. Data points 
represent the mean of 3 independent experiments performed in triplicate. Error 
bars represent standard error of the mean. 
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Fig. 5.12 Growth of SL1344 vs Δstm3071 with 1,2-propanediol (ppd) with 
or without cyanobobalamin (CN-B12 ) under anaerobic conditions. 
Anaerobic growth with 1,2-propanediol as a carbon source is not 
supported when the electron acceptor is not provided. Overnight cultures, 
grown in NCE glycerol medium were prepared in aerobic conditions. Growth 
medium was pre-equilibrated to anaerobic conditions overnight. Cultures were 
inoculated with overnight culture 1:50 and incubated at 37°C, 80 rpm 
anaerobically. 1,2-propanediol was added as carbon source. Data points 
represent the mean of 3 independent experiments performed in triplicate. Error 
bars represent standard error of the mean. 
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It was observed (fig. 5.12) that in the anaerobic environment 1,2-propanediol 
cannot be utilised without the presence of an alternative electron acceptor, even 
when CNB12 was already provided. Thus, sodium tetrathionate was added to a 
final concentration of 40 mM to test whether loss of stm3071 affected S. 
Typhimurium ability to utilise propanediol. Exceptionally precise preparation of 
the media for this experiment was required. Media were pre-equilibrated under 
anaerobic conditions. Overnight cultures were set up in NCE glycerol to avoid 
any carryover growth from aerobic to anaerobic conditions (glycerol is not 
metabolised anaerobically). Each experiment was carried out with positive 
controls (NCE glucose) to test medium in case no growth with 1,2-propanediol 
occurred (fig. 5.13).  
Obtained results suggest that the mutant strain was unable to survive under 
anaerobic conditions using 1,2-propanediol. However, it was not clear if that 
was due to inability to produce cobalamin. 
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Fig 5.13 Growth curve of SL1344 & Δstm3071 under anaerobic conditions 
on 1,2-propanedion as a source of carbon. Loss of stm3071 affects growth 
on 1,2-propanediol under anaerobic conditions. Overnight cultures, grown in 
NCE glycerol medium were prepared in aerobic conditions. Growth medium 
was pre-equilibrated to anaerobic conditions overnight. Sodium tetrathionate 
was provided as an alternative final electron acceptor with medium 
supplemented with 1,2-propanediol. Strains cultured anaerobically with 50mM 
1,2-propanediol or 11mM glucose in NCE medium. Error bars represent 
standard error of the mean. Paired t-test was conducted to compare 1,2-
propanediol utilisation of SL1344 and Δstm3071, with p≤0.05 showing 
statistically significant difference in growth.  
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5.4.3 B12 assay 
To test the ability to produce cobalamin, a B12 assay was carried out. 
MacConkey base agar plates were prepared as described in chapter 2. Plates 
contained 1,2-propanediol and cobalt for test controls. For negative controls, 
media were prepared without cobalt. Medium was inoculated 1:50 from the 
aerobic overnight culture and incubated anaerobically overnight. Then, bacteria 
were cultured on MacConkey base agar plated and incubated at 37°C for 24h. If 
growth occurred and 1,2-propanediol was used as a carbon source pH indicator 
turned colonies pink.  
Number of positive and negative controls was designed to confirm the reliability 
of this assay. Personal communication with John Roth enabled to address 
number of solutions in terms of growth with propanediol. Additionally, Roth lab 
kindly provided reference strains previously described and characterised as 
cobalamin-defective. WT strains were used in this assay as negative controls - 
TR10000  (S. Typhimurium LT2, Roth lab) and SL1344. TT17104 and was used 
as positive control – pocR defective strain, cannot grow on propanediol and 
should not be able to synthesise B12. TT10327 also used as positive control – 
this strain cannot synthesise B12.  
Results show (fig. 5.14) that the loss of stm3071 does not affect the ability to 
produce B12. WT controls were also able to produce B12. Positive controls 
TT17104 & TT10327 were unable to produce vitamin B12 – as expected. 
TT17104 strain is pocR defective mutant of LT2 hence it was not expected to 
utilise 1,2-propanediol. TT10327 has a defective cbiD hence it cannot make 
B12 and so it is unable to utilise 1,2-propanediol (Bobik et al., 1992).   
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Fig 5.14 Loss of stm3071 does not affect the ability to synthesise vitamin 
B12. B12 assay carried out with bacterial cells cultured overnight anaerobically. 
Cells were then plated out and incubated with plates containing pH indicator 
and 1,2-propanediol as a carbon source. Pink indicates the ability to produce 
cobalamin and hence use propanediol. Bacteria that were unable to produce 
B12 indicate in yellow. Growth did not occur only with defined mutant strains 
that is deficient in B12 synthesis; Δstm3071 was able to produce B12. 
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5.4.4 β-galactosidase activity of Pstm3071 in response to cobalt 
Earlier in this chapter it was described that concentration of 50 µM of cobalt has 
a certain level of inhibitory effect on S. Typhimurium SL1344 and Δstm3071. 
There was no observed difference in cobalt tolerance between the two strains. 
Constructs containing promoter region of Pstm3071, Arrach et al., (2008) version 
of Pstm3071 and PcbiA were electroporated into LB5010a. LB5010a is a restriction 
minus, modification plus S. Typhimurium strain that allows more efficient 
manipulations. Selected ampicillin resistant transformants were cultured 
overnight at 37°C. Plasmid DNA was isolated, confirmed by restriction digest 
and electroporated into S. Typhiurium SL1344 and Δstm3071.  
This was to test conditions in which Pstm3071, is expressed. Additionally, as it is 
predicted that stm3071 might function as a transcriptional regulator of 
downstream genes, construct was introduced into Δstm3071 strain as well as 
SL1344. 
β-galactosidase assays were carried out with 0, 10 and 50 µM [Co2+] under 
anaerobic conditions in M9 medium. Constructed pcbiA::lacZ control was used 
as control - predicted the region as slightly upregulated in anaerobic 
environment.  
Elevated beta-galactosidase activity of pstm3071::lacZ (pTP), pArrach 
(stm3071::lacZ) (pArrach) was observed in in response to cobalt but only in the 
mutant strain. pcbiA::lacZ appears marginally switched on and not cobalt 
dependent. 
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Fig. 5.15 β-galactosidase activity measured in SL1455 and Δstm3071. All 
experiments were carried under the same conditions (anaerobic, 37°C until 
OD600 0.3 was reached) in triplicate on three different occasions.  Error bars 
represent standard error. Paired t-test was carried out to compare β-
galactosidase of pstm3071::lacZ SL1344 and pstm3071::lacZ Δstm3071, with 
p≤0.05 showing statistically significant difference in β-galactosidase activity – 
this indicated with an *.  
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 Summary 5.4
In this chapter the work was addressed from two separate angles. Firstly, in 
order to investigate the importance of stm3071 a deletion mutant was 
constructed. Secondly, Pstm3071 was tested against a range of conditions to 
determine the conditions that induce the expression of stm3071. 
Considering the close location to predicted metal transport genes and its 
predicted function as a transcriptional regulator, a constructed deletion strain 
was tested in the presence of cobalt. Due to the well described fact that 
Salmonella needs to scavenge cobalt for de novo biosynthesis of vitamin B12 
(Adkins et al., 2006) it was hypothesised that in the absence of an 
anaerobically-induced transcriptional regulator, anaerobic growth might be 
affected. It was observed that concentration of 50 µM [Co2+], has an inhibitory 
effect on bacterial growth. However, under anaerobic conditions bacteria does 
not seem to react to metal toxicity in as severe way as under aerobic 
environment. It is possible that since cobalt is required more anaerobically then 
bacteria has evolved with mechanisms that allow it to withstand higher 
concentrations of this toxic metal. 
Although there was no obvious phonotype observed in terms of cobalt tolerance 
it was hypothesised that if a hypothetical operon encodes for an importer, the 
ability to produce vitamin B12 might be abolished. As described earlier, vitamin 
B12 is necessary for utilisation of 1,2-propanediol. Hence, a mutant strain was 
tested for the ability to both produce vitamin B12 and 1,2-propanediol. 
Although we could observe that the loss of stm3071 affected the ability to grow 
in defined medium with 1,2-propanediol under anaerobic conditions. 
Conversely, in medium supplemented with glucose and cobalt, under anaerobic 
conditions mutant strain Δstm3071 was still able to produce vitamin B12. This 
however might be due to the compensational effect of a different gene, possibly 
cob operon. The observed difference might be due to the fact that in a defined 
minimal medium it is more likely to see distinctive changes. Expression 
experiments show that Pstm3071 promoter was cobalt responsive but only in 
Δstm3071. This was difficult to explain. However, it is possible that there are 
differences of intracellular metal levels between mutant and the wild type strain. 
Those differences might be subtle and might not have a direct effect on survival.  
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6 Chapter 6 – Discussion 
6.1 Occupying the niche 
Salmonella is a facultative anaerobic and pathogenic organism that in response 
to the environment, adapted and evolved in an excellent way that give it 
advantages over the competing microbiota (Raffatellu et al., 2009). It thrives in 
the inflamed gut and utilises substrates that cannot be utilised by other 
organisms (Bäumler & Sperandio, 2016). It was described earlier that that 
during the infection reactive oxygen species convert thiosulfate to tetrathionate 
which in turn serves as an alternative electron acceptor in 1,2-propanediol 
utilisation (Winter et al., 2010).  
The ability to utilise 1,2-propanediol takes place in an adenosylocobalamin-
dependent manner (Adkins et al., 2006). B12 synthesis only occurs under 
anaerobic environment and it requires cobalt (Jeter et al., 1984). Cobalt on the 
other hand is toxic when present in excess; however it is essential for B12 
synthesis. In order to overcome competing microbiota, Salmonella occupies 
niches that allow this smart pathogen to utilise resources that nobody else 
competes over (Winter et al., 2010). 
Constructed Δstm3071 did not behave differently to a wild type strain in a 
fluctuating metal environment. However, in precisely calibrated minimal media 
supplemented with 1,2-propanediol as the only carbon source, Δstm3071 was 
not able to grow conversely to the wild type strain. It remains unclear why it 
continued to synthesise cobalamin. The strain should not be able to grow on 
1,2-propanediol if vitamin B12 is not synthesised. It is hypothesised however, 
that the very subtle phenotype difference can only be observed in a defined 
environment, where other genes that play compensational role are upregulated. 
It is thus proposed that in order to see more distinctive phenotypical change, 
stm2021 and stm3073, encoding for ABC-type cobalt transporter should be 
eliminated and tested for the ability to produce cobalamin and utilise 1,2-
propanediol under anaerobic conditions (Fig. 6.2). 
 Metal transport 5.5
The mechanisms of which bacterial cells are trafficking metals are still not very 
well understood. Identified stm3071 was proposed to be responsible for 
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upregulation of proximal downstream cluster predicted to encode cobalt 
transport genes. Similar organisation of the identified genes was also noted in 
other organisms associated with gut colonisation. The sequence similarities of 
investigated operon suggest that they encode for the ECF cobalt transporter. 
The abundance of this system might suggest they are likely to be functional 
since the course of evolution did not eliminate them. Additionally, it was also 
hypothesised, that STM3071 might act as a transcriptional regulator in other 
more distant cluster. The question as to whether STM3071 functions as a DNA-
binding protein remained unanswered. The conducted EMSA experiment had 
limitations due to the possibility of improper secondary or tertiary structure of 
STM3071. It is possible that in order to achieve appropriate conformation that 
determined functionality it needed overexpression and purification under anoxic 
conditions.  NsrR, a nitric oxide oxygen-sensitive transcriptional repressor from 
Bacillus subtilis was shown to expose greater affinity towards consensus site 
when overexpressed under anaerobic conditions (Kommineni et al., 2010). It is 
also possible that the binding site of STM3071 is distant from the operon. It is 
also possible the protein is only functional in the presence of metal. Thus, 
metal-binding assay should be conducted to determine whether STM3071 has 
the affinity towards cobalt or/and possibly nickel (Rodionov et al., 2006). lt also 
needs clarification whether the system is metal specific. It was previously 
determined experimentally that the substrate specificity for the S component of 
the CbiMN ECF system is particularly precise. Metal specificity assay showed 
strong preference for Co2+ over Ni2+ (Rodionov et al., 2006). Other similar 
bacterial systems such as NikMN (Ni2+), BioY (biotin) (Hebbeln et al., 2007), 
RibU (riboflavin) (Duurkens et al., 2007) were described to have substrate 
specific S component. ECF system, as mentioned in chapter 3, class I of ECF 
transporters is encoded by operons that have two genes encoding for A unit, T 
unit and specific S component unit. This suggest strong specificity towards 
particular substrate (Rodionov et al., 2009). Interestingly, amongst class I of 
ECF components there were not found significant similarities (with maximum 
11-21% identity) between transporters from different subfamilies. The only 
exception that showed similarities were the homologous CbiM and NikM 
families. Thus CbiM and NikM transporters were subdivided into separate 
subfamilies of cobalt and nickel transporters (Rodionov et al., 2006). 
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Based on similarities identified in amino acid sequence of STM3071 it was 
hypothesised that STM3071 possibly has a similar mode of action to 
CarD/CarG (Garcia-Moreno et al., 2010) complex that interacts with another 
protein, which contains specific AT-gook binding motif. Due to the presence of 
three conservative His residues and putative zinc-binding site it is possible that 
STM3071 plays role in DNA-binding and it is involved in transcription regulation 
of the putative cobalt uptake system. Another possible limitation of the 
performed EMSA experiment was that regions used as probes could have 
overwhelmed the protein with their size and as a result, no shift was observed. 
Overall, for future EMSA experiments, there need to be established: 1) whether 
metal is required for proper folding of STM3071; 2) the protein should be 
overexpressed under anaerobic conditions; 3) probes should be redesigned and 
two predicted consensus sequences should be tested at first instance 
(Kommineni et al., 2010; Osman et al., 2015; Sydor et al., 2013). 
 Metal sequestering 5.6
Cellular proteins assist in metal transport. Those are specific however these 
proteins tend to select essential divalent cations with a ranked in order of 
preference defned by Irving-Williams series: Mg2+, Mn2+, Fe2+, Co2+, Ni2+, Cu2+, 
Zn2+ (IRVING & WILLIAMS, 1948). Thus, competitive metals must be kept out of 
binding sites for the weaker ions. It often occurs that in vivo metal preferences 
do not match the absolute metal preferences. As reported, InrS (nickel-
responsive efflux derepressor), CoaR (cobalt-responsive efflux activator), ZiaR 
and Zur (zinc-responsive efflux derepressor and influx activator, respectively) 
do not match the Irving rule (Foster et al., 2012; Rutherford, Cavet, & Robinson, 
1999; Thelwell, Robinson, & Turner-Cavet, 1998; Tottey et al., 2012). For 
instance, even though nickel correlated with higher activity, it was zinc that 
coupled DNA-binding to zinc binding. CoaR for was found to preferentially bind 
cobalt and activate coaT operator-promoter region of cobalt efflux system. 
There is evidence that CoaR is membrane-associated and cobalt acquisition 
may involve channelling through cobalamin biosynthetic complex, also 
membrane-associated. CoaR is likely not to be able to sense cobalt directly but 
intermediates in the cobalamin biosynthetic pathway. (Rutherford et al., 1999). 
This suggests that proteins have the specific affinity towards specific metals. 
STM3071 as a predicted ECF importer possibly requires to metallate cobalt or 
zinc to allow transcription derepression or repression. Concluding from the beta-
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galactosidase experiments, overexpression of Pstm3071 was cobalt responsive, 
thus it confirms to be cobalt specific. It requires clarification whether it would 
also be nickel or possibly zinc responsive. The promoter was cobalt responsive 
however only in the mutant strain. It is then possible that in the absence of 
STM3071 the transcription of the cobalt uptake system is constitutively 
derepressed resulting in continuous transcription of higher more effective influx 
of cobalt in the mutant strain. This remained unanswered, however conducting 
metal content assay of cells exposed to cobalt anaerobically could provide with 
the explanation.   
 Operon prediction 5.7
As summarised in chapter 3, it is likely that stm3071/3072/3073/3074/3075 
represent a putative operon. Genes arranged in a tandem, delimited by 
promoter-operator site located upstream from the beginning, are classified as 
promoters (Chen et al., 2004). Co-existance and similar organisation within 
other organisms suggests strong evidence in the operon prediction (Rogozin et 
al., 2004). Transcription orientation, genes encoding proteins of related function, 
conservancy amongst other Salmonella strains gives the additional indication 
that analysed tandem of genes is likely to be an operon. High conservancy 
amongst other species associated with the gut suggest that this type of putative 
importer of cobalt is specific for intracellular survival. It was also found to be 
flanked with conserved genes at most instances amongst other species, such 
as Citrobacter. Similar clusters can be found mostly in Salmonella strains, but 
also in other pathogens, such as Shigella or Klebsiella, which may serve as a 
direct suggestion that they are required for full virulence and intracellular 
survival. From the phylogenetic tree browser analysis it can be concluded that 
the conserved COG1661 (stm3071) was acquired by horizontal gene transfer. 
Predicted proteins share high conservancy especially analogues of stm3074 
and stm3075 suggesting how metal transport is essential for organisms 
associated with the gut. It is possible that predicted operon exists as a copy for 
cbiMNQO. However, it is also likely that those are functional under the 
completely different conditions. Additionally to the evidence provided in chapter 
3, RNAseq data was obtained from (Srikumar et al., 2015). This RNAseq data 
shows that conditions that switch the expression of both queries are similar.  
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Fig. 6.1 Visual representaito of the RNAseq data showing relative 
expression levels of stm3071/3072/3073/374/3075 and cbiMNQO. Both 
operons are expressed under the anaerobic shock conditions intracellularly 
(Srikumar et al., 2015). 
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Fig. 6.2 Schematic representation of current understanding and 
hypothesis of the role of STM3071 in S. Typhimurium. Currently based on 
the findings of this work it can be understood, that under conditions when cobalt 
is needed, STM3071 derepresses the transcription, ECF importer is expressed 
and cobalt is transported inside the cell. However, when Co2+ is present inside 
the cell, STM3071 represses the transcription. In the event where Δstm3071 is 
not present, it is possible that Pstm3071 is expressed constitutively and 
additionally responds to cobalt elevated levels, resulting in higher expression 
levels. It was found that Δstm3071 does not utilise 1,2-propanediol under 
anaerobic conditions. B12 assay however showed that the mutant strain was 
able to produce B12. Thus, it can be predicted that in a limited setting the 
phenotype might be subtle, as the complementary operon might not be 
expressed under defined conditions. 
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 Antitumor aspect  5.8
In work presented by Arrach et al, (2008), promoter region of stm3071 was 
noted to be preferentially activated within solid tumours. Salmonella as a 
facultative anaerobic bacterium has a natural ability to accumulate in niches of 
solid tumors (Arrach et al., 2010; Wall et al., 2010; Zhao et al., 2007). Necrotic 
regions of tumours are hypoxic. Hypoxia, which means low oxygen or 
anaerobicity which is similar to conditions required for activation of cob and pdu 
operons. Tumour environment was found to act upon Pstm3071 expression. In this 
study Pstm3071::lacZ fusion was constructed to determine what conditions induce its 
expression.  
Constructed expression fusion of Pstm3071 promoter was shown to be cobalt 
responsive; however it was only observed when the expression was induced in 
Δstm3071. It remains unanswered as to whether this activity is cobalt specific. It 
is possible that STM3071 regulates genes involved in cobalt transport, and this 
possible accumulation of the metal inside the cell resulted with elevated 
expression levels.    
Accordingly, with full understanding of the function and role of STM3071 it can 
be investigated further whether attenuated Salmonella strains with tumour 
targeting abilities could serve as a novel and selective way of introducing anti-
tumour therapeutics under control of selectively induced promoter. Therefore, 
attenuated Salmonella strains with tumour-targeting abilities could serve as a 
novel delivery system of anticancer therapeutics under control of promoters 
selectively induced in tumours (Arrach et al., 2009). This strategy can provide a 
therapeutic tool of reduced highly toxic for normal tissue side effects and 
become selective approach for metastatic cancer.  
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